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MECHANICALLY ADJUSTABLE AND DEGRADABLE SCAFFOLDS FOR 
THE TREATMENT OF ARTICULAR CARTILAGE DEFECTS 
Kuan Yong Ching 
Articular cartilage (AC) has long been known as the tissue that “once destroyed, is 
not repaired”. Damage to the AC may impair joint function, leading to osteoarthritis, 
joint  destruction,  and  ultimately,  joint  replacement.  Although  current  surgical 
procedures to repair AC defects may decrease the pain and restore the joint function 
in the short term, they are unable to restore the long term mechanical stability and 
durability  of  authentic  AC.  Tissue  engineering  holds  great  promises  to  repair 
cartilage  defects.  As  yet,  there  are  still  significant  challenges  that  need  to  be 
overcome for the design and fabrication of structural supports to direct the repair of 
AC.  So  far,  no  synthesized  tissue-engineered  cartilage  can  mimic  the  long-term 
mechanical stability and durability of the authentic AC. Based on tissue engineering, 
structural supports were developed by electrospinning biodegradable polymers into 
scaffolds that exhibit a mechanical environment similar to the native AC. Two types 
of  scaffolds  were  developed:  poly(3-hydroxybutyrate)/poly(3-hydroxyoctanoate) 
[P(3HB)/P(3HO)],  and  chitosan/poly(ethylene  oxide)  (PEO)  crosslinked  with 
genipin. For the P(3HB)/P(3HO) scaffolds, the fibril size decreased and the stiffness 
increased with increasing composition of P(3HO). Using P(3HB)/P(3HO) at a ratio 
of 1:0.25, a fibril size that was sixfold larger than the collagen fibrils, and a stiffness 
of  868  ±  540  kPa,  which  was  comparable  to  the  stiffness  of  human  AC,  was 
obtained.  In addition, the degradation of this scaffold was accompanied with the 
formation of new cartilage. For the chitosan/PEO scaffolds, the fibril size decreased 
and the stiffness increased with higher genipin concentration. The overall fibril size 
was approximately twofold larger than the collagen fibrils. Unfortunately, the mesh 
size was too small to allow cell migration into the scaffolds, which resulted in low 
formation of neo-cartilage. Taken together, the electrospinning of P(3HB)/P(3HO) at 
a ratio of 1:0.25 demonstrated promising results to serve as supporting scaffolds 
towards  an  effective  treatment  for  AC  defects,  thus,  minimising  the  risk  of 
developing  secondary  osteoarthritis.  The  blends  of  P(3HB)/P(3HO)  can  be 
developed  into  a  toolbox  with  diverse  structures,  mechanical  and  degradation 
properties  to  meet  the  requirements  of  structural  supports  for  various  tissue 
engineering applications, such as for bone repair and cardiovascular stents.     
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IT-AFM  - Indentation-type atomic force microscopy 
ITS-G   - Insulin-Transferrin-Selenium-G 
mcl-PHAs  - Medium-chain-length polyhydroxyalkanoates 
MEM α  - Minimum essential medium α medium 
NH2    - Amino functional group 
OH    - Hydroxyl functional group 
P(3HB)  - Poly(3-hydroxybutyrate) 
P(3HHx)  - Poly(3-hydroxyhexanoate) xx 
 
P(3HO)  - Poly(3-hydroxyoctanoate) 
P(3HV)  - Poly(3-hydroxyvalerate) 
P(4HB)  - Poly(4-hydroxybutyrate) 
PBS    - Phosphate buffered solution 
PEG    - Poly(ethylene glycol) 
PEO    - Poly(ethylene oxide) 
PGA    - Poly(glycolic acid) 
PHAs    - Polyhydroxyalkanoates 
PLA    - Poly(lactic acid) 
PLGA   - Poly(lactic-co-glycolic acid) 
PVA    - Poly(vinyl alcohol) 
RMS    - Root mean square 
scl-PHAs  - Short-chain-length polyhydroxyalkanoates 
SEM    - Scanning electron microscopy 
TGF-β3  - Transforming growth factor-β3 
TKR    - Total knee replacement 
a    - Radius of contact angle 
A    - Projected contact area 
E    - Elastic modulus 
|E*|    - Dynamic elastic modulus 
h    - Total depth 
hc    - Contact depth 
hf    - Final depth 
hs    - Displacement of the surface at the perimeter of the contact 
hmax    - Maximum indentation depth 
kc    - Cantilever spring constant 
m    - Power law fitting constant 
Mn    - Number-average molecular weight 
Mw    - Weight-average molecular weight 
P    - Load 
Pmax    - Maximum applied load 
r    - Radius  
S    - Contact stiffness 
t    - Time xxi 
 
ν    - Poisson’s ratio 
z    - Vertical displacement 
β    - Power law fitting constant 
θ    - Water contact angle, half-opening angle of the tip 
φ    - Phase angle 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
I dedicate this thesis to my beloved parents 1 
 
CHAPTER 1 
 
INTRODUCTION 
 
 
1.1  Synovial joints 
 
Joints are the sites where two bones come together. The two general categories of 
joints are (i) synovial joints, which allow free movements, and (ii) solid joints, which 
allow  limited  movements,  or  are  immovable.  Synovial  joints  are  predominantly 
found in the limbs. The main characteristics of synovial joints are (i)  a layer of 
articular cartilage (AC) that covers the articulating surfaces of the skeletal elements, 
and (ii) the presence of a joint capsule consisting of an inner synovial membrane and 
an outer fibrous membrane. Figure 1.1 shows a synovial joint with bones, AC and 
joint cavity. 
 
 
Figure 1.1: The structure of a synovial joint. The two opposing bones in a synovial 
joint are separated by a narrow joint cavity. The AC is the smooth and glistening thin 
layer of tissue that provides minimal wear between the two opposing bones. The 
joint cavity contains synovial fluid that is produced by the synovial membrane. The 
synovial  membrane  is  surrounded  by  the  fibrous  membrane,  forming  articular 
capsule that encloses the joint cavity. Several ligaments provide stability to the joint 
(Marieb and Hoehn, 2013).  2 
 
This thesis mainly focuses on the knee and hip joints, because they are the most 
important joints for our mobility. The knee joint is the largest synovial joint in the 
body and holds almost the entire body weight. The hip joint is mainly responsible for 
supporting  the  body  and  for  maintaining  balance  in  standing,  in  positioning,  in 
walking and also in running. Both joints are mainly subjected to high compressive 
and torsional forces and, therefore, are susceptible to injuries. Injuries often lead to 
osteoarthritis and, ultimately, joint replacement, which is a burden for the individual 
and costly for the society. 
 
 
1.2  Articular cartilage 
 
Articular cartilage is a type of hyaline cartilage with a shiny bluish-white appearance. 
It is a highly specialised tissue that has developed over millions of years to withstand 
the repetitive loading in our daily activities and to minimise stresses between the 
bones during joint movement. In conjunction with its lubricant, the synovial fluid, 
AC allows for an almost frictionless gliding of the joints. The thickness of AC varies 
from joint to joint and also with the location on a joint surface. Its thickness in the 
knee and hip joints is between 1.5 and 3.5 mm. Articular cartilage located on the 
lateral facet of the patella can be up to 5 mm in thickness (Bader and Lee, 2000). 
 
Articular cartilage consists of approximately 65-80% water, 10-20% collagen and 4-
7% proteoglycan by wet weight (Mankin et al., 2000). Chondrocytes are the only 
single type of cell in the AC. The chondrocytes account for 1-10% of the tissue 
volume, which is lower than in most other tissues. Depending on the zones, the size 
of chondrocytes varies between 7 to 30 µm in diameter. Chondrocytes are contained 
within spaces called lacunae and are responsible for the production and maintenance 
of the extracellular matrix in AC. Since AC in the skeletally mature person lacks 
blood vessels, nerves and a lymphatic system, nutrients from the synovial fluid and 
waste  products  from  the  tissues  are  transported  across  the  cartilage  surface  by 
diffusion (Campbell, 1969, Bader and Lee, 2000). 
   
The structure and composition of AC varies throughout its depth. Under the light 
microscope and as depicted in Figure 1.2, four zones can be identified in normal 3 
 
adult AC, namely, the superficial zone, the middle zone, the deep zone, and the zone 
of calcified cartilage.  
 
 
Figure  1.2:  The  distribution  of  four  distinct  zones  in  an  AC,  with  each  zone 
exhibiting a different structural organisation (Mow et al., 2005).  
 
The superficial zone is the uppermost zone that makes up approximately 10-20% of 
the AC thickness. The thin collagen fibrils are arranged parallel to the surface in a 
meshwork  of  pseudo-random  oriented  collagen  fibrils.  The  chondrocytes  in  the 
superficial zone exhibit a flattened elliptical shape. The proteoglycan content is the 
lowest  compared  to  the  other  zones  while  the  water  and  collagen  content  is  the 
highest.  The  chondrocytes  in  this  zone  preferentially  express  proteins  that  have 
lubricating and protective functions, such as lubricin, providing a smooth gliding 
surface with low shear resistance.  
 
The middle zone encompasses 40-60% of the overall thickness. The collagen fibrils 
in this zone are larger in diameter and packed loosely, with a random orientation. 
The chondrocytes exhibit a rounded shape. The middle zone mainly provides short- 
and long-term resistance to compressive loading forces. The short-term support is an 
intrinsic  property  of  the  solid  matrix,  whereas  the  long-term  poroviscoelastic 
properties largely depend on the fluid flow. 
 
The deep zone makes up about 30% of the AC. The collagen fibrils in this zone form 
large  fibre  bundles  that  are  organized  perpendicular  to  the  joint  surface.  The 
chondrocytes are relatively large with small nuclei, exhibiting a spherical shape and 4 
 
are  organised  in  groups  of  four  to  eight  cells  that  are  arranged  in  columns 
perpendicular to the articular surface. The proteoglycan content in this zone is the 
highest while the collagen and water content is the lowest. The deep zone has the 
highest resistance to compression, and is separated from the calcified zone by the 
tidemark,  which  appears  as  a  bluish  line  when  stained  histologically  with 
haematoxylin and eosin (Mankin et al., 2000).  
 
The zone of calcified cartilage is located beneath the tidemark and represents the 
deepest layer that separates the AC from the subchondral bone. Bundles of collagen 
fibres cross the tidemark and reach into the calcified cartilage to provide a strong 
anchoring  with  the  subchondral  bone.  The  chondrocytes  in  the  zone  of  calcified 
cartilage appear as small, roundish cells with large nuclei.  
 
Alternatively, the extracellular matrix of AC can also be structured based on the 
proximity  to  the  chondrocytes.  The  extracellular  matrix  surrounding  each 
chondrocyte can be divided into three regions, namely, pericellular, territorial and 
interterritorial  regions.  The  pericellular  region  is  a  thin  layer  surrounding  the 
chondrocytes,  which  primarily  contains  proteoglycans  and  other  non-collagenous 
matrix  components,  but  almost  without  collagen  fibrils.  The  pericellular  region 
initiates signal transduction from load bearing to the chondrocytes. The territorial 
region surrounds the pericellular region and is characterised by a large amount of 
thin  collagen  fibrils  that  bind  to  the  pericellular  matrix  and  form  a  basket  like 
structure  to  protect  the  chondrocytes  from  damage  during  loading.  The 
interterritorial region, encompassing entire matrix between the territorial matrices of 
the individual cells or clusters of cells, comprises the majority of the tissue volume 
(~96%). It contains large collagen fibrils and the majority of the proteoglycans. The 
interterritorial region largely determines the material properties of the AC.  
 
Proteoglycan complex molecules of high molecular weight are formed by a core 
protein to which one or more glycosaminoglycan (GAG) side chains are covalently 
linked.  Eighty  to  ninety  percent  of  all  proteoglycans  in  AC  are  aggrecan,  which 
exhibit a ‘bottle brush’ structure. As shown in Figure 1.3A, the aggrecan exists as 
huge multimolecular aggregates that formed by up to 100 aggrecan molecules that 
are non-covalently attached to a linear filament of hyaluronan, of which the bonding 5 
 
is further stabilised by  a link protein. The formation of these large proteoglycan 
aggregates stabilises the aggrecan molecules within the cartilage matrix. Figure 1.3B 
shows a closer look into the structure of the aggrecan molecule, which comprises 
GAG side chains, such as chondroitin sulfate (Fig. 1.4A) and keratan sulfate (Fig. 
1.4B), covalently bound to a long, extended protein core. Each aggrecan molecule 
consists of up to 100 chondroitin sulphate and 50 keratin sulphate chains, which 
carry highly negatively charged carbonyl (COO
-) and sulphate (SO3
-) groups.  
 
 
Figure  1.3:  Schematic  representation  of  (A)  the  aggrecan  molecules  as  a 
multimolecular aggregate and (B) aggrecan molecule. (A) The aggrecan molecules 
bind to a hyaluronan, forming proteoglycan aggregate with a typical ‘bottle brush’ 
structure. (B) Aggrecan molecule consists of a protein core covalently bound with 
the negatively charged GAGs. The binding of aggrecan molecule to hyaluronan is 
stabilised by a link protein (Mankin et al., 2000). 
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Figure 1.4: Structure of the primary GAGs in proteoglycans: (A) chondroitin sulfate, 
(B) keratan sulfate (Wight et al., 1991). 
 
In physiological solution, the negative charges on the GAG chains of aggrecan are 
balanced by an influx of cations (e.g. sodium, Na
+ and calcium, Ca
2+). This creates a 
large difference in the ion concentration between the cartilage and its surrounding 
environment, and gives rise to the Donnan osmotic pressure. Due to this osmotic 
imbalance, water is drawn into the cartilage, causing the aggrecan-rich matrix to 
swell.  This  water-swollen  matrix  is  critical  for  the  ability  of  AC  to  resist 
compressive loads and to recover upon mechanical deformation (Grodzinsky, 1983, 
Buschmann et al., 1992, Buschmann et al., 1995).  
 
AC consists of mainly type II collagen fibrils (90-95%), whereas type XI collagen 
can be found in the core of the fibrils and type IX collagen on the surface of the 
fibrils (Mow et al., 2005). Type II collagen fibrils in cartilage are thinner compared 
to type I collagen fibrils in tendons or bone. The thickness of collagen fibrils in AC 
varies between 10 and 300 nm, and may vary with age and disease (Mankin et al., 
2000, Mow et al., 2005). Type XI collagen is responsible for the formation of type II 
collagen fibrils. Both collagen types XI and IX are covalently linked to the type II 
collagen.  In  addition,  there  are  intra-  and  intermolecular  covalent  crosslinking 
among the type II collagen. These extensively crosslinked networks stabilize the AC 7 
 
and  restrain  the  swelling  pressure  exceeded  by  the  embedded  negatively-charged 
proteoglycans.  
 
 
1.3  Biomechanical properties of articular cartilage 
 
The AC serves as the load bearing tissue and as a shock absorber to protect the bones 
from high impact loads. In normal function, forces subjected on the AC regularly 
attain several times body weight, e.g., approximately 3500 N during the heel-strike 
(Felson,  1996,  Bader  and  Lee,  2000).  During  vigorous  sporting  activities,  joint 
forces can even exceed 10,000 N. Contact stresses of ~5 MPa are commonly applied 
on the major load bearing joints during normal walking (Bader and Lee, 2000). The 
AC is able to sustain such high loading forces due to its biphasic characteristics: a 
solid phase comprises collagen, proteoglycans, minor amounts of other proteins and 
chondrocytes, and a fluid phase comprises water and electrolytes (Mow et al., 2005). 
An  illustration  of  the  organisation  of  solid  phase  and  fluid  phase  in  the  AC  is 
depicted in Figure 1.5. 
 
 
Figure 1.5: Schematic representation of the solid matrix of AC showing how the 
collagen fibril meshwork reinforces the aggrecan. The interstitial fluid is partially 
bound to the aggrecan and partially free flowing (Mow et al., 2005). 
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The solid matrix is porous and permeable, which is composed of the strong collagen 
fibril meshwork that reinforces the soft, gel-like proteoglycan aggregates. A large 
proportion of interstitial fluid within the AC is freely exchangeable with the synovial 
fluid in the joint space to support the lubrication of the tissue, whereas the remainder 
either forms hydrogen bonding with the collagen fibril, or binds to the proteoglycan 
anionic sites (Jaffe et al., 1974). When a compressive load is applied to the AC, fluid 
pressure is generated within the solid matrix to support the applied load. An instant 
response of the tissue to deformation occurs due to the intrinsic elastic properties of 
the solid matrix. This deformation increases the hydrostatic pressure in the cartilage 
matrix  and  then  causes  an  extrusion  of  fluid  from  the  cartilage  matrix  into  the 
surrounding synovial fluid. When the load is removed, proteoglycan draws the fluid 
back  into  cartilage  by  osmosis  until  the  tensile  stresses  in  the  resisting  collagen 
fibrils balance the swelling pressure. A part of the viscoelasticity of AC is attributed 
to the solid matrix. However, most of the viscoelastic behaviour of AC is the result 
of  fluid  flow  through  the  porous  structure.  Fluid  pressurization  and  energy 
dissipation  generated  through  these  fluid-solid  interactions  provide  an  efficient 
method to shield high peak stresses in normal joint loading that otherwise would 
damage the underlying bone (Bader and Kempson, 1994, Shepherd and Seedhom, 
1997).   
 
 
1.4  Articular cartilage defects 
 
Each year there are approximately 1.2 million cartilage repair surgeries performed 
worldwide (Leichman, 2013), with an estimate of 10,000 surgeries in the United 
Kingdom (NICE, 2008). A high load that is suddenly applied onto the joint can 
rupture  the  matrix  macromolecular  framework  or  damage  the  cells.  Articular 
cartilage is frequently injured by high peak stresses during impact loading, (e.g., 
traffic accidents, falling down the stairs or from a ladder), or by torsional loading 
(e.g., twisting of the knee in skiing). One consequence of cartilage injuries is that the 
joints lose their ability to dampen and distribute the loads. Over time, the patients 
experience pain, swelling and mechanical symptoms such as locking and catching of 
the joint.  
 9 
 
There  are  two  types  of  cartilage  defects:  chondral  and  osteochondral.  Chondral 
defects do not penetrate into the underlying bone and are also often called partial 
thickness defects. Osteochondral or full thickness defects extend through the full 
thickness cartilage layer and penetrate into the subchondral bone. Figure 1.6 shows 
an osteochondral defect.  
 
 
Figure 1.6: The photograph shows an osteochondral defect in the knee joint. Scale 
bar: 4 cm (The Center for Orthopaedics & Sports Medicine, 2003). 
 
Although chondral defects can stimulate the chondrocytes to synthesise extracellular 
matrix, this process is very slow because of the avascular nature of AC, and the 
resulting new tissue is of minor quality and insufficient for a long-term AC repair 
(Laurencin et al., 1999). Osteochondral defects may trigger spontaneous repair that 
is associated by bleeding and hematoma formation. However, the blood clots usually 
only adhere well to the surface of the bony tissue, but not to the defect floor and 
cartilage walls, leading to an inefficient filling of the defect site (Hunziker, 2002). 
Moreover,  the  fibrocartilage  formed  at  the  defect  site  largely  consists  of  the 
disorganised  type  I  collagen,  which lacks  the  strength  and  properties  of  AC  and 
makes the newly formed tissue vulnerable to weight-bearing.  
 
Due  to  the  limited  self-healing  capacity  of  AC,  the  degradation  of  extracellular 
matrix leads to further degeneration of other structures and of the joint (Buckwalter 
et al., 2005). Consequently, patients with AC injuries are at high risk of developing 
secondary osteoarthritis, typically within ten years (Roos et al., 1995, Gillogly et al., 
1998). Indeed, it has been documented that the lifetime risk of knee osteoarthritis 10 
 
among persons with a history of prior knee injury is 57% (Murphy et al., 2008). 
Approximately  12%  of  osteoarthritis  is  attributed  to  secondary  osteoarthritis, 
resulting  in  a  financial  burden  of  over  $3  billion  annually  in  the  United  States 
(Szczodry et al., 2009). Further progression of osteoarthritis to disabling stages may 
lead to total joint replacements and even higher costs. Kurtz et al. (2007) predicted 
the demand for total knee replacement (TKR) in the United States to grow by 673% 
to 3.48 million procedures between 2005 and 2030. However, the need for TKR 
could be avoided or postponed with a robust cartilage repair procedure. Therefore, 
the  present  work  aims  to  add  to  the  current  body  of  research  on  AC  repair  by 
developing novel scaffolds to restore the function of AC and minimise the risk of 
developing  secondary  osteoarthritis,  and  subsequent  total  joint  replacement 
(Buckwalter and Brown, 2004).  
 
 
1.5  Surgical techniques for the treatment of articular cartilage defects 
 
Over the past decades, multiple surgical techniques have been developed to treat AC 
defects,  including  marrow  stimulation  techniques,  mosaicplasty  and  autologous 
chondrocytes transplantation (ACT). Among the three fundamentally different types 
of  surgical  techniques,  marrow  stimulation  techniques  are  the  least  invasive 
techniques,  because  they  require  only  one  surgery  that  typically  can  be  done 
arthroscopically. They are suitable for patients with lesions of smaller than 2 cm
2. 
For patients who are suffering larger lesions, restorative surgical procedures such as 
mosaicplasty and ACT are the methods of choice. Mosaicplasty requires only one 
surgery,  whereas  ACT  requires  two  surgeries.  Unfortunately,  all  current  surgical 
techniques for cartilage repair do not provide satisfying clinical results (Peterson et 
al., 2002). 
 
 
1.5.1  Marrow stimulation techniques 
 
Marrow  stimulation  techniques  are  considered  as  the  first-line  treatment  for  AC 
injuries. Established marrow stimulation techniques include Pridie drilling, abrasion 
arthroplasty and microfracture technique. These techniques induce bleeding of the 11 
 
underlying bone to release bone marrow stem cells from the bone into the defect site. 
This leads to blood clot formation that fills the space in the cartilage defect. The 
stems cells in the blood clot then initiate the cartilage repair process (Bert, 1997).  
 
Pridie drilling was introduced by Pridie in 1959 (Pridie, 1959). This technique uses 
a high-speed drill or wire to drill through the defect into the underlying bone to cause 
bleeding (Pridie, 1959). Drilling is effective in removing bone to access the marrow 
stroma from where the stem cell rich blood fills the cartilage defect. Unfortunately, 
Pridie drilling produces fibrocartilage, which contains abundant of type I collagen 
and lack of type II collagen. A disadvantage of the utilisation of a high-speed drill is 
that it causes heating and thermal necrosis to the underlying bone (Beiser and Kanat, 
1990).  
 
Abrasion arthroplasty uses a rotating burr to remove both the dead osteons and a 
superficial layer of subchondral bone to expose the interosseous vessels (Johnson, 
1986). The fibrous repair tissue was reported to maintain its integrity for up to 6 
years (Johnson, 1986). However, a 5-year follow up reported that 25% of the treated 
patients needed to undergo total joint replacement surgeries due to unsatisfactory 
results from the procedure (Bert and Maschka, 1989). Abrasion arthroplasty also 
often resulted in significant pain for the patients during and post-surgery (Singh et al., 
1991).  Due  to  the  high  failure  rate  of  the  repair  tissue,  and  the  prolonged 
rehabilitation  phase,  abrasion  arthroplasty  is  not  utilised  as  a  primary  treatment 
(Goldman et al., 1997, Fluhme and Cohen, 2002).   
 
In  the  1990’s,  the  microfracture  technique  largely  replaced  Pridie  drilling  and 
abrasion  arthroplasty  mainly  because  it  is  less  damaging.  The  arthroscopic  awl 
produces  less  significant  thermal  necrosis  of  the  bone  compared  to  a  drill  or  a 
rotating burr. As shown in Figure 1.7, the microfracture technique utilises a tiny awl 
to perforate the bone and to induce bleeding from the underlying bone into the defect 
site (Steadman et al., 1997).  
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Figure  1.7:  Schematic  representation  of  the  microfracture  technique:  (A)  the 
damaged cartilage is removed, (B) an awl is used to make holes in the subchondral 
bone, (C) bleeding of the bones is induced which provides the defect site with bone 
marrow cells (Mithoefer et al., 2006). 
 
The microfracture technique is most commonly applied in patients with near full 
thickness  or  full  thickness  cartilage  defects  that  measure  up  to  2  cm
2.  The 
microfracture technique shows good results for smaller defects, 
 but causes early 
secondary osteoarthritis when applied for larger defects (Anders et al., 2009). Also in 
the  microfracture  technique  often  the  structurally  inferior  and  non-durable 
fibrocartilage is formed (Johnson, 1986, Ochi et al., 2001, Mithoefer et al., 2009, 
Sharma et al., 2013). The fibrocartilaginous repair tissue causes further damage to 
the  joints  that  results  in  limitations  of  the  patients’  mobility  and  increases  the 
likelihood of reinjury. Indeed, the failure rate as the consequence of fibrous tissue 
generation attributes to about 50% failure rate of the surgical procedure (Mithoefer 
et  al.,  2009,  Sharma  et  al.,  2013).  The  insufficient  tissue  filling  of  the  defect  is 
another problem. A 24-month study using magnetic resonance imaging reported that 
only 54% of the patients displayed over 67% tissue filling, and 92% of patients had 
gaps between the repair and native tissue (Mithoefer  et al., 2005). Another 6-18 
months post-surgery study  reported that about  47% of patients had defect filling 
between 67% and 100%, and 53% of them had large fissures (Brown et al., 2004). 
Moreover, the de-differentiation of chondrocytes and bone marrow stem cells into 
fibroblast or osteogenic lineage causes bone invasion into the cartilage repair tissue 
and, ultimately, resulted in treatment failure (Brown et al., 2004).   
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1.5.2  Mosaicplasty  
 
Mosaicplasty was introduced during the nineties. It was regarded as the only surgical 
technique that can restore the height and shape of the articulating surface in focal 
osteochondral  defects.  As  shown  in  Figure  1.8,  plugs  of  healthy  cartilage  and 
subchondral bone are obtained from the low loaded regions of the host joint, e.g., the 
patella, femoral condyle or proximal fibula, and transplanted to the cartilage defect 
site (Bobić, 1996, Hangody et al., 1997). The cartilage-bone plugs are then press-
fitted into the defect site, without requiring additional fixing or suturing procedures. 
 
 
Figure  1.8:  Schematic  of  the  mosaicplasty  technique  employing  autografts. 
Cartilage-bone  plugs  are  removed  from  the  non-weight  bearing  periphery  of  the 
patellofemoral joint and implanted into the cartilage defect of the weight bearing 
condylar surface (Hangody et al., 2004). 
 
Mosaicplasty technique employing autografts (from the host joint) are suitable for 
lesions smaller than 2 cm
2. This limitation is based on concerns on the possible 
damage to the donor site. Allograft transplantation from cadaveric donors can be 
applied if the lesions are larger than 2 cm
2. The transplanted cartilage-bone plugs 
contain structurally intact AC that closely replicates the lost tissue. Therefore, the 
repair cartilage is more durable and behaves biomechanically normal compared to 
the  fibrocartilaginous  repair  tissue  (Hangody  et  al.,  2001,  Giannini  et  al.,  2002, 
Hangody  and  Fules,  2003).  Indeed,  a  10  year  follow-up  reported  92%  good  or 14 
 
excellent  results  in  597  knees  (Hangody  and  Fules,  2003).  However,  the  main 
problem with this transplantation technique is the naturally limited availability of 
autografts. When allografts are used for larger defects, the accompanying risks are 
disease transmissions and possible immune reactions that could cause inflammation. 
In addition, it is difficult to reconstruct the contour of the defect area and to fill the 
entire defect site. The differences in orientation and thickness, the lack of integration 
and the existence of gaps between the donor plugs and the adjacent native cartilage 
are some of the clinical challenges. Cartilage-bone plugs that are not entirely fixed 
may  cause  movement  of  the  plugs,  which  creates  loose  bodies  and  subsequent 
damage to the joint (Chow et al., 2004).  
 
 
1.5.3  Autologous chondrocyte transplantation  
 
Autologous chondrocytes transplantation (ACT) was introduced in 1987 and first 
published in 1994 (Brittberg et al., 1994). ACT was developed because all existing 
techniques at that time were ineffective in treating cartilage lesions larger than 2 cm
2. 
The ACT is a two-stage surgical procedure. During the first surgery that can be done 
arthropscopically, chondrocytes are harvested from a small biopsy that is taken from 
a non-weight bearing area of the patient’s joint. After isolation, the chondrocytes are 
expanded  in  monolayer  culturing  until  sufficient  cells  are  obtained.  This  process 
takes 2 to 3 weeks’ time. Next, in a second open surgery, the periosteal flap, which is 
the layer of bone-lining tissue, is harvested and sutured over the cartilage defect area. 
The lab-expanded chondrocytes are injected into the pocket under the periosteal flap 
(Brittberg, 1999, Brittberg et al., 2001). Figure 1.9 shows the steps involved in the 
ACT technique.  
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Figure  1.9:  Schematic  of  the  autologous  chondrocyte  transplantation  (ACT) 
procedure. In the first surgery, a biopsy is taken from the low loaded region of the 
patient’s joint and then chondrocytes are isolated and expanded in the laboratory. 
During the second surgery, the periosteal flap is sutured over the defect site and the 
chondrocytes are injected into the pocket under the flap (Brittberg et al., 1994).  
 
The ACT shows good results particularly in younger patients. An evaluation based 
on 61 patients 2 years post-surgery found that 50 of the patients (82%) had good or 
excellent clinical results. In 8 of the 11 patients that were further evaluated, stiffness 
of the repair site was reported as 90% or higher of normal AC (Peterson et al., 2002). 
However, there are major problems related to the use of ACT, and, in particular of 
using periosteal flaps. Several studies have been reported that cells are often lost due 
to  cell  leakage  once  load-bearing  activity  was  resumed  (Driesang  and  Hunziker, 
2000,  Micheli  et  al.,  2001).  In  addition,  due  to  the  de-differentiation  of  the 
transplanted chondrocytes during the monolayer culture expansion, calcified tissue 
and the functionally weak fibrocartilage was produced (Lefebvre et al., 1990, Briggs 
et al., 2003, Horas et al., 2003, Knutsen et al., 2004). In addition, approximately 25-
36% of the patients undergoing ACT required subsequent surgical procedures as a 
consequence  of  complications  caused  by  the  periosteal  flap,  e.g.,  graft  failure, 
delamination,  disturbed  integration  and  tissue  hypertrophy  (Wood  et  al.,  2006, 
Niemeyer et al., 2008). Moreover, clinical studies that compared ACT with other 16 
 
simpler and less invasive surgical techniques, e.g., the microfracture technique, have 
not found significant improvements in the clinical outcomes.  
 
 
1.5.4  Tissue engineering of cartilage 
 
Tissue  engineering  applies  the  principles  of  biology  and  engineering  to  develop 
functional substitutes for damaged tissues (Langer and Vacanti, 1993). This idea is 
developed  based  on  the  tendency  of  cells  to  reform  and  the  ability  of  tissues  to 
remodel into the appropriate tissue structure under suitable experimental conditions. 
A schematic of tissue engineering principles is depicted in Figure 1.10.  
 
 
Figure  1.10:  The  steps  involved  in  the  tissue  engineering  of  cartilage.  First, 
chondrocytes are isolated from a cartilage biopsy and expanded in monolayer culture 
until a sufficient amount of cells is obtained. Subsequently, the chondrocytes are 
seeded onto a scaffold and supplemented with growth factors to form a construct in a 
bioreactor. Once neo-cartilage is formed, the construct can be implanted into the 
defect site [adapted from Nesic et al. (2006)]. 
 
Similar  to  the  ACT  technique,  the  first  step  in  tissue  engineering  of  cartilage  is 
isolating the cells from a small tissue biopsy and expanding the isolated cells in 
culture to obtain a sufficient number of cells for seeding a scaffold. Next, the cells 
are seeded into a scaffold that serves as a structural support to evenly distribute and 
support the chondrocytes in the defect site, and to promote chondrogenesis (Tuan, 17 
 
2007, Brittberg, 2010). The cell-seeded construct can either be cultured in vitro to 
produce an engineered graft, or it can be implanted into the body to enhance in vivo 
tissue formation (Vunjak-Novakovic and Goldstein, 2005).  
 
Due to its structural simplicity, cartilage was predicted to be one of the first tissues 
to be successfully regenerated when the idea of tissue engineering was introduced 
(Huey  et  al.,  2012).  Cartilage  has  only  one  single  cell  type  (chondrocytes),  it  is 
avascular (lacks blood vessels), aneural (no neurons and nerves), and alymphatic (no 
lymphatic system). However, this goal has yet to be achieved. The success of an 
engineered  cartilage  requires  optimisation  of  a  huge  number  of  parameters  that 
interplay  between  each  other.  Tissue  engineering  of  cartilage  needs  controlled 
culture  conditions,  suitable  cell  type,  and  probably  most  importantly,  a  suitable 
structural material to guide the chondrocytes towards cartilage formation.  
 
 
1.6  The role of scaffolds in the tissue engineering of cartilage 
 
In  the  popular  ACT  technique,  the  injection  of  suspension  of  cells  under  the 
periosteal flap lacks cell retention ability and generates functionally weak fibrous 
cartilage. All current surgical procedures employed to repair AC defects often leave 
the  patients  in  a  pre-arthritic  state.  These  unsatisfactory  outcomes  require  the 
development  of  new  strategies  for  cartilage  repair.  More  recently,  scaffold-based 
tissue  engineering  approaches  have  become  the  focus  of  clinical  research  (Tuan, 
2007).  The  idea  is  that  the  utilisation  of  scaffolds  in  the  tissue  engineering  of 
cartilage may enhance the growth of extracellular matrix (Johnstone et al., 2013). As 
shown  in  Figure  1.11,  with  the  support  of  a  scaffold  material,  cells  are  evenly 
distributed within the defect. In contrast, without a scaffold, cells that have been 
migrating from the adjacent tissue gather at the corners and walls of defect site and 
do not fill the entire defect space. 
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Figure  1.11:  Partial  thickness  cartilage  defects  treated  with  the  support  of  (A) 
scaffold (fibrin clot), and (B) without scaffold. (A) The entire volume of the defect is 
richly populated with mesenchymal stem cells. The cells are able to migrate from the 
host cartilage through the synovial membrane. (B) Multilayers of cells are generated 
but the defect is not filled completely (Hunziker and Rosenberg, 1996). 
 
The use of scaffolds provides an improved filling of the defect space. In addition, the 
scaffolds  act  as  a  temporary  support  for  cell  attachment  and  for  guiding  tissue 
development  (Lu  et  al.,  2001).  The  porous  structures  provided  by  scaffolds  also 
facilitate  the  transport  of  nutrients,  metabolites,  and  regulatory  molecules  to  and 
from the adjacent tissue and to and from the surrounding synovial fluid. Numerous 
scaffolds have been developed: they can be made of natural or synthetic polymers, or 
by employing various fabrication techniques to produce different structures.  
 
 
1.7  Current scaffolds for tissue engineering of cartilage 
 
Hydrogels  constitute  a  major  class  of  scaffold  materials  for  the  engineering  of 
cartilage. They are solids with defined shape at the macroscopic scale, but behave 
fluidic with water soluble molecules diffusing within the structure at the molecular 
scale. The easiest approach of guided cartilage repair is to mix a suspension of cells 
with the liquid precursor of hydrogels to form a gel construct, or to directly seed a 
suspension of cells into an existing hydrogel. These constructs can then be cut into 
the shape and placed into the defect site. The high water content of hydrogels that is 
similar to the native extracellular matrix facilitates the diffusion of nutrients and 
waste products. Hydrogels also provide a porous three-dimensional (3D) structure 
that allows for a uniform distribution of cells and to maintain the cells’ phenotype.  
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Examples of hydrogels that have been investigated for cartilage repair are collagen 
(Wakitani et al., 1994), alginate (Bonaventure et al., 1994, Hauselmann et al., 1994), 
agarose (Buschmann et al., 1992, Mauck et al., 2000), hyaluronan (Marcacci et al., 
2005), chitosan (Suh and Matthew, 2000, Hoemann et al., 2005), poly(vinyl alcohol) 
(PVA) (Stammen et al., 2001), poly(ethylene glycol) (PEG) (Elisseeff et al., 2000, 
Bryant et al., 2004) and double network hydrogels (Gong et al., 2003, Zhang et al., 
2009). Over the last decade, some hydrogels have been applied in clinical trials, e.g., 
hydrogels made of collagen (Schneider and Andereya, 2003, Behrens et al., 2006), 
hyaluronan (Marcacci et al., 2005), chitosan (Stanish et al., 2013), PEG (Sharma et 
al., 2013, Regentis, 2014) and PVA. A few products even obtained regulatory status 
(Schneider and Andereya, 2003, Marcacci et al., 2005, Stanish et al., 2013, Regentis, 
2014).  
 
To  avoid  the  time  and  high  costs  for  in  vitro  culturing,  the  liquid  precursors  of 
chitosan (Stanish et al., 2013) and PEG hydrogels (Sharma et al., 2013, Regentis, 
2014)  have  been  combined  with  the  microfracture  technique  to  provide  a  3D 
environment for the differentiation of bone marrow stem cells into chondrocytes. 
The flow properties of the in situ forming gels have the advantage over pre-shaped 
hydrogels to improve filling of the irregular shaped defects (Sharma et al., 2013, 
Stanish et al., 2013). However, the microfracture technique induces the migration of 
bone marrow stem cells over the blood flow into the defect site but mainly produces 
fibrocartilage (Steadman et al., 1997, Mithoefer et al., 2009, Geistlich, 2010).  In 
addition, AC is avascular and lacks the innate ability to self-organise into structured 
cartilage  without  a  guiding  environment,  e.g.,  structural  support,  mechanical 
microenvironment  and  chemical  growth  factors.  Therefore,  an  effective  in  vitro 
synthesis of engineered cartilage remains as a pre-requisite step for successful AC 
repair,  even  when  considering  that  this  procedure  is  more  time  consuming  and 
requires higher cost than injecting an in situ forming gel into the defect site. 
 
Macroscopically, hydrogels can be designed to have the water content, smoothness 
and shiny appearance similar to native AC. Formation of repair tissue has also been 
reported (Marcacci et al., 2005, Sharma et al., 2013). However, as shown in Figure 
1.12, the amorphous hydrogels represent a different class of materials compared to 
the hierarchically structured extracellular matrix of native AC. The important point 20 
 
is  that  cells  are  sensitive  to  their  surroundings.  In  a  hydrogel,  the  chondrocytes 
experience  a  different  cell-matrix  interaction  and  have  a  greater  tendency  to  de-
differentiate when bound onto a scaffold with a fundamentally distinct ultrastructure 
compared to the collagen fibril meshwork in native AC (Stevens and George, 2005).  
 
    
Figure  1.12:  Comparison  of  the  ultrastructure  of  a  hydrogel  with  the  collagen 
meshwork  in  AC.  (A)  Scanning  electron  micrograph  of  a 
gelatin/hyaluronan/chondoitin sulfate hydrogel (De Colli et al., 2012). (B) Scanning 
electron micrograph of collagen fibril meshwork in the human AC. Scale bars: (A) 
30 µm, (B) 500 nm. 
 
Scaffold  materials  for  the  repair  of  AC  require  sufficient  mechanical  strength  to 
withstand  the  in  vivo  joint  loading  forces.  However,  hydrogels  employed  for 
cartilage repair exhibit inferior mechanical properties compared to native AC (Liao 
et al., 2013, Sharma et al., 2013). One reason for this lack of strength is the tendency 
of hydrogels to swell under osmotic pressure, which drastically lower their stiffness 
and wear properties (Kamata et al., 2014). This mismatch of mechanical properties 
between the hydrogel and the surrounding host tissue induces shear stresses on the 
interfaces,  which  prevent  the  ingrowth  of  new  cartilage.  Small  gaps  (<2  mm) 
between repair tissue and the host tissue have been reported in a clinical study that 
combined the microfracture technique with a PEG hydrogel (Sharma et al., 2013). 
Due to weak mechanical fixation and adherence of the constructs, the soft hydrogels 
were  worn  out  quickly  (Efe  et  al.,  2010),  sometimes  within  six  months  post 
operation  (Alparslan  et  al.,  2001).  When  higher  polymer  concentrations  were 
employed to match the stiffness of native cartilage the result was a reduction of cell 
viability  (Bryant  and  Anseth,  2002).  Equally  important,  cells  within  the 
mechanically  inferior  hydrogels  experience  a  different  mechanical 
microenvironment compared to the extracellular matrix in AC. These differences in 21 
 
cell-matrix  interactions  and  stimuli  to  the  cell-surface  receptors  alter  the  cell 
signalling  pathways,  protein  synthesis  and  tissue  formation.  Both,  the  lack  of 
integration  of  repair  tissue,  as  well  as  the  differences  in  the  extracellular 
microenvironments may be the reasons for the development of fibrous cartilage.  
 
Another popular class of scaffolds for the engineering of cartilage are polymers from 
the family of poly(α-hydroxy acids), such as poly(glycolic acid) (PGA), poly(lactic 
acid) (PLA) and copolymers of both, poly(lactic-co-glycolic acid) (PLGA) (Mikos et 
al., 1993, Freed et al., 1994, Li et al., 2006). These Food and Drug Administration 
(FDA)  approved  biomaterials  have  been  used  as  resorbable  suture  materials  for 
decades, and more recently have been produced into resorbable 3D scaffolds for 
repairing chondral and osteochondral defects (Ossendorf et al., 2007, Carmont et al., 
2009).  They  have  been  electrospun  into  fine  fibrils  to  mimic  the  collagen  fibril 
meshwork of AC (Freed et al., 1993, Li et al., 2002). Non-woven scaffolds with 
randomly oriented fibrils can be obtained by electrospinning the fibrils onto a static 
metal  collector,  whereas  tube-like  scaffolds  with  specific  fibril  orientation  are 
obtained  by  electrospinning  the  fibrils  onto  a  rotating  drum.  By  controlling  the 
polymer  molecular  weight  or  compositions  of  their  copolymers,  a  range  of 
degradation and physical properties such as strength and elasticity can be controlled 
and  adjusted.  Despite  progresses  in  scaffold  fabrication,  concerns  about  the 
biocompatibility  of  these  polymers  have  been  frequently  discussed.  Their  fast 
degradation  process  increases  the  acidity  in  their  microenvironment,  which 
negatively affects the cell viability and also cell migration into the scaffolds (Sung et 
al.,  2004).  The  release  of  large  amounts  of  acidic  by-products  can  be  toxic  and 
trigger  inflammatory  responses  of  the  host  body,  particularly  in  orthopaedic 
applications where implants with considerable sizes are often required  (Li  et al., 
1990, Bergsma et al., 1995, Athanasiou et al., 1996, Gunatillake and Adhikari, 2003).   
 
There is currently no scaffold available exhibiting a biodegradation rate that matches 
the  growth  rate  of  cartilage.  A  too  rapid  degradation  rate  of  scaffold  material 
diminishes the structural integrity before new cartilage is formed (Hutmacher, 2000). 
For example, natural hydrogels such as collagen and fibrin are usually soluble or 
degrade  rapidly,  together  with  the  loss  of  biological  relevant  properties  during 
cartilage formation compromises their use for cartilage repair (Nimni et al., 1987, 22 
 
Meinel et al., 2004, Puppi et al., 2010). In contrast, mechanically strong polymers 
such as double network hydrogels (Gong et al., 2003, Yasuda et al., 2005, Arakaki et 
al.,  2010),  and  PVA  that  have  been  employed  as  hydrogels  (Oka  et  al.,  2000, 
Stammen et al., 2001) or nanofibrous scaffolds (Coburn et al., 2012), do not degrade 
and  prevent  the  ingrowth  of  newly  produced  cartilage  into  the  defect  site.  Such 
permanent materials do not comply with basic tissue functioning and remodelling (Li 
et al., 2006). In addition, some of the degradation mechanisms of some degradable 
polymers, e.g., PGA and PLA, leads to the release of large amounts of acidic by-
products (Li et al., 1990, Bergsma et al., 1993, Bergsma et al., 1995, Athanasiou et 
al., 1996, Agrawal and Athanasiou, 1997).  
 
 
1.8  The role of microenvironment in promoting chondrogenesis  
 
Despite 20 years of efforts, a common problem in cartilage tissue engineering is the 
de-differentiation  of  chondrocytes  during  cell  expansion,  as  well  as  de-
differentiation when the cells are seeded into the scaffolds. The de-differentiation of 
chondrocytes limits the production of functional cartilage. It is therefore important to 
understand  how  the  cells  interact  with  their  microenvironment,  and  how  the 
microenvironment  modulates  the  cellular  processes  and  tissue  formation.  The 
formation, function and regeneration of cartilage is the result of complex cell fate 
processes, induced by a myriad of mechanical and chemical (growth factors) signals 
from the extracellular matrix (Lutolf and Hubbell, 2005). As depicted in Figure 1.13, 
signals  from  the  extracellular  matrix  are  transmitted  through  various  cell  surface 
receptors, which then induce the intracellular signaling pathways that regulate gene 
expression, establish cell phenotype and direct tissue formation (Lutolf and Hubbell, 
2005, Bissell and Hines, 2011).  
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Figure 1.13: Modulation of cell fate by four important external signals: (1) soluble 
signals such as growth factors, (2) physical signals from the extracellular matrix, (3) 
environmental stresses such as mechanical and shear forces, (4) cell-cell interactions. 
The signals obtained from these interactions induce complex intracellular signalling 
cascades  that  converge  to  regulate  gene  expression,  establish  cell  phenotype  and 
direct tissue formation, homeostasis and regeneration (Lutolf and Hubbell, 2005). 
 
When cells anchor their pseudopodia on their surrounding matrix, they establish a 
tight connection between the cytoskeleton and the surrounding matrix through cell 
surface  receptors.  The  anchoring  supports  the  cells  in  their  capacity  for  tactile 
sensation,  to  sense  the  surrounding  mechanical  stiffness  and  transduce  the 24 
 
mechanical  induced  signals  into  intracellular  signalling  pathways  (Galbraith  and 
Sheetz, 1998, Lutolf and Hubbell, 2005). This flow of information between the cells 
and their extracellular matrix allows the cells to adjust into different morphologies 
and motility rates in response to changes in their mechanical microenvironment (Lo 
et al., 2000, Discher et al., 2005). For example, a chondrocyte cannot attach and 
exert forces against its adhesive contacts on a gel that is very soft compared to the 
native AC (Engler et al., 2004), whereas it spread-flattens on a substrate that is much 
stiffer  compared  to  the  native  AC,  such  as  a  polystyrene  culture  plate.  In  such 
spread-flatten  morphology,  the  chondrocyte  exhibits  a  distinct  actin  stress  fiber 
meshwork,  which  does  not  exist  in  their  rounded  shaped  appearance  in  the  3D 
context of cartilage or more generally in tissues. Taken together, cells only grow and 
function  normally  in  their  appropriate  microenvironment.  Changes  of  the 
microenvironment  result  into  changes  of  their  phenotype.  In  particular,  the  de-
differentiation  of  chondrocytes  represents  a  major  problem  in  cartilage  tissue 
engineering, leading to an altered protein expression, particularly, in a reduction of 
synthesis of aggrecan and type II collagen (Francioli et al., 2010). 
 
Cells also respond to the ultrastructures of their microenvironment. In native AC, 
chondrocytes anchor tightly on collagen fibrils with typical diameters between 10 
and 300 nm. Therefore, scaffolds with similar fibril size are able to provide sufficient 
binding  sites  to  cell  membrane  receptors  and  maintain  the  cell  phenotype. 
Conversely,  when  chondrocytes  reside  on  fibrils  that  are  tens  of  microns,  they 
respond similarly to their behavior on a two-dimensional (2D) culture plates, i.e., 
acquiring  an  unnatural  flat  shape,  leading  to  a  non-physiological,  asymmetrical 
occupation of adhesion receptors (Lutolf and Hubbell, 2005). As illustrated in Figure 
1.14, the cells behave differently according to different pore size and fibril size. This 
shows the importance of providing the cells with a scaffold that supports optimal cell 
attachment (Stevens and George, 2005).  
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Figure 1.14: Effects of scaffold architecture on the cell behaviour. (A, B) Cells bind 
to  the  micrometre  scale  scaffolds  exhibit  a  spread-flattened  behaviour,  which  is 
similar  to  their  2D  growth  in  culture  plates.  (C)  Cells  distributed  between  the 
nanometre sized fibrils maintain their phenotype (Stevens and George, 2005). 
 
It  has  been  demonstrated  that  scaffolds  with  nanofibrous  structure  adsorbed  four 
times  more  human  serum  proteins  (i.e.,  fibronectin  and  vitronectin)  compared  to 
scaffolds with solid pore walls. The high protein adsorption may contribute to an 
increase  in  cell  attachment  (Woo  et  al.,  2003).  Indeed,  chondrocytes  have  been 
reported  to  show  higher  cell  growth  rates  and  tissue  formation  when  they  were 
grown on nanofibrils, rather than when they were grown on sponge-like scaffolds 
(Freed et al., 1993, Freed and Vunjak-Novakovic, 1998) or on porous cast films (Lee 
et al., 2004, Kwon et al., 2007), which are all structures that are distinctly different 
compared to the microenvironment of native AC.  
 
The  importance  of  microenvironment  and  how  it  determines  cell  fate  has  been 
demonstrated in the field of cancer research. According to their microenvironment, 
cells  can  either  develop  into  normal  or  malignant  tissues  (Weaver  et  al.,  1997, 
Bissell and Hines, 2011, Chaudhuri et al., 2014). Isolated human breast cells that 
were grown within a structure similar to their native extracellular matrix maintained 
their original function, but the cells lost their function when they were placed into a 26 
 
culture plate. It has also been shown that the use of a structure similar to the native 
extracellular matrix was even able to revert the malignant phenotype of a cancer cell 
back into a normal cell (Bissell, 2012). So far, the importance of microenvironment, 
which  may  have  major  implications  for  cartilage  repair,  is  however  less 
acknowledged in the field of cartilage tissue engineering. 
 
 
1.9  Research objectives 
 
The  aim  of  this  research  is  to  heal  cartilage  defects,  by  developing  a  scaffold 
material to provide a suitable microenvironment for the chondrocytes to produce 
functional cartilage. The scaffold should provide: 
 
(i)  an  ultrastructure  similar  to  the  collagen  fibril  meshwork  in  native 
cartilage, 
(ii)  sufficient  mechanical  support  for  the  chondrocytes  until  the  newly 
formed cartilage has grown into a functional stable extracellular matrix,   
(iii)  a  biodegradable  structure  that  is  completely  resorbable  to  avoid  the 
storage of unnecessary foreign materials in the body, and which allows 
the ingrowth of new cartilage.  
 
 
1.10  Research scope and methodology 
 
To  improve  the  engineering  of  cartilage,  novel  scaffold  materials  were  selected 
based  on  their  biocompatibility  and  their  capacity  to  support  chondrogenesis, 
mechanical  properties  and  biodegradability.  In  this  study,  two  different  types  of 
biocompatible  polymer  scaffolds  that  exhibit  the  potential  to  provide  adjustable 
mechanical and degradation properties were focused. The first type of scaffold was 
made of natural polymers from the family of polyhydroxyalkanoates (PHAs), which 
are  poly(3-hydoxybutyrate),  [P(3HB)],  and  poly(3-hydroxyoctanoate),  [P(3HO)]. 
These polymers are biodegradable and release hydroxyl acids that are less acidic and 
less inflammatory than other currently used synthetic absorbable polymers. Both the 
P(3HB) and P(3HO) were blended at different compositions to produce different 27 
 
structural, mechanical and degradation properties. The second type of scaffold is a 
blend of chitosan and poly(ethylene oxide) (PEO), which combines the advantages 
of natural and synthetic polymers: by having the essential amino acid sequences of 
chitosan and the easily controlled PEO. They were subsequently crosslinked with the 
natural crosslink agent genipin to obtain a stable structure in physiological (liquid) 
conditions. Various concentrations of genipin crosslinker were employed to obtain a 
range of structural, mechanical and degradation properties. 
 
To produce the nanofibrous polymer scaffolds, electrospinning was employed. The 
physical and chemical properties of the produced scaffolds were characterised by 
scanning  electron  microscopy  (SEM)  for  the  scaffold  structure,  atomic  force 
microscopy (AFM) for the surface morphology, water contact angle analysis for the 
wettability  and  Fourier  transform  infrared  (FTIR)  spectroscopy  for  the  chemical 
functional  groups  present  in  the  polymer  blends.  The  stiffness  properties  of  the 
scaffolds were measured by indentation-type atomic force microscopy (IT-AFM). 
Next,  in  a  series  of  experiments,  the  scaffolds  were  subjected  to  hydrolytic 
degradation for up to 4 months, and the structure, stiffness and molecular weight of 
the  degraded  scaffolds  were  examined  by  SEM,  IT-AFM  and  gel  permeation 
chromatography  (GPC),  respectively.  In  vitro  biocompatibility  of  scaffolds  was 
tested by culturing human articular chondrocytes (HACs) with the scaffolds for three 
weeks. Cell viability was determined by counting the number of live and dead cells, 
whereas chondrogenesis was determined from the specific protein expression. These 
results  allowed  to  better  understand  how  the  structure  and  mechanical 
microenvironment affect chondrogenesis.  
 
This  thesis  also  includes  a  comparison  between  stiffness  measurements  by  the 
relatively new IT-AFM and the more conventional instrumented indentation testing 
(IIT).  Finally,  a  brief  introduction  on  wet-electrospinning  is  included  as  a 
recommendation for an improved scaffold fabrication.   
 
 
 29 
 
CHAPTER 2 
 
SCAFFOLD FABRICATION AND CHARACTERISATION  
 
 
2.1  Electrospinning 
 
Scaffolds serve as a template to promote cell interactions and for the formation of 
extracellular matrix in cartilage repair. To mimic the essential intercellular reactions, 
a structure similar to the native collagen meshwork in AC is most desirable because 
cell behaviour is largely dependent on the pore size and fibril size, as well as the 
mechanical properties of scaffolds (Stevens and George, 2005).  
   
Electrospinning was first introduced in 1902 as a technique to produce nanometre 
sized fibrils from polymer solutions (Morton, 1902). As shown in Figure 2.1, a basic 
electrospinning  apparatus  consists  of  three  major  components:  a  spinneret,  a 
collector and a high voltage power supply. 
 
 
Figure  2.1:  Schematic  of  electrospinning.  The  polymer  solution  is  placed  in  a 
syringe and ejected through a spinneret. A high voltage power is connected between 
the  spinneret  and  the  collector.  Fibrils  are  electrospun  from  the  spinneret  and 
deposited on a grounded collector (Bhardwaj and Kundu, 2010). 
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For electrospinning, a high voltage electric field is applied between the spinneret and 
the collector. When the polymer solution (which consists of a polymer dissolved in a 
solvent) is extruded from the syringe, a hemispherical droplet is formed at the tip of 
the  spinneret.  Due  to  the  applied  high  voltage,  the  charged  polymer  droplet  is 
elongated to form a conical shape, known as a Taylor cone (Taylor, 1969). Once the 
surface charge overcomes the surface tension of the Taylor cone, a fine polymer jet 
is ejected to the nearest grounded surface (Taylor, 1964). During travelling of the jet 
through the high voltage gradient, the solvent in the polymer jet evaporates, allowing 
solidification of the fibrils. The fibrils eventually deposit on the collector, forming 
non-woven  fibril  mats.  Depending  on  the  operation  parameters,  fibrils  from 
micrometre to nanometre size can be produced. 
 
Polymers  need  to  be  dissolved  in  a  suitable  solvent  to  form  an  electrospinning 
solution  that  favours  the  elongation  of  the  electrified  jet  into  strands,  while 
minimising the unfavoured electrospraying phenomenon, which is shown in Figure 
2.2. 
  
 
Figure  2.2: Schematic  of electrospraying phenomenon. The electrified jet breaks 
into droplets and forms particles on the collector [adapted from Bhardwaj and Kundu 
(2010)]. 
 
There are several parameters that need to be optimised to obtain homogeneous fibrils 
with constant thickness. The concentration of the polymer in solvent determines the 
ability  of  the  solution  to  be  electrospun.  If  the  concentration  of  the  solution  is 31 
 
insufficient, the solution will not contain the required amount of material to form 
stable  solid  fibrils.  Meanwhile,  an  overly  concentrated  solution  with  too  high 
viscosity  makes  the  solution  unspinnable.  The  viscosity  of  the  electrospinning 
solution, together with the solution flow rate, determines the diameter of electrospun 
fibrils. A higher solution viscosity and solution flow rate would result into fibrils of 
larger  diameters.  In  addition,  environmental  parameters  such  as  temperature  and 
humidity  should  be  held  constant  during  the  process  as  they  can  influence  the 
viscosity of the electrospinning solutions. The applied voltage is generally correlated 
to  the  morphology  of  the  electrospun  fibrils,  in  particular  the  formation  of  bead 
defects in the fibrils (Deitzel, 2001). To minimise the formation of bead defects, the 
applied voltage should be sufficient for the formation of a solution droplet at the 
spinneret tip, so that a polymer jet can be initiated in the shape of a cone from the 
bottom of the droplet, with a semi-vertical angle in agreement with the Taylor’s 
theoretical prediction of 49.3° for a viscous fluid in an electric field (Taylor, 1964; 
1969). As the polymer jet travels in air, the working distance between the spinneret 
and the collector allows the evaporation of solvents and the solidification of fibrils. 
The  simultaneous  effect  of  the  stretching  of  polymer  jet  through  the  working 
distance and the evaporation of solvent determines the diameter and the morphology 
of  the  fibrils.  Taken  together,  the  properties  of  electrospinning  solutions  and  the 
operating parameters need to be optimised to produce fibrils with uniform size and 
smooth surface morphology.    
 
 
2.2  Scaffold characterisation  
 
2.2.1  Scanning electron microscopy 
 
Scanning electron microscopy (SEM) was invented by Ernst Ruska and Max Knoll 
in 1931, and first commercialised in 1965. The SEM produces 2D images of surface 
structures,  which  provide  detailed  morphological  information  that  are  easily 
interpretable. The SEM uses electrons rather than light to generate an image, with a 
typical resolution of better than 10 nm. Since the operation of SEM relies on an 
electric field, the sample needs to be conductive; otherwise, a non-conductive sample 
needs to be coated by a conductive material, typically gold, platinum or carbon. This 32 
 
limits  the  application  of  SEM  for  investigating  non-conductive  samples  in  their 
original  conditions.  For  imaging,  a  sharp  electron  beam  is  produced  either  by 
thermionic emission that uses electrical current to heat up a tungsten filament for the 
emission of electrons, or by field emission that applies a high negative potential on a 
single crystal tungsten tip and causing the emission of electrons from the atoms. The 
emitted electrons are then accelerated and focused by magnetic lenses, before the 
beam interacts with the sample. When the electron beam interacts with the sample, 
low energy secondary electrons are emitted from the sample surface, which are then 
collected by a secondary detector before they are further amplified electronically. 
The electron beam scans across the sample surface and the variations in the emission 
of  secondary  electrons  generate  an  image  of  the  sample  external  morphology. 
Besides the secondary electrons, backscattered electrons that contain higher energy 
are also produced and they can be collected by employing a different type of detector. 
The backscattered electrons provide information on the material composition.  
 
 
2.2.2  Atomic force microscopy 
 
Advances in the field of nanotechnology were accelerated by the invention of atomic 
force microscopy (AFM) by Gerd Binnig, Calvin Quate and Christopher Gerber in 
1986 (Binnig et al., 1986). The AFM allows the observation of surface topography 
of samples in their close-to-native conditions at a molecular resolution. The AFM 
scans across the sample surface with a sharp tip at the end of a cantilever. As the tip 
traces various surface features, its upward and downward movements are monitored 
by a laser beam that is reflected off the back of the cantilever, and detected by a 
position-sensitive photodiode. A feedback system is used to control the tip-sample 
interactions, allowing the tip to be lifted and lowered, keeping the tip height constant 
over surface features. The AFM is capable of measuring in the vertical dimension (z-
axis),  giving  information  on  the  height  and  depth  of  the  surface  features,  which 
optical microscopy and SEM are not capable of. As the AFM is operated based on 
piezoelectric  actuators,  it  provides  a  very  high  dimensional  precision,  with  the 
resolution of height (z-axis) up to 0.01 nm and the resolution of sample stage (x- and 
y-axis) up to 0.1 nm. A major advantage of AFM is that it requires only minimal 
sample  preparation  without  the  need  of  electrical  conduction,  sample  fixation, 33 
 
coating  or  staining,  and  the  sample  can  be  scanned  in  vacuum,  air  or  liquid 
conditions, making it very useful for biomedical application. Various information 
related to the nanoscale features of a sample can be obtained, e.g., topographical 
information by imaging, as discussed in Section 3.4.1 and stiffness by IT-AFM, as 
discussed in Chapter 4.  
 
 
2.2.3  Fourier transform infrared spectroscopy  
 
Infrared  (IR)  spectroscopy  was  invented  in  late  1950s  and  allows  to  provide 
structural  information  including  the  identification  of  molecules  (Griffiths,  1983). 
Infrared  absorption  is  based  on  a  change  in  the  dipole  moment  (polarity)  of  the 
molecule.  When  a  sample  is  exposed  to  IR  radiation,  the  molecule  can  absorb 
radiation  of  a  specific  wavelength  when  it  matches  the  same  wavelength  of  the 
molecules’ fundamental mode of vibration, i.e., if the wavelength of the absorbed 
radiation  matches  the  transition  energy  of  the  bond  or  group  of  molecules  that 
vibrates. It represents the absorption and transmission of radiation by the molecules, 
thereby creating a fingerprint that is unique for each molecule. Fourier transform 
infrared spectroscopy (FTIR) was introduced in 1965 by James Cooley and John 
Tukey (Cooley and Tukey, 1965) and is the most commonly used IR spectroscopy. 
By employing an interferometer, all wavelengths can be measured simultaneously, 
forming inteferogram signals which are then converted into an IR spectrum using 
Fourier  transformation.  As  shown  in  the  example  in  Figure  2.3,  the  resulting 
spectrum is a plot of the intensity of radiation absorption versus the wavelength of 
radiation.  
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Figure 2.3: The FTIR spectrum of ethanol. Each peak is characteristic to a specific 
chemical bond or atom (Spectra Database for Organic Compound, 2014). 
 
The wavelength of the absorption peak is determined by the transition energy, which 
corresponds  to  the  vibrating  wavelength  of  a  bond  or  group  of  molecules.  The 
intensity of absorption peaks is a direct measure of the amount of material that is 
present. Through the molecules’ characteristic absorption of IR radiation, the types 
of chemical bonds (functional groups) and possible elements can be identified. The 
application  of  FTIR  allows  a  simultaneous  collection  of  spectra  data  in  a  wide 
spectral range within a few seconds with improved sensitivity. The commonly used 
region for IR spectroscopy is in the range of 4000-400 cm
-1 because the absorption 
frequency of most organic compounds and inorganic ions is within this region.   
 
 
2.2.4  Gel permeation chromatography 
 
Gel permeation chromatography (GPC) is a type of separation technique that allows 
to measure the molecular weight distribution of polymers (Lathe and Ruthven, 1956). 
Unlike small molecules, which have a single molecular weight, polymers contain a 
mixture of polymer chains with different molecular weights. The GPC separates the 
different polymer chains based on their sizes, rather than their molecular weight. As 
shown in Figure 2.4, the separation takes place in a column that is filled with porous 
material with pores of known size. When dissolved polymer molecules flow into the 35 
 
column,  the  smaller  molecules  flow  slowly  through  the  column  as  they  are 
penetrating  deep  into  the  pores,  thus  increasing  their  retention  time.  Conversely, 
molecules that are larger than the pores cannot penetrate into the porous medium and, 
hence, flow through the column quickly and are eluted earlier.  
 
 
Figure 2.4: Schematic of the size separation mechanism in GPC and the resulting 
chromatogram.  The  dissolved  sample  is  injected  into  a  column  that  consists  of 
porous spherical particles. The molecules flows through the porous particles and are 
retained in the column at different rates based on their sizes. The eluted molecules 
are detected by a concentration detector and the time taken for a specific fraction of 
molecules to elute is represented as retention time in the chromatogram (Meunier, 
1997).  
 
The  concentration  by  weight  of  polymer  in  the  eluting  solvent  is  monitored 
continuously  by  a  detector.  The  resulting  chromatogram  represents  the  weight 
distribution of the polymer as a function of retention time. The retention time in the 
chromatogram is the time taken for a specific compound to elute from the column 36 
 
after  injection.  It  is  the  identification  of  a  specific  compound  in  the  sample. 
Quantitative measurement of the amount of a compound in sample (concentration) 
can then be determined from the peak height and the peak area.  
 
 
2.2.5  Histology 
 
Histology  has  been  developed  since  the  19
th  century  to  study  the  microscopic 
structure of cells and tissues using light microscopy. When a specimen is obtained 
from a biological source, it is chemically fixed to prevent tissue degradation. Then 
the  specimen  is  cut  into  sections  with  thickness  typically  of  5-10  µm.  Since 
biological  tissue  have  low  inherent  contrast  in  the  light  microscope,  the  tissue 
specimen  has  to  be  stained  to  give  contrast  to  the  tissue  as  well  as  to  highlight 
particular features of interest. The staining techniques can either be non-specific, e.g., 
staining most of the cells in similar ways, or be specific, e.g., selectively staining of 
particular chemical groups or molecules within cells or tissues. The most commonly 
used  histological  stains  for  light  microscopy  are  haematoxylin  and  eosin. 
Haematoxylin is a basic dye, which stains the cell nuclei blue due to affinity to 
nucleic acids in the cell nucleus, whereas eosin is an acidic dye, which stains the 
cytoplasm, connective  tissue  and  other  extracellular  substances  pink  or  red  pink. 
There are hundreds of various other specific staining used to selectively stain tissue, 
e.g., Safranin-O, Toluidine blue, oil red O, fast green, silver salts, and numerous 
natural  and  artificial  dyes  that  often  originated  from  the  textile  industry  (Elliott, 
2012).  
 
One  of  the  most  common  dyes  for  cartilage  staining  is  Alcian  blue,  a  type  of 
polyvalent  basic  dyes  often  used  to  stain  the  acidic  polysaccharides  such  as  the 
GAGs. The intensity of staining is a measure for the amount of proteoglycans. The 
most  intense  staining  is  typically  found  around  the  cartilage  cells.  However, 
interactions with other tissue components (collagen, elastin, matrix proteins) may 
greatly  influence  the  affinity  of  Alcian  blue  for  proteoglycans  in  tissue  sections 
(Ippolito  et  al.,  1983).  To  visualise  collagen  fibres  in  the  cartilage,  Sirius  red 
dissolved in saturated picric acid solution is used with both light microscopy and 
polarised light microscopy. It is a long-lasting dye that binds specifically to collagen 37 
 
fibres. Therefore, the application of both Alcian blue and Sirius red dyes allows the 
visualisation  of  the  two  most  important  components  in  the  cartilage ̶  the 
proteoglycans and the total collagen contents.  
 
 
2.2.6  Immunohistochemistry 
 
Immunohistochemistry  was  first  implemented  in  1941  (Coons  et  al.,  1941).  It 
employs the principles of specific binding of an antibody to a specific antigen or 
protein in cells or tissues, and visualise them by applying dyes. Following binding of 
the primary antibodies to the antigens, there are two types of labelling methods: (i) 
direct  labelling  and  (ii)  indirect  labelling  associated  with  signal  amplification 
(Ramos-Vara, 2005). In the direct labelling method, the primary antibody is attached 
(or  conjugated)  to  an  indicator,  e.g.,  fluorescent  dye,  biotin  or  enzyme  such  as 
peroxidase  or  alkaline  phosphate.  Next,  the  antigen-antibody  interactions  are 
visualised by fluorescence microscopy mediated by the fluorescent dye, or by light 
microscopy  mediated  by  the  chromogen.  In  the  indirect  method,  a  secondary 
antibody that recognises the primary antibody is added to the mixture. Signals that 
can be obtained from the indirect method are amplified due to the binding of several 
secondary antibodies to each primary antibody. Further signal amplification can be 
achieved using a biotinylated secondary antibody and an amplification reagent such 
as avidin or streptavidin (Key, 2009). The avidin-biotin method is widely used today 
and relies on the strong affinity of avidin or streptavidin for the vitamin biotin that is 
conjugated to the secondary antibody. Both the avidin and streptavidin possess four 
binding sites for biotin. Among the two, streptavidin, being an uncharged molecule 
and does not contain carbohydrate groups that might bind to tissue lectins, is a recent 
innovation to substitute the avidin. It eliminates electrostatic binding to the tissue 
and reduces background staining due to binding to the tissue lectins. The labelled 
streptavidin-biotin method involves three layers, as shown in Figure 2.5.  38 
 
 
Figure 2.5: Schematic of the indirect immunohistochemical labelling method utilises 
signal amplification by streptavidin-biotin. The primary antibody binds to a specific 
tissue  antigen.  Signals  from  the  primary  antibody  can  be  amplified  by  adding  a 
biotinylated secondary antibody and a streptavidin-peroxidase conjugate. Each single 
primary  antibody  can  be  associated  with  multiple  peroxidase  molecules,  and  the 
large enzyme-to-antibody ratio amplifies the signals (Key, 2009). 
 
The  first  layer  is  unlabelled  primary  antibody.  The  second  layer  is  biotinylated 
secondary antibody. The third layer is enzyme-streptavidin conjugates (horseradish 
peroxidase-streptavidin). This method was employed in this study to determine the 
presence  of  specific  proteins  in  the  neo-cartilage.  The  enzyme  horseradish 
peroxidase  is  visualised  by  the  application  of  substrate  chromogen  solutions  to 
produce colorimetric end products. In the presence of chromogen (an electron donor), 
the enzyme forms a complex with the substrate (hydrogen peroxide), and then results 
in the oxidation of the electron donor. There are several commonly used chromogens, 
e.g., 3,3’ diaminobenzidinetrahydrochloride (DAB), which produces a brown end 
product upon oxidised and 3-amino-9-ethylcarbazole (AEC), which produces a rose 
red end product upon oxidised. This allows the localisation of specific genes and 
proteins produced during chondrogenesis, as discussed in Chapter 6 of this thesis.   
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CHAPTER 3 
 
PREPARATION OF P(3HB)/P(3HO) SCAFFOLDS 
 
 
3.1  Polyhydroxyalkanoates 
 
Polyhydroxyalkanoates (PHAs) are a family of biopolyesters synthesized by a wide 
variety  of  bacteria  under  the  conditions  of  limiting  nutrients  (e.g.,  ammonium, 
potassium, sulphate, magnesium and phosphate) but excess carbon source (Sudesh et 
al.,  2000,  Chen  and  Wu,  2005).  This  unbalanced  supply  causes  the  bacteria  to 
accumulate PHA granules as their internal carbon and energy storage, in the form of 
insoluble cytoplasmic inclusions, as shown in Figure 3.1.  
 
 
Figure 3.1: Schematic of a PHA granule. The core consists of PHA polymer that is 
enwrapped by a phospholipid monolayer and proteins on the outside. The proteins 
consist of PHA polymerase, PHA depolymerase, structural proteins (phasins), and 
proteins of unknown function (Zinn et al., 2001). 
 
To date, approximately 125 different PHAs are known (Sudesh et al., 2000), with a 
general structure as shown in Figure 3.2.  
 
 
Figure 3.2: General structure of PHAs, with R indicates the alkyl pendant group. 40 
 
The types of monomer being synthesized by the bacterium are determined by the 
carbon source. The major monomer has the same chain length as the carbon source. 
Monomers  containing  odd  numbers  of  carbon  atoms  are  synthesized  when  the 
carbon  source  with  odd  numbers  of  carbon  atoms  is  utilised,  while  monomers 
containing even numbers of carbon atoms are synthesized from carbon sources with 
even numbers of carbon atoms. For example, when a bacterium is cultivated with n-
octane  (8  carbon  atoms)  as  the  only  carbon  source,  the  produced  PHAs  consist 
mainly  of  3-hydroxyoctanoate  units  (8  carbon  atoms),  with  small  amounts  of  3-
hydroxyhexanoate units (6 carbon atoms) (Desmet et al., 1983). 
 
Polymers  from  the  family  of  PHAs  exhibit  a  wide  range  of  structural, 
physicochemical  and  thermal  properties.  Depending  on  the  length  of  the  alkyl 
pendant group, R, PHAs can be categorised into short-chain-length PHAs (scl-PHAs) 
and  medium-chain-length  PHAs  (mcl-PHAs).  The  scl-PHAs,  which  contain  3-5 
carbon atoms, are thermoplastics exhibiting a high degree of crystallinity. The mcl-
PHAs,  which  contain  6-14  carbon  atoms,  are  elastomers  with  a  low  degree  of 
crystallinity.  With  variations  in  the  length  of  R,  PHAs  change  their  properties. 
Blending  different  monomers  of  PHAs  allows  optimising  their  properties  for 
biomedical application and in particular for cartilage repair, where mechanical and 
biodegradation properties are important. 
 
 
3.1.1  Poly(3-hydroxybutyrate)  
 
Poly(3-hydroxybutyrate) [P(3HB)] is an example of scl-PHAs and is the most often 
used PHAs. It represents the simplest member of the PHAs family, with its chemical 
structure indicated in Figure 3.3.  
 
 
Figure 3.3: Structure of P(3HB). 41 
 
P(3HB) is an amorphous to highly crystalline material with a degree of crystallinity 
of 30-90% (Sudesh et al., 2000). In spite of its relative brittle and stiff properties, 
with a strain at break typically less than 5%, P(3HB) can be fabricated into textiles 
with satisfactory flexibility. Due to its high  crystallinity, P(3HB) exhibits a very 
slow  degradation  rate.  Thus,  it  has  been  investigated  for  tissue  engineering 
applications that require a longer retention time or a high stability in the surrounding 
environment (Chen et al., 2013, Chen and Wu, 2005), e.g., bone repair (Doyle et al., 
1991, Luklinska and Bonfield, 1997), nerve conduits (Young et al., 2002, Hazari et 
al., 1999) and pericardial substitutes (Duvernoy et al., 1995, Kalangos and Faidutti, 
1996). In vitro tests also showed that P(3HB) is biocompatible with various cell lines, 
including osteoblasts, epithelial cells and rabbit chondrocytes (Doyle et al., 1991, 
Zheng et al., 2005).  
 
The material properties of P(3HB) can be fine-tuned for specific  applications by 
incorporating it with a second monomer unit. There are two approaches: 
(i)  co-synthesis of P(3HB) with hydroxyalkanoate monomeric units of higher 
chain  length,  by  co-feeding  different  carbon  sources.  Some  common 
examples  are  poly(3-hydroxybutyrate-co-3-hydroxyvalerate)  [P(3HB-co-
3HV)], which are also available commercially as Biopol (Köse et al., 2005, 
Sun  et  al.,  2005,  Weng  et  al.,  2011),  poly(3-hydroxybutyrate-co-3-
hydroxyhexanoate) [P(3HB-co-3HHx)] (Doi et al., 1995, Wang et al., 2005) 
and poly(3-hydroxybutyrate-co-4-hydroxybutyrate) [P(3HB-co-4HB)] (Ying 
et al., 2008).  
(ii)  physical blending of P(3HB) with higher chain length PHAs, e.g., P(3HV) 
(Satoh et al., 1994, Gassner and Owen, 1996), P(3HHx) (Deng et al., 2003, 
Deng et al., 2002, Kai et al., 2003, Zheng et al., 2005) and P(3HO) (Dufresne 
and Vincendon, 2000, Basnett et al., 2013).  
 
The physical and thermal properties of microbial copolyesters can be regulated by 
varying  their  molecular  weights  and  compositions.  In  general,  the  resulting 
copolyesters are more flexible and elastic than P(3HB) (Barker et al., 1990). The 
blending  approach  has  several  advantages  in  comparison  to  synthesising  new 
copolyesters,  including  the  ease  of  preparation  and  optimisation  of  its  final 
properties (Ha and Cho, 2002). Blending reduces the crystallinity of P(3HB) and as a 42 
 
result of macrophase separation and the effective surface area, increases the surface 
erosion rate (Satoh et al., 1994, Ha and Cho, 2002).  
 
 
3.1.2  Poly(3-hydroxyoctanoate) 
 
One  of  the  most  extensively  studied  mcl-PHAs  that  can  be  synthesized  as 
homopolymer at high yield is poly(3-hydroxyoctanoate) [P(3HO)] (Rai et al., 2011). 
The chemical structure of P(3HO) is depicted in Figure 3.4. 
 
 
Figure 3.4: Structure of P(3HO). 
 
The long alkyl pendant group provides P(3HO) with elastomeric properties. P(3HO) 
is  semicrystalline  with  a  degree  of  crystallinity  of  26-37%  (Rai  et  al.,  2011, 
Sanguanchaipaiwong, 2006). It is flexible with high elongation to break between 
250-380%, which allows for biomedical applications where flexible biocompatible 
biomaterials  are  required.  The  physical  and  chemical  properties  of  P(3HO)  are 
different from P(3HB), which makes it a suitable material for blending with P(3HB), 
to produce scaffolds with a wide range of mechanical and degradation properties. 
 
 
3.1.3  Polyhydroxyalkanoates for tissue engineering of cartilage 
 
The use of PHAs for cartilage tissue engineering has been limited to the copolymers 
of P(3HB), such as P(3HB-co-3HV) (Chen and Wu, 2005, Williams et al., 1999), 
and P(3HB-co-3HHx), because they are commercially available. Rivard et al. (1996) 
transformed P(3HB-co-3HV) into 3D foams and cultured ovine chondrocytes and 
osteoblasts  on  it.  After  3  weeks,  a  high  cell  density  was  observed,  and  cellular 
diffusion taking place throughout the porous foams. A further study indicated that 43 
 
chondrocytes seeded in P(3HB-co-3HV) scaffolds and cultured for 7 days in vitro, 
maintained  their  phenotype  and  synthesised  both  type  II  collagen  as  well  as 
cartilage-specific  proteoglycans  (Sun  et  al.,  2005).  Köse  et  al.  (2005)  produced 
scaffolds  for  the  tissue  engineering  of  cartilage  by  using  P(3HB-co-3HV)  and 
implanted the scaffolds into full thickness cartilage defects (4.5 mm in diameter and 
4 mm in depth) in the knee joint of rabbits. Early cartilage formation resembling 
normal AC and complete resurfacing in the grafted area was demonstrated by 20 
weeks.  Nanofibrous  scaffolds  with  ultrastructure  that  mimics  the  collagen  fibril 
meshwork of the native AC were also produced by electrospinning. Studies carried 
out  by  Lee  et  al.  (2004)  and  Kwon  et  al.  (2007)  demonstrated  an  enhanced 
attachment  of  chondrocytes  on  the  surface  of  electrospun  P(3HB-co-3HV) 
nanofibrous mats, in comparison to on a flat solution cast film.  
 
The  P(3HB-co-3HHx)  copolymers  were  mainly  used  by  blending  with  P(3HB). 
Rabbit articular chondrocytes were found to have higher proliferation on the blend of 
P(3HB-co-3HHx)/P(3HB)  than  on  P(3HB)  alone  (Deng  et  al.,  2002).  Improved 
mechanical properties were also found on the blends of P(3HB-co-3HHx)/P(3HB), 
in comparison to on P(3HB-co-3HHx) alone (Kai et al., 2003). A polymer blend that 
exhibits  a  lower  crystallisation  degree  can  improve  the  surface  morphology,  and 
hence, promote better cell attachments and growth.  
 
Mild inflammatory reaction and synovitis has been reported when employing PHAs 
(Köse et al., 2005, Duvernoy et al., 1995, Chaput et al., 1995). These adverse effects 
may be due to the residual proteins, surfactants, endotoxin, or potent pyrogen that 
are remained in the polymers, because most of the commercially available PHAs and 
the procedures involved in their purification were not developed for the specifically 
high purification standards required for medical implant application (Williams et al., 
1999). So far, besides the most commonly available P(3HB), homopolymer of PHAs 
that can be synthesised at high yield in the laboratory is P(3HO). The present study 
produced  nanofibrous  scaffolds  by  blending  both  P(3HB)  and  P(3HO)  and 
electrospinning them into nanofibrils. The mechanical properties of the electrospun 
P(3HB)/P(3HO) scaffolds can be tailored to those of the collagen meshwork in AC 
by controlling the composition of monomers in the blends. 
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3.2   Materials and methods 
 
3.2.1  Electrospinning of P(3HB)/P(3HO) scaffolds 
 
Both  P(3HB)  and  P(3HO)  polymers  were  kindly  provided  by  the  Department  of 
Applied and Molecular Sciences, University of Westminster, UK. The production 
and purification of the polymers was done as described elsewhere (Basnett et al., 
2013,  Rai  et  al.,  2011).  In  brief,  P(3HB)  was  produced  by  the  Gram-positive 
bacterium Bacillus cereus SPV using glucose as the sole carbon source, whereas 
P(3HO) was produced  by the  Gram-negative bacterium Pseudomonas  mendocina 
using mineral salt medium. Both the P(3HB) and P(3HO) polymers were extracted 
using  the  chloroform/sodium  hypochlorite  dispersion  method.  The  P(3HO)  was 
further  purified  by  dissolving  in  acetone  and  precipitating  in  methanol/ethanol 
solution to remove the contaminating lipopolysaccharides. To produce the scaffolds, 
P(3HB)/P(3HO) were blended at weight ratios of 1:0.25, 1:0.43, 1:0.67 and 1:1. The 
blends were dissolved in chloroform (anhydrous 99%; 288306; Sigma-Aldrich) to 
produce polymer solutions with concentration of 30% (w/w) for electrospinning.  
 
Electrospinning was performed in a custom-made chamber at room temperature and 
under atmospheric conditions. The electrospinning apparatus mainly consists of a 
high voltage power supply (PS/EL30R01.5-22; Glassman High Voltage, Hampshire, 
UK),  and  a  stainless  steel  needle  spinneret,  which  was  connected  to  a  grounded 
aluminium  plate  covered  with  an  aluminium  foil  collector  (14  ×  14  cm).  The 
electrospinning solution was controlled by a syringe pump (KD Scientific, Holliston, 
MA) at a flow rate of 5 µl/min. A solution flow rate of 5 µl/min was employed as it 
was the lowest possible flow rate that allowing the electrospinning to occur while 
preventing the polymer jet from solidifying before being ejected from the spinneret.  
The voltage was increased to ~12 kV, at which a Taylor cone was produced (see 
Section 2.1). A glass slide was placed in front of the collector to collect fibrils for 
examination  under  light  microscopy.  The  distance  between  the  spinneret  and 
collector was adjusted to ~20 cm, for the formation of a stable jet and minimum 
amount  of  bead  defects.  Fibrils  were  deposited  layer  by  layer  on  the  collector, 
forming a non-woven fibrous scaffold.  
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3.2.2  Preparation of human articular cartilage   
 
Small  pieces  of  human  AC  with  no  apparent  signs  of  damage  or  disease  were 
dissected from the femoral head of patients undergoing hip replacement surgery at 
the Southampton General Hospital, with the approval of the Southampton General 
Hospital and South West Hants Local research Ethnics Committee (LREC 194/99/1 
& 210/01). The proteoglycan content was extracted in phosphate buffered solutions 
(PBS; H15-002; PAA Laboratories, Pasching, Austria) containing 1 mg/ml bovine 
hyaluronidase (type I; H3506; Sigma-Aldrich) and 1 mg/ml trypsin (Trypsin-EDTA; 
T4174; Sigma-Aldrich) at 37ºC for 3 days. These specimens were then ﬁxed in 4% 
paraformaldehyde (P/0840/53; Fisher Scientific, Loughborough, UK) in PBS for 4 
hours at room temperature, rinsed with water and dehydrated in a series of graded 
ethanol. 
 
 
3.2.3  Characterisation of scaffold structure 
 
3.2.3.1 Scanning electron microscopy 
 
The structure of scaffolds and human AC was investigated by SEM (JSM-6500F; 
JEOL, Tokyo, Japan). Prior to imaging, all the samples were gold coated with a 
sputter coating system (Hummer 6.2 Sputter System; Anatech, Union  City, CA). 
Images  were  obtained  using  an  emission  current  of  10  µA  and  an  accelerating 
voltage of 10 kV.   
 
 
3.2.3.2 Atomic force microscopy 
 
Atomic  force  microscopy  (MFP-3D;  Asylum  Research,  Santa  Barbara,  CA)  was 
employed for imaging the electrospun P(3HB)/P(3HO) fibrils, using a rectangular 
cantilever with a sharp pyramidal tip and nominal spring constant of 6.8 N/m (type 
NCSTR; Nanoworld, Neuchatel, Switzerland).  Tapping mode  was  employed at  a 
scan rate of 0.5 Hz. For each sample, images of at least 3 fibrils were recorded. The 
surface roughness was calculated as root mean square (RMS). 46 
 
3.2.4  Water contact angle analysis 
 
The contact angle, θ, is defined as the angle between the surface of the liquid and the 
outline of the contact surface when an interface exists between a liquid and a solid. 
The contact angle (wetting angle) is a measure of the wettability of a solid by a 
liquid.  According  to  the  literature,  materials  with  a  θ  value  less  than  90°  are 
considered  as  hydrophilic,  whereas  those  with  θ  value  greater  than  90°  are 
hydrophobic. The wettability of electrospun P(3HB)/P(3HO) scaffolds was measured 
using a drop shape analysis system (DSA; DSA100S; Krüss, Hamburg, Germany). 
The DSA software controlled liquid dosing unit dispensed droplets of distilled water 
with a volume of 1 µl. A volume of 1 µl allows a spherical droplet to be formed as a 
result of water surface tension and the effect of gravity is minimal. After placing the 
droplet  onto  the  sample,  an  image  of  the  drop  was  recorded  using  a  camera,  as 
shown in Figure 3.5.  
 
 
Figure 3.5: A sessile drop on the electrospun fibrous scaffold during water contact 
angle analysis. The shape of the droplet is assumed to be part of the outline of an 
imaginary  circle.  The  contact  angle,  θ,  is  determined  as  the  angle  between  the 
surface and the tangent to the circular shaped droplet. 
 
Next, the image was transferred to the water contact angle analysis software (Drop 
Shape Analysis 1.9). The contact angle was determined by the angle between the 
calculated  drop  shape  function  and  the  sample  surface.  Six  images  at  different 
locations were averaged for each sample. 
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3.2.5  Fourier transform infrared spectroscopy  
 
The presence of chemical functional groups in a particular sample can be determined 
from  the  IR  absorption  bands.  The  vibration  of  atoms  and  chemical  bonds  in  a 
molecule  absorbs  characteristic  frequencies  of  IR  radiation  and  produces  IR 
absorption spectra that are generally presented as wavenumbers (unit of cm
-1). The 
wavenumber defines the number of waves per unit length and is directly proportional 
to the frequency, as well as the energy of the IR absorption. The chemical functional 
groups present in the raw P(3HB) and P(3HO) and blends of the two at different 
compositions  were  identified  using  a  FTIR  spectrometer  (Thermo  Nicolet  380; 
Thermo Electron Scientific Instrument, Madison, WI) equipped with a Smart Orbit 
detector and OMNIC 32 software. The FTIR spectra were recorded in the range of 
4000-400 cm
-1 at a resolution of 8 cm
-1. A total of 32 scans were used for signal 
averaging. Spectra analysis was done by referring to the correlation table (Appendix 
A). 
 
 
3.3  Results  
 
3.3.1  Structure of P(3HB)/P(3HO) scaffolds 
 
P(3HB) and P(3HO) were blended at different ratios and electrospun into almost 
defect-free solid fibrils. The fibrils were randomly oriented, similar to the collagen 
fibril meshwork in native cartilage. Figure 3.6, A and B show the collagen fibril 
meshwork in human AC after enzymatic extraction of the proteoglycan and cellular 
contents. As shown in Figure 3.6, C-F, the electrospun fibrils generally exhibited 
larger fibril sizes than the collagen fibrils. Clear boundaries between the fibrils can 
be  seen,  with  some  crosslinkages  between  fibrils  at  the  junctions.  Even  after 
immersing in the PBS solution for 7 days, the scaffolds were structurally similar 
(results not shown).  
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Figure 3.6: SEM micrographs comparing the collagen meshwork of AC with the 
scaffolds made of  electrospun P(3HB)/P(3HO) fibrils. (A,  B) The  collagen fibril 
meshwork  of  human  AC  after  proteoglycan  and  cellular  extraction  consists  of  a 
pseudo-random meshwork of smooth collagen fibrils. Scale bars: 500 nm (A), 2 µm 
(B). (C-F) Electrospun fibrils with smooth surfaces and different diameters were 
fabricated  from  different  ratios  of  P(3HB)/P(3HO):  (C)  1:0.25,  (D)  1:0.43,  (E) 
1:0.67, and (F) 1:1. Crosslinkages between some fibrils can be observed as indicated 
by the white arrow heads. Scale bars: 2 µm (C-F). 
 
The  fibril  diameters  shown  in  Figure  3.7  were  calculated  as  averages  from 
approximately  50  fibrils.  The  scaffold  with  a  P(3HB)/P(3HO)  ratio  of  1:0.25 
exhibited the smallest fibril size of 336 ± 98 nm, which is approximately sixfold 
larger than the average diameter of collagen fibrils (54 ± 7 nm). The diameter of 49 
 
fibrils increased with the increasing composition of P(3HO) in the blend systems.  
 
 
Figure  3.7:  Average  diameters  of  electrospun  P(3HB)/P(3HO)  fibrils  with 
increasing composition of P(3HO), in comparison to the diameter of collagen fibrils 
in human AC.  
 
Figure 3.8 shows AFM height images of single fibril surfaces and their 3D profiles. 
A variety of protrusions and pores are visible on the fibril surfaces. The presence of 
these protrusions and pores increased with increasing composition of P(3HO). The 
roughness of each fibril surface was averaged from three fibrils and displayed as 
RMS values in Table 3.1. The surface roughness increased on scaffolds that contain 
higher P(3HO) composition.  
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Figure  3.8:  AFM  height  images  (A,  C,  E,  G)  and  3D  images  (B,  D,  F,  H)  of 
P(3HB)/P(3HO) single fibril with the ratio of: (A, B) 1:0.25, (C, D) 1:0.43, (E, F) 
1:0.67 and (G, H) 1:1. Pores and protrusions are observed on all samples. 51 
 
Table 3.1: The RMS values of electrospun P(3HB)/P(3HO) fibrils measured with 
AFM. 
P(3HB)/P(3HO) ratio  1:0.25  1:0.43  1:0.67  1:1 
RMS (nm)  14.6 ± 6.7  32.4 ± 13.7  44.4 ± 22.9  44.8 ± 6.7 
 
 
3.3.2  Water contact angle measurement on P(3HB)/P(3HO) scaffolds 
 
Water contact angles were measured from the angle between a sessile drop contour 
function and the sample surface. Figure 3.9 shows the average water contact angle 
on the electrospun P(3HB)/P(3HO) scaffolds. In general, water contact angle of all 
samples  read  higher  than  120°,  indicating  their  intrinsic  hydrophobicity.  The 
P(3HB)/P(3HO) 1:0.25 scaffold exhibited the highest water contact angle among the 
four  scaffolds,  which  was  approximately  127º.  With  increasing  composition  of 
P(3HO), there was a slight decrease in the contact angle.  
 
 
 
Figure  3.9:  Water  contact  angle  measurement  on  four  different  blends  of 
P(3HB)/P(3HO).  The  water  contact  angle  slightly  decreased  with  an  increasing 
composition of P(3HO), but the increment is not statistical significant.   
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3.3.3  Chemical functional groups of P(3HB)/P(3HO) scaffolds 
 
Figure 3.10 shows the FTIR spectra of raw P(3HB), raw P(3HO) and the electrospun 
scaffolds  with  different  P(3HB)/P(3HO)  ratios.  The  analysis  of  spectra  is 
documented in Table 3.2. FTIR spectroscopy is capable of detecting the chemical 
functional groups present in an individual polymer, as well as showing the combined 
spectra of a blends of different polymers. The most prominent absorption band in all 
the FTIR spectra is visible at ~1720 cm
-1, corresponding to the absorption band of 
the ester carbonyl group (C=O), which is the main functional group of PHAs. The 
highly crystalline P(3HB) shows a lower C=O absorption band, at 1720 cm
-1. The 
blends  of  P(3HB)/P(3HO)  also  exhibited  C=O  absorption  band  at  a  similar 
wavenumber. The C=O absorption band slightly shifted to higher wavenumbers with 
increasing amount of P(3HO), which reflects the decreased level of crystallinity in 
the polymer. The C=O absorption band was at 1722 cm
-1 for P(3HB)/P(3HO) 1:1 
and  1729  cm
-1  for  P(3HO),  indicating  the  more  amorphous  nature  of  P(3HO) 
(Furukawa et al., 2006). The crystalline structure of P(3HB) is further confirmed by 
the presence of the crystalline phase C-O-C stretching at 1276 cm
-1, which was not 
detected in the raw P(3HO). The crystalline phase of C-O-C in P(3HB) also shows 
an absorption band at 1181 cm
-1, but this absorption band was shifted to a lower 
band at 1161 cm
-1 for raw P(3HO).  
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Figure  3.10:  FTIR  spectra  comparing  raw  P(3HB),  raw  P(3HO)  and  the  four 
different blends of P(3HB)/P(3HO).  
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Table  3.2: FTIR spectra analysis for the raw P(3HB), raw P(3HO) and the four 
different blends of P(3HB)/P(3HO). 
  Wave number (cm
-1)  Assignment 
Raw 
P(3HB) 
2976  Symmetric stretching mode of CH3 
2934  Asymmetric stretching mode of CH2 
2875  Asymmetric stretching mode of CH3 
1720  Stretching mode of C=O (crystalline phase) 
1524  Deformation mode of N-H of amide (Amide band II) 
1453  Asymmetric bending mode of CH3 
1379  Symmetric bending mode CH3 
1276, 1181  Stretching mode of C-O-C (crystalline phase) 
Raw 
P(3HO) 
3748  Stretching mode of O-H from polymer end group 
3370  Stretching mode of N-H 
2956  Symmetric stretching mode of CH3 
2929  Asymmetric stretching mode of CH2 
2859  Symmetric stretching mode of CH2  
1729  Stretching mode of C=O (amorphous phase) 
1650  Stretching mode of C=O of amides (Amide band I) 
1557  Deformation mode of N-H of amide (Amide band II) 
1316  Amide band III 
1458  Asymmetric bending mode of CH3 
1378  Symmetric bending mode CH3 
1161  Stretching mode of C-O-C (amorphous phase) 
725  Rocking mode of CH2 
 
Absorption bands due to the symmetric and asymmetric C-H stretching in methyl 
group (CH3) and methylene group (CH2) of all samples are mainly at the higher 
wavenumber  of  the  spectrum,  i.e.,  in  the  region  of  3000-2850  cm
-1.  The  C-H 
stretching bands are readily differentiated depending on the molecules they are in: 
CH3 or CH2 groups; and the types of stretching: symmetric or asymmetric stretching. 
For P(3HB), symmetric C-H stretching of CH3, asymmetric C-H stretching of CH2 
and  of  CH3  were  observed  at  2976,  2934  and  2875  cm
-1,  respectively.  Similar 55 
 
absorption  bands  were  found  in  the  P(3HB)/P(3HO)  blends.  For  P(3HO),  the 
asymmetric C-H stretching of CH2 at 2929 cm
-1 is the strongest C-H stretching band 
and the symmetric C-H stretching of CH2 at 2859 cm
-1 might have overlapped the 
asymmetric stretching band of CH3. Meanwhile, the C-H bending vibrations were 
mainly in the region of 1470-1350 cm
-1 and did not provide much information to 
distinguish between P(3HB) and P(3HO). A significant absorption band at 725 cm
-1 
was present in the raw P(3HO) but absent in the raw P(3HB) is the rocking vibration 
mode of CH2. Its intensity decreased with the decreasing amount of P(3HO) in the 
P(3HB)/P(3HO) blends. This CH2 rocking vibration mode only appears when there 
are four or more CH2 groups existing in a polymer chain (Stuart, 2004), as can be 
seen in P(3HO) with a pentyl pendant group (C5H11). It was absent in P(3HB) that 
does not have CH2 group longer than one carbon atom.  
 
 
Absorption bands due to the presence of protein was also detected in the raw P(3HO), 
indicated by the stretching band of C=O bond of amides at 1650 cm
-1 (usually called 
Amide band  I), out-of-phase combination of N-H bending  and C-N stretching  at 
1557 cm
-1 (usually called Amide band II), and in-phase combination of N-H bending 
and C-N stretching at 1313 cm
-1 (usually called Amide III). The sharp absorption 
band at 3748 cm
-1 is due to free N-H stretching, while the broad absorption band at 
3370 cm
-1 is the result of N-H stretching with the effect of hydrogen bonding. The 
presence of these bands indicates that some protein residues were precipitated and 
extracted together during purification of the polymers.  
 
 
3.4  Discussion 
 
3.4.1  Structure of P(3HB)/P(3HO) scaffolds 
 
Meshworks of various blends of P(3HB)/P(3HO) were produced by electrospinning 
to  mimic  the  native  collagen  meshwork  in  AC  in  terms  of  its  structure  and 
mechanical properties. The scaffolds formed of fine fibrils featuring a high surface 
area-volume ratio, interconnectivity and pore void volume. These structures have 
been proven to facilitate cell attachment onto the fibrils, penetration in between the 
voids and maintenance of their phenotype (Stevens and George, 2005, Coburn et al., 56 
 
2012). The fibril diameter and surface topography produced from P(3HB)/P(3HO) is 
dependent on the experimental setup (solution flow rate and acceleration voltage) 
and on the polymer chemistry. P(3HB) is the member of the PHA family with the 
simplest chemical structure, a linear 3-carbon atom polyester with a CH3 pendant 
group. It has a regular molecular structure with all the pendant groups in the polymer 
chain pointing into the same direction. This so-called isotactic structure causes the 
chains to form helical structures, with the pendant groups all pointing away from the 
centre of the helix to minimise steric hindrance. The chains easily pack together to 
form crystals, which makes the P(3HB) brittle and stiff. To improve its flexibility, 
P(3HB) can be blended with P(3HO), which has a C5H11 pendant group. This long 
pendant group inhibits the close packing of P(3HO) in a regular 3D fashion to form 
crystalline array (Sanchez et al., 2003), giving P(3HO) its amorphous and flexible 
properties. It also reduces the potential for electrostatic force to stretch the polymer 
fibrils when the elctrospun jet was ejected from the spinneret to the collector (Lyons 
et al., 2004). The different blends in Figure 3.6 document that through blending 
P(3HB) with P(3HO), the overall structure of the polymer becomes irregular with a 
reduced crystallinity, which results into increased fibril diameters with an increasing 
amount of P(3HO) in the blends.  
 
Without the need of crosslinking agents, the P(3HB)/P(3HO) scaffolds demonstrate a 
stable conformation, even after being immersed for several days in PBS solution. 
The structure stability is contributed by the molecular structure of PHAs, which has 
a  C=O  bond  oriented  perpendicular  to  the  polymer  backbone.  Consequently,  the 
polymer  backbone  can  orientate  along  the  fibril  axis,  with  the  C=O  bond  aligns 
perpendicular to the fibril axis (Chan et al., 2009). As illustrated in Figure 3.11, this 
configuration is further enhanced by the hydrogen bonding between the CH3 group 
and C=O group (C-H···O=C) in PHAs (Hu et al., 2006, Sato et al., 2004).  
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Figure 3.11: Hydrogen bonding (light blue shaded) between the H atoms of the C-H 
bonds of the CH3 group and the O atoms of the C=O groups (Sato et al., 2004). 
 
Another factor that stabilizes the non-woven fibrils may be the “pseudo crosslinks” 
between the adjacent polymer chains. “Pseudo crosslinks” exists due to the hydrogen 
bonding introduced by water in the PHAs. Water is an integral component of PHAs 
granule and acts as a plasticizer for the polymers (Barnard and Sanders, 1989). The 
presence  of  water  allows  the  existence  of  hydrogen  bonding  between  the  water 
molecules  and  the  carbonyl  groups  of  PHAs  backbone  (Sudesh  et  al.,  2000, 
Ravenelle  et  al.,  2002).  “Pseudo  crosslinks”  can  be  destroyed  by  heat  during 
processing  of  the  polymer  and  re-appear  when  the  polymer  cools  down.  The 
hydrogen  bonding  allows  for  an  interconnection  between  the  fibrils,  and  hence, 
forming a 3D network among the fibrils (Vaz et al., 2010). 
 
By  using  P(3HB)/P(3HO)  ratio  of  1:0.25,  the  current  electrospinning  set-up 
produced fibrils with diameters of approximately 336 nm, which are almost sixfold 
larger than the collagen fibrils of approximately 54 nm (Fig. 3.7). The electrospun 
fibril size is largely dependent on the viscosity of polymer solution, the ejection flow 
rate, the applied voltage and the distance between the spinneret and the collector. To 
produce fibrils with smaller diameter size as in native AC, the viscosity of polymer 
solution and the ejection flow rate need to be lowered and all other experimental 
parameters  need  to  be  adjusted.  In  addition,  the  electrospinning  of  fibrils  with  a 
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smaller  diameter  requires  a  much  longer  electrospinning  time  to  build  up  the 
scaffolds.   
 
Despite the considerable changes on the fibril diameter with response to the blend 
compositions (Fig. 3.7), as shown in Figure 3.8, changes on the surface roughness 
were relatively smaller. The surface roughness of a material is largely dependent on 
the evaporation rate of the solvent. A slow evaporation rate allows for the formation 
of a smother surface (Zhu et al., 2012). The relatively small differences of surface 
roughness obtained with the different compositions of P(3HB)/P(3HO) suggests that 
the surface morphologies of electrospun fibrils are more affected by the experimental 
conditions,  rather  than  by  the  chemistry  of  the  components.  This  is  a  major 
difference compared to other fabrication techniques such as solution casting, where 
the  surface  roughness  of  the  films  is  significantly  determined  by  the  polymer 
chemistry. Previous researches on solution cast films made of P(3HB)/P(3HO) and 
P(3HB)/P(3-HB-co-3HHx)  both  revealed  significantly  reduction  of  surface 
roughness  with  the  increasing  amount  of  P(3HO)  or  P(3HB-co-3HHx).  Both  the 
P(3HO)  and  P(3HHx)  have  longer  alkyl  pendant  groups,  and,  therefore,  exhibit 
slower  crystallisation  rates  compared  to  P(3HB).  A  slower  crystallisation  rate 
provides enough time for molecules to rearrange in the polymers and allow them to 
release the stress during crystallization process. This produces a smoother surface 
morphology  (Kai  et  al.,  2003).  In  the  electrospinning  process,  the  high  speed 
whipping of the polymer jet when it travels through the voltage gradient allows for 
an effective evaporation of the solvent, therefore, the effects of polymer chemistry 
and crystallization rate are less significant for fibril formation. 
 
 
3.4.2  Hydrophilicity of P(3HB)/P(3HO) scaffolds 
 
Wetting is an important surface property, as it  determines the water uptake of a 
scaffold  and  influences  the  hydrolytic  degradation  property.  Wetting  can  be 
controlled  by  both  the  chemical  nature  and  the  geometrical  structure.  The 
hydrophilicity  of  PHAs  is  determined  by  the  ratio  between  the  number  of  ester 
groups  and  the  number  of  carbon  atoms  along  the  chain.  The  P(3HB)  monomer 
comprises only 4 carbon atoms, and is more hydrophilic compared to P(3HO) that 59 
 
has 8 carbon atoms in its monomer. As shown previously, the water contact angle of 
P(3HB)/P(3HO)  solution  cast  films  increased  with  the  increasing  composition  of 
P(3HO) (Basnett et al., 2013). Conversely, as shown in Figure 3.9, the water contact 
angle of electrospun P(3HB)/P(3HO) scaffolds slightly decreased with an increasing 
P(3HO) composition. This indicates that the surface hydrophilicity was not primarily 
due to the polymer chemistry but also affected by the geometrical structure. Due to 
the size and random orientation of the fibrils, and also the interconnection between 
the  internal  spaces,  the  electrospun  fibrous  scaffolds  exhibit  a  more  complex 
structure  compared  to  the  solution  cast  films.  As  shown  in  Figure  3.6,  the 
electrospun fibril size increased with the increasing composition of P(3HO). The 
P(3HB)/P(3HO)  1:0.25  scaffold  exhibited  the  smallest  fibril  size,  which  the 
accumulation of these small fibrils will give rise to dense fibrous mats with low 
porosity. During the initial contact with water (the first few seconds in the water 
contact  angle  measurement),  these  dense  fibrils  may  inhibit  the  water  from 
penetrating effectively in between the fibrils. Due to the more complex structure and 
more air that is trapped between the small fibrils, scaffolds with a smaller fibril size 
provide a smaller contact area between the water droplet and the scaffolds. Therefore, 
the anti-wetting property is increased (Zhu et al., 2006). In addition, due to a higher 
surface  roughness  contributed  by  the  randomly  oriented  fibril  meshworks,  the 
electrospun scaffolds generally exhibit a higher water contact angle than solution 
cast films (Zhu et al., 2012).  
 
 
3.4.3   Chemical functional groups of P(3HB)/P(3HO) scaffolds 
 
Changes in the FTIR spectra provide information on the crystallinity of a polymer. 
For PHAs, the two most polar bonds are the C=O and C-O bonds, and the actual 
wavenumbers  of  the  absorption  bands  of  these  two  bonds  show  the  degree  of 
crystallinity. The C=O stretching band for polyesters typically occurs at 1750-1730 
cm
-1  (Stuart,  2004).  However,  the  absorption  bands  due  to  C=O  stretching  were 
relatively lower in the present study, recorded at 1729 cm
-1 for raw P(3HO), and 
shifted to a lower band at 1720 cm
-1 for raw P(3HB). The lower C=O absorption 
bands indicates that the crystallinity of PHAs is generally higher compared to other 
polyesters, whereas among the PHA polymers, P(3HB) exhibit a higher crystallinity 60 
 
than P(3HO) (Hong et al., 1999). From the structural point of view and as illustrated 
in Figure 3.11, a more crystalline structure exhibits a stronger hydrogen bonding 
between the oxygen atom of the C=O group and hydrogen atom of the CH3 group 
(C-H•••O=C), i.e., the distance between H•••O is closer (Xu et al., 2002, Guo et al., 
2010).  This  weakens  the  C=O  bond  and  results  in  a  lower  stretching  frequency 
(Colthup et al., 1975). Therefore, the stronger the hydrogen bonding, the larger is the 
frequency shift. As the crystallinity of polymers decreases from P(3HB) to P(3HO), 
the structure of P(3HO) is less ordered and the effects of hydrogen bonding towards 
the stretching frequency of C=O are reduced, thus the frequency shift is smaller, 
resulting in a C=O absorption band at 1729 cm
-1. The crystalline structure of P(3HB) 
was further confirmed by a strong C-O-C stretching band at 1276 cm
-1 (Furukawa et 
al., 2006). This crystalline-sensitive band was detected in the raw P(3HB) and in 
blends of P(3HB)/P(3HO), but it was absent in the raw P(3HO) due to the relatively 
amorphous nature of P(3HO) (Choi et al., 2004). The presence of hydrogen bonding 
is  essential  for  stabilizing  the  electrospun  fibril  structure.  Due  to  the  stronger 
hydrogen bonding, scaffolds with a higher composition of P(3HB) are exhibiting a 
more stable structure. 
 
The detection of absorption bands attributed to Amide band I, II and III shows that 
there are residues of membrane-associated proteins and lipids left on the polymers 
(Xiao and Jiao, 2011, Kansiz et al., 2000, Hong et al., 1999). As shown in Figure 3.1, 
the surface of intracellular PHA granules is surrounded by a 15-20 nm thin layer of 
granule-associated  proteins  and  lipids  (Potter  and  Steinbuchel,  2005,  Ellar  et  al., 
1968). In the PHAs granules, there are approximately 97.5% PHAs, 2% protein and 
0.5% lipid (Griebel et al., 1968). During the extraction of PHAs, the PHA granules 
are dissolved in chloroform, followed by separation of the dissolved PHAs from the 
undissolved non-polymer cell materials. However, some of the proteins and lipids 
might also be soluble in the chloroform and co-precipitate with the polymers (Rai et 
al., 2011, Valappil et al., 2007). The absorption bands due to the presence of these 
membrane-associated proteins and lipids were mainly detected in P(3HO), but were 
almost negligible in P(3HB) sample. This may be explained by the relatively lower 
composition of these protein and lipid components in the P(3HB).  
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3.5  Summary 
 
Electrospinning of P(3HB)/P(3HO) produced randomly oriented fibril meshworks 
that  allow  to  closely  mimic  the  collagen  fibril  meshwork  in  native  AC.  These 
meshworks exhibit a stable conformation due to the presence of hydrogen bonding in 
the  polymer  chains,  which  was  also  confirmed  by  FTIR  spectroscopy.  By  using 
different compositions of P(3HB)/P(3HO), scaffolds with different fibril sizes were 
produced. A P(3HB)/P(3HO) ratio of 1:0.25 produced the smallest fibril size, which 
is sixfold larger than the average diameter of collagen  fibrils; and the fibril size 
increased with an increasing composition of P(3HO) in the blends. In comparison to 
the significant variations in fibril sizes, the effects of blend compositions on the 
surface roughness of fibrils were lesser, due to effective solvent evaporation and 
fibril solidification during electrospinning process. In comparison to other scaffold 
fabrication  techniques,  electrospinning  produces  scaffolds  with  a  more  complex 
structure and a wettability behaviour that was mainly affected by the fibril size, but 
not the polymer chemistry. The electrospun scaffolds exhibited a lower wettability 
behaviour compared to scaffolds fabricated with other techniques.  
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CHAPTER 4 
 
STIFFNESS OF P(3HB)/P(3HO) SCAFFOLDS 
 
 
4.1  Poroviscoelastic properties of articular cartilage 
 
Articular cartilage is a biologically active and rheologically unique structure. It can 
be described as a porous structure that is filled with interstitial fluid. The viscoelastic 
properties of cartilage are the result of (1) a fluid flow within the tissue, which is 
adding to (2) the intrinsic viscoelastic properties of the solid matrix inherent in any 
polymer  (Fung,  1993).  When  a  load  is  applied  onto  the  joint  and  removed 
instantaneously, the AC acts as an elastic solid and behaves resilient. It deforms 
briefly until the load is removed and then returns to its normal shape. When a load is 
applied at a slow rate, the extracellular matrix of AC deforms slowly with a phase 
shift between the applied load and the material’s response. The reduction in volume 
leads to the extrusion of fluid, an increase of charge density  among the charged 
GAGs and the overall tissue’s viscoelastic behaviour. When the load is removed, the 
proteoglycans recoil and the fluid flows back into the interstices of the tissue. This 
slow movement of fluid is often described as the cartilage’s poroviscous behaviour 
(Dewire and Einhorn, 2001, Bader and Kempson, 1994, Shepherd and Seedhom, 
1997).  
 
 
4.2  Measuring the poroviscoelastic properties of articular cartilage   
 
4.2.1  Compression test 
 
Since AC is mainly subjected to compressive forces, compression testing is the most 
straight forward method for measuring the primary function of AC. One of the most 
extensively  studied  compressive  testing  methods  is  the  uniaxial  confined 
compression test as shown in Figure 4.1.  64 
 
 
Figure  4.1:  Schematic  of  a  confined  compression  test  to  study  the  compressive 
behaviour of AC. A cartilage sample is placed in a confined chamber with a solid 
platform and a water permeable rigid-porous filter. The chamber is surrounded by 
bathing solution that represents the fluid surrounding the cartilage in physiological 
conditions.  Load,  PA,  is  applied  to  the  cartilage  sample  through  porous  filter.  h: 
cartilage thickness; z: displacement coordinate (Mow et al., 2005). 
 
During the measurement, a parallel cut piece of cartilage is compressed under quasi-
static loading conditions, while its lateral expansion is prevented by the confined 
chamber. The interstitial fluid is extruded out of the cartilage and allowed to escape 
through  the  porous  filter,  causing  creep  deformation.  The  aggregate  modulus  is 
determined at creep equilibrium, which can extend from 2.5 to 6.0 hours (Mow et al., 
2005). Since at creep equilibrium, there is no fluid flow or pressure gradients present 
within the tissue, the compressive modulus will reflect the ‘intrinsic’ compressive 
stiffness of the cartilage solid matrix. Under these test conditions, the entire load is 
assumed to be borne by the compressed collagen-proteoglycan solid matrix (Mow et 
al., 2005).  
 
Despite  the  fact  that  collagen-proteoglycan  solid  matrix  of  AC  shows  a  highly 
poroviscoelastic behaviour, the results obtained from quasi-static compression tests 
are not sensitive and do not reflect this intrinsic poroviscoelasticity behaviour. It is 
also difficult to uncouple both the elastic and viscoelastic responses from a simple 
compression test, because it is difficult to define the point at which fluid flow starts 
(Bader and Kempson, 1994). Another limitation of quasi-static compression tests is 
the  requirement  of  highly  parallel  top  and  bottom  surfaces,  which  can  only  be 
achieved  by  cutting  the  cartilage  off  the  bone  and  trimming  the  curve  articular 
specimens.  Such  a  process  is  problematic  as  it  will  alter  the  collagen  network 
structure and hence mechanical response of the tissue under loading.  65 
 
4.2.2  Indentation test    
 
A  simple  method  for  measuring  the  viscoelasticity  of  AC  is  the  indentation  test 
(Fung, 1993). Indentation tests have traditionally evolved from indentation hardness 
tests and have been used to determine the resistance of a material to deformation. 
Indentation tests are conducted by pressing an indenter tip with specific geometry 
into  the  materials  to  be  tested.  Forces  and  displacements  are  measured 
simultaneously. The load placed on the indenter tip increases as the tip penetrates the 
surface of the sample to either a desired depth or an applied force. The four most 
commonly  used  indenter  geometries  are  Vickers  pyramid,  Berkovich  pyramid, 
sphere and cube edge. For evaluating the mechanical properties of AC, flat-ended 
cylindrical  or  spherical  probes  with  diameters  of  a  few  millimetres  have  been 
developed (Aspden et al., 1991, Lyyra et al., 1995, Appleyard et al., 2001). Such 
relatively  large  scale  clinical  indenters  average  the  mechanical  properties,  in 
particular, the viscoelastic nature of the biological tissue over a large volume, i.e., 
several mm
3 of material. As the direction of biological science continues towards 
studying the basis of properties on much smaller scales, IT-AFM has been explored 
to measure the mechanical properties of biological tissues and soft polymers.  
 
 
4.2.2.1 Indentation-type atomic force microscopy 
 
The capabilities of AFM have been rapidly expanding beyond topographical imaging 
to also allow the measurement of mechanical properties. One of the most common 
mechanical tests that can be performed by AFM is the indentation test, to measure 
the elastic modulus, or more generally spoken the stiffness. The high force resolution 
of  AFM  allows  to  apply  well-defined  small  forces  by  using  a  sharp  tip  as  the 
indenter to measure the local response of a sample. The movement of the tip is 
controlled by a position transducer. When the tip is indented into the sample, the 
deflection of the cantilever is monitored. Depending on the stiffness of the sample, 
the indentation of the tip into the sample can be deduced from the z-displacement of 
the position transducer. A displacement-deflection curve is analysed and the elastic 
modulus or the stiffness can be calculated from the curve. Figure 4.2 shows the 
principal components of an AFM.  66 
 
 
Figure 4.2: Schematic representation of the principal components of an AFM. A tip 
at the end of cantilever is used for indenting the sample. The deflection of cantilever 
is monitored by a laser beam that is reflected from the back of the cantilever onto a 
position  sensitive  photodiode.  A  position  transducer  is  used  for  controlling  the 
movement of the sample and cantilever [adapted from Stolz et al. (2003)]. 
 
The  AFM  is  based  on  piezoelectric  actuators;  it  has  far  greater  dimensional 
sensitivity compared to conventional indentation testing devices. The utilisation of 
AFM as a tool for quantitative determination of local stiffness properties was first 
demonstrated  by  Tao  and  Lindsay  (Tao  et  al.,  1992).  Since  then,  it  has  been 
employed to determine the stiffness of hard and soft samples including polyurethane, 
rubber, cartilage and living cells (Weisenhorn et al., 1993). The requirements for a 
very  low  force  and  penetration  depth  allow  for  indentation  testing  on  a  smaller 
volume of materials at nanometre scales. Two-dimensional mapping of the sample 
stiffness can be achieved by raster-scanning across the sample (Radmacher et al., 
1994). In this so-called force-mapping mode the stiffness properties of an area of 
location can be mapped with a lateral resolution of only a few nanometres. Recent 
exploration on IT-AFM even allows examining the extracellular matrix molecular 
components and their interactions, as well as the tissue-level mechanical properties. 
Such multi-scale measurements can further improve the understanding of cartilage in 67 
 
health and disease states from a molecular to a macroscopic perspective (Han et al., 
2011).  
 
The local variations on the stiffness properties of AC at both the micrometre and 
nanometre scales can be performed when utilising probes of different sizes (Stolz et 
al., 2004, Stolz et al., 2009, Loparic et al., 2010). As shown in Figure 4.3, stiffness 
data with a unimodal distribution was revealed when a micrometre-sized spherical 
probe was used, whereas a bimodal distribution was obtained with a nanometre-sized 
pyramidal probe. This is because at the micrometre scale, the load is distributed 
across components in AC and the overall mechanical properties of a local tissue 
were  measured,  whereas  at  the  nanometre  scale,  the  stiffness  contributed  by  the 
individual  component  of  collagen  fibrils  and  proteoglycans  was  measured. 
Furthermore,  the  nanostiffness  of  aged  and  early  stage  osteoarthritic  cartilage 
changed with the changes in morphology (Stolz et al., 2009).  
 
 
Figure 4.3: Distribution of contact stiffness values (scaled slopes) obtained from IT-
AFM measurements on cartilage. (A) Measurement at the micrometre scale shows a 
unimodal stiffness distribution. (B) Measurement at the nanometre scale shows a 
bimodal distribution, with different range of stiffness for proteoglycan and collagen 
components (Loparic et al., 2010).   
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4.3  The importance of measuring the stiffness properties of scaffolds 
 
Since AC is a load bearing tissue, stiffness is regarded as the most clinically relevant 
mechanical  property  of  an  engineered  cartilage.  The  stiffness  properties  of 
engineered  cartilage  should  be  similar  to  the  AC  to  ensure:  (i)  an  appropriate 
mechanical microenvironment for cells to attach, to maintain their phenotype, and to 
function  properly,  (ii)  that  no  stresses  are  created  at  the  interface  between  the 
implants and adjacent native AC, and (iii) an integration with surrounding tissue to 
avoid detachment of the construct from the defect site.  
 
A recent guidance published by the FDA recommended to provide mechanical test 
results prior to initiating clinical studies on a product (FDA, 2011). In particular, the 
static  mechanical  behaviour  of  the  product  should  be  assessed  by  measuring  the 
maximum recoverable compressive strain, the aggregate modulus, the shear modulus, 
and permeability, whereas the dynamic mechanical behaviour should be assessed 
from  complex  shear  modulus  tests.  The  FDA  also  recommended  that  various 
mechanical  properties  at  discrete  time  points  should  be  characterised,  especially 
when the scaffolds are populated by cells and ultimately form a load-bearing tissue. 
Such data may allow to better understand the effect of neo-cartilage development 
and the mechanical properties of the overall construct at the time of implantation. 
Accordingly, it is important to measure the stiffness properties of each synthesised 
scaffold before it can be considered for AC repair. 
 
 
4.4  Materials and methods 
 
4.4.1  Preparation of human articular cartilage   
 
Human AC sample was obtained as described in Section 3.2.2. Cartilage pieces with 
thickness of approximately 1.5-2.0 mm were cut off the underlying bone, kept in 
minimum essential medium alpha medium (MEM α; 119-016; Life Technologies, 
Paisley, UK) and were used on the same day. The cartilage samples were glued onto 
a  glass  slide  with  a  5-minute-curing  epoxy  resin  (Araldite  Rapid;  Huntsman 69 
 
Advanced  Materials,  Basel,  Switzerland).  To  prevent  drying,  the  sample  was 
immersed in PBS for the measurements. Samples from three patients were analysed. 
 
 
4.4.2  Preparation of electrospun P(3HB)/P(3HO) scaffolds 
 
Electrospun  fibrils  were  collected  as  non-woven  mesh  on  aluminium  foil,  as 
described  in  Section  3.2.1.  They  were  cut  into squares  of  0.5  ×  0.5  cm  and  the 
aluminium foil base was glued onto a glass slide using a 5-minute-curing epoxy resin. 
The samples were covered with PBS for the measurements.  
 
 
4.4.3  Indentation-type atomic force microscopy  
 
A spherical probe for indentation testing was prepared by gluing a borosilicate glass 
sphere  (radius  =  5  µm;  02715-AB;  SPI  Supplies,  West  Chester,  PA)  using  a  5-
minute-curing  epoxy  resin  onto  the  end  of  a  tipless  rectangular  cantilever  that 
exhibits a spring constant of kc ~6.0 N/m (type All In One-TL; BudgetSensors, Sofia, 
Bulgaria), as shown in Figure 4.4.  
  
 
Figure 4.4: SEM micrograph of a tipless cantilever glued with a hard borosilicate 
glass sphere with radius of 5 µm. Scale bar: 10 µm. 
 
A  micrometre-sized  spherical  indenter  was  used  to  measure  the  overall  stiffness 
properties  of  the  various  structural  elements  composing  the  AC,  as  well  as  the 70 
 
overall stiffness contributed by the electrospun fibril meshwork (Stolz et al., 2004, 
Akhtar et al., 2011). The kc of each cantilever was determined before gluing the 
sphere. Thermal noise method was used to obtain the cantilever’s resonant frequency 
for the calculation of kc (Butt and Jaschke, 1995, Hutter and Bechhoefer, 1993).  
 
Indentation tests were carried out with a MFP-3D AFM, in a temperature controlled 
room. A maximum deflection of 100 nm was employed, which corresponds to a 
maximum applied load of ~600 nN. Calibration of the system was carried out by 
indenting on a mica surface, which acts as an infinitely stiff sample (tip of a low 
stiffness  cantilever  cannot  penetrate  or  deform  it  in  any  way).  Cyclic  load 
displacement curves were recorded at a vertical displacement frequency of 0.5 Hz. 
Each individual data set consisted of 1024 load displacement curves in a 32 × 32 
curve grid, covering a sample area of 30 × 30 µm. At least 3 different locations were 
measured. In all cases, the indentation depths were less than 10% of the sample 
thickness and thus within the indentation limit (Bueckle, 1973).  
 
 
4.4.4  Data acquisition and stiffness calculation  
 
Figure 4.5 illustrates the cross section of an indentation experiment.  
 
 
Figure  4.5:  Schematic  illustration  of  an  indent  created  during  loading  and  the 
residual indent after unloading. P: load; h: total depth; hc: contact depth; hs = h – hc; 
hf: final depth; a: radius of contact circle (Oliver and Pharr, 1992). 
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During loading, the total displacement, h, is the sum of the vertical distance along 
which contact is made, hc, and the displacement of the surface at the perimeter of the 
contact, hs. Upon unloading, the elastic displacement is recovered, and when the 
indenter is fully withdrawn, in the case of plastically deformable materials the final 
depth  of  the  residual  hardness  impression  is  hf.  A  schematic  of  a  typical  load-
displacement curve obtained during one complete cycle of loading and unloading is 
presented in Figure 4.6.  
 
 
Figure 4.6: Schematic representation of load-displacement curve obtained from one 
complete  cycle  of  loading  and  unloading.  Pmax:  maximum  applied  load,  hmax: 
maximum indentation depth; S: slope of the hypotenuse (Stolz et al., 2004). 
 
During the loading phase, both elastic and plastic deformation occurs on the material 
to  a  maximum  indentation  depth,  hmax.  During  the  unloading  phase,  only  elastic 
portion of the displacement is recovered, which distinguishes the elastic properties 
from the plastic properties of a material. To calculate stiffness, only data from the 
unloading curves were employed to ensure that the displacement data do not contain 
any irreversible (e.g., plastic) deformation or other extraneous displacement effects. 
Curves were analysed by the method developed by Oliver and Pharr (1992). The 
initial part of the unloading curve can be fitted using a simple power-law equation, 
as described by Equation 4.1, 
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where P is the indenter load, h is the vertical displacement of the indenter, hf is the 
final displacement after complete unloading, β and m are power law fitting constants 
depending on the material and geometry of indenter, in which m = 1.5 for spherical 
indenters and m = 2 for pyramidal tip geometries (VanLandingham et al., 1997). The 
indenter load was obtained by simple multiplication of the cantilever deflection with 
the kc. 
 
To calculate the elastic modulus from indentation load-displacement data, the elastic 
contact stiffness, S, and the projected contact area under load, A, are needed. The 
contact  stiffness  is  the  slope  of  the  unloading  curve  at  the  maximum  depth  of 
displacement,  h  =  hmax  (Fig.  4.6).  It  is  defined  as  the  mean  ratio  of  cantilever 
deflection (an expression of force) to piezoelectric displacement, as described by 
Equation 4.2,  
 
              =  
  
   
      
                  (Equation 4.2) 
where dP/dh has the dimension of force per unit length. When a spherical indenter 
was applied, it is usually sufficient to fit only the upper 25% portion of the unloading 
data (Hay and Pharr, 2000, Loparic et al., 2010, Stolz et al., 2004).  
 
For a spherical indenter, the projected contact area, A, at a depth of indentation was 
calculated by Equation 4.3, 
 
               =   (2 ℎ  − ℎ 
 )                            (Equation 4.3) 
where r is the radius of sphere, hc is the contact depth (hc = hmax – hf). 
 
Once  the  contact  stiffness  and  projected  contact  area  were  known,  the  elastic 
modulus, E, for indentation testing at the micrometre scale can be calculated by 
Equation 4.4, 
 
      = 
  
   (1 −   )
 
                     (Equation 4.4) 
where ν is the Poisson’s ratio of sample, S is the contact stiffness with the dimension 
of force per unit, A is projected contact area.  
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The above-mentioned modelling method was originally developed for measuring the 
elastic modulus of homogeneous materials (Oliver and Pharr, 1992). However, as 
shown in Figure 4.7, AC is a poroviscoelastic solid with its viscoelastic behaviour 
represented by the dynamic elastic modulus, |E*|, which is the vector sum of the 
viscous and the elastic component.   
 
 
Figure 4.7: Stiffness parameter relationships for a viscoelastic material subjected to 
a  cyclic  dynamic  load.  |E*|  is  the  vector  sum  of  the  elastic  component  and  the 
viscous  component.  The  effect  from  the  viscous  components  increases  when  the 
cyclic frequency is low. With the cyclic frequency increasing, the phase angle, φ, 
decreases, and the elastic component becomes dominant (Loparic et al., 2010).  
 
To adapt the modelling method that is used in material science for determining the 
stiffness of the poroviscoelastic cartilage, the cyclic load-displacement was applied 
at a functionally appropriate frequency, to mimic the movement of water through the 
structure in gait. According to Figure 4.7, when the cyclic loading frequency is high, 
the elastic component becomes dominant and the viscoelastic solid behaves stiffer, 
which is described by the ‘dynamic elastic modulus’. The volume was assumed to be 
conserved during deformation, so a Poisson’s ratio, v, of 0.5 was applied for the 
calculation of E (Stolz et al., 2004). Instead of using the term ‘elastic modulus’ that 
is specifically for linear elastic materials, a more general term ‘stiffness’ is used for 
poroviscoelastic solids such as cartilage, to describe their mechanical properties.  
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4.5  Results 
 
4.5.1  Stiffness of human articular cartilage  
 
Figure 4.8 shows the unloading part of the typical load-displacement curves obtained 
from indentation on a hard surface and on human AC. The superficial zone is the 
uppermost part of the piece of AC and the deep zone is the part of the cartilage that 
is connected adjacent to the underlying bone. The y-axis of the graph represents the 
deflection of cantilever signal detected by photodiode, while x-axis represents the 
displacement  of  piezoelectric  actuators,  which  control  the  vertical  movement  of 
cantilevers. When the tip is pushed towards a hard sample (in this case mica), which 
exhibits a surface stiffness >> kc, there is no indentation taking place. Hence, the 
force  is  solely  related  to  the  deflection  of  the  cantilever  and  the  deflection  of 
cantilever is proportional to the piezo displacement. This is represented by a straight 
line with slope near to one (reference slope). During indentation of the sample, the 
depth  of  indentation  on  the  sample  is  equivalent  to  the  total  piezo  displacement 
subtracted by the piezo displacement on the hard surface.  
 
 
Figure 4.8: The unloading part of the load-displacement curves measured on human 
AC, by employing a spherical indenter (radius = 5 µm). A reference slope obtained 
by indentation on a hard surface is also depicted. 
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A distribution of the measured stiffness is depicted in the histogram in Figure 4.9. 
The stiffness of human AC is 600 ± 150 kPa at the superficial zone and 1854 ± 483 
kPa at the deep zone. 
 
 
Figure 4.9: Distribution of stiffness data from measurements at the superficial zone 
and deep zone of human AC. Normal distribution of the data is indicated with blue 
curve. Bin size: 50 kPa. 
 
 
4.5.2  Stiffness of P(3HB)/P(3HO) scaffolds 
 
The stiffness of 4 different scaffolds with different compositions of P(3HB)/P(3HO) 
was  compared.  Figure  4.10  shows  the  unloading  part  of  the  typical  load-
displacement curves obtained from indentation testing on the electrospun scaffolds. 
The load-displacement curves measured on the scaffolds show a different behaviour 
compared  to  the  load-displacement  curves  obtained  on  human  AC.  For  the 
electrospun scaffolds the unloading curves are straight lines, showing a more linear 76 
 
behaviour of the polymer matrix, whereas for the human AC, the unloading curves 
are exponential lines, showing a more viscoelastic behaviour of the biological tissue.  
 
 
Figure  4.10:  The  unloading  part  of  the  load-displacement  curves  measured  on 
P(3HB)/P(3HO) scaffolds that composed of different ratios of P(3HB) to P(3HO), in 
comparison to that of human AC. 
 
Figure 4.11 compares the stiffnesses of the scaffolds to the superficial zone and deep 
zone  of  human  AC.  The  stiffness  of  scaffolds  was  lower  with  the  increasing 
composition of the soft and elastomeric P(3HO). P(3HB)/P(3HO) scaffold with the 
ratio of 1:0.25 exhibited the highest stiffness values, 868 ± 540 kPa, corresponding 
to about 53% of that of the deep zone AC (1854 ± 483 kPa) and about 45% higher 
than  that  of  the  superficial  zone  AC  (600  ±  150  kPa).  The  stiffness  of 
P(3HB)/P(3HO)  1:0.43  scaffold  is  similar  to  the  superficial  zone  human  AC, 
measured at 654 ± 505 kPa. Both the stiffness of scaffolds with P(3HB)/P(3HO) 
ratios of 1:0.67 and 1:1 were relatively low, 274 ± 222 kPa and 346 ± 205 kPa, 
respectively. 
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Figure  4.11:  Stiffness  of  the  P(3HB)/P(3HO)  scaffolds  in  comparison  to  the 
superficial zone and deep zone of human AC. As indicated by the dashed curve, the 
stiffness of scaffolds decreases with the increasing composition of P(3HO). The area 
in light grey shows the range of stiffness measured on the superficial zone human 
AC, whereas the area in dark grey shows the range of stiffness measured on the deep 
zone human AC.  
 
 
4.6  Discussion 
 
4.6.1   Stiffness of human articular cartilage 
 
Articular cartilage exhibits site and direction-specific stiffness properties due to its 
highly structured and anisotropic properties. As shown in Figure 4.9, the stiffness of 
human  AC  increased  with  depth,  with  600  ±  150  kPa  at  the  superficial  zone, 
threefold lower than the stiffness of 1854 ± 483 kPa at the deep zone. This is in good 
agreement with previous AFM measurements on rabbit AC, which increased from 
520 ± 50 kPa (superficial zone) to 1690 ± 120 kPa (calcified zone) (Tomkoria et al., 
2004) and confined compression test on bovine AC, which increased from 79 ± 39 
kPa (superficial layer) to 2100 ± 2690 kPa (adjacent to subchondral bone) (Schinagl 
et al., 1997). However, it is also found that the stiffness of AC at the superficial zone 
was twofold lower than the previously reported measurement with the similar IT-78 
 
AFM method (Stolz et al., 2009). Possible reasons for this discrepancy are attributed 
to systematic differences of the experimental setup and AFM instruments. 
 
The current study employed a cyclic loading of 0.5 Hz, in comparison to a frequency 
of 3 Hz employed by Stolz and co-workers. A frequency of 0.5 Hz was selected as it 
resulted  in  load-displacement  curves  that  contain  less  noise  and  lower  standard 
deviation compared to a frequency of 1 Hz. With a cyclic loading of 0.5 Hz, the tip 
velocity  during  indentation  was  set  to  3  µm/s.  When  referring  to  the  load-
displacement curves in Figure 4.8, this resulted in an indentation of ~750 nm on the 
superficial zone AC within ~0.5 seconds, and an indentation of ~550 nm on the deep 
zone AC within ~0.4 seconds. The loading and unloading phases are transient events 
that occur in less than 1 second. Therefore, a frequency of 0.5 Hz was sufficient for 
the forces to be resisted elastically in the cartilage, with no time for interstitial fluid 
to flow through the structure (Loparic et al., 2010, Stolz et al., 2004). Although the 
IT-AFM instrument employed in this study was capable of performing cyclic loading 
at  a  maximum  frequency  of  1  Hz,  this  higher  frequency  caused  difficulties  for 
measuring  the  fibrous  scaffolds  because  the  electrospun  fibrils  deposited  on  an 
aluminium foil were not firmly adhered to the foil. Therefore, a fast cyclic motion 
may cause the non-woven fibrils to detach and, hence, the higher cyclic frequency of 
1 Hz was not employed. For a valid comparison among the scaffold samples with the 
cartilage, a frequency of 0.5 Hz was applied for all measurements. However, the 
lower cyclic loading may have allowed some water movement through the cartilage 
structure  and  resulted  in  the  lower  stiffness  values.  As  illustrated  in  Figure  4.7, 
contribution from the viscous components increases when the cyclic loading is lower.  
 
Another factor that might contribute to the differences in stiffness measurement may 
be a systematic error by employing different instruments. The AFM employed in this 
study was MFP-3D (Asylum Research), whereas the works reported by Stolz et al. 
were  performed  with  a  MultiMode  AFM  (Veeco  Metrology).  The  possibility  of 
systematic error was further verified by comparing the measurements by IT-AFM 
with the measurements by Instrumented Indentation Testing (Appendix B). It was 
found that the stiffness measurements by IT-AFM are most accurate when the spring 
constant  of  cantilever  is  of  similar  magnitude  to  the  sample  stiffness.  However, 
systematic errors are difficult to distinguish because all the data are consistently off 79 
 
in the same direction. This makes comparison of stiffness values among literature 
reports  that  employed  different  instruments  and  methods  difficult.  Nonetheless, 
relative comparison among samples using the same machine can still be made, as 
long as there is consistency in the experimental parameters, e.g., size of spherical 
indenter, spring constant of cantilever, frequency of cyclic loading and maximum 
applied force.  
 
 
4.6.2  Stiffness of P(3HB)/P(3HO) scaffolds 
 
The fabrication of scaffolds exhibiting stiffness properties similar to native AC is the 
goal of this work. Mechanically matched materials would minimise the mechanical 
shear stresses along the interfaces between the engineered cartilage and native AC, 
as well as provide a mechanical microenvironment for the chondrocytes. P(3HB) 
exhibits a crystalline structure that is rigid and stiff, whereas P(3HO) exhibits a more 
amorphous structure that is soft and flexible. Blending of these two polymers in 
different volume fractions allow to vary the mechanical properties of the scaffolds to 
fine-tune and match the functional properties to that of native AC. As shown in 
Figure 4.11, the scaffold with P(3HB)/P(3HO) ratio of 1:0.25 exhibited the highest 
stiffness, approximately 868 ± 540 kPa, which is similar to the stiffness of AC. The 
stiffness of scaffolds decreased with the increasing amount of P(3HO), a reflection 
of the soft and elastomeric properties of P(3HO) (Rai et al., 2011, Asrar et al., 2002, 
Zhu et al., 1991). 
 
It is interesting to note that besides the chemistry of the blends, stiffness was also 
influenced by the fibril size. The stiffness of scaffold with P(3HB)/P(3HO) ratio of 
1:1 was slightly higher than that with the ratio of 1:0.67, due to its larger fibril 
diameter (744 ± 462 nm vs 583 ± 191 nm) (Fig. 3.6). Larger fibril size results in a 
stiffer scaffold. This phenomenon has also been found in copper nanowires where 
thicker nanowires have a smaller equilibrium compressive strain compared to the 
thinner nanowires (Liang et al., 2005). Due to the pseudo-random fibril formation by 
electrospinning, the surface topography of fibril meshworks is more irregular and 
uneven compared to cartilage. Therefore, there were large standard deviations on the 
stiffness measurements of P(3HB)/P(3HO) scaffolds.  80 
 
 4.7  Summary 
 
Indentation testing at the micrometre scale was performed using a hard spherical 
indenter with radius of 5 µm. It measures the overall stiffness properties contributed 
by various structure components of cartilage. For the P(3HB)/P(3HO) scaffolds, the 
stiffness properties are contributed by a meshwork of fibrils. The stiffness properties 
of  P(3HB)/P(3HO)  scaffolds  can  be  tailored  by  adjusting  the  composition  of 
scaffolds. A P(3HB)/P(3HO) ratio of 1:0.25 resulted in the highest stiffness, 868 ± 
540  kPa,  which  is  comparable  to  the  stiffness  of  human  AC.  The  stiffness  of 
scaffolds decreased with increasing P(3HO) constituents, due to the softer and more 
elastomeric nature of P(3HO).  
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CHAPTER 5 
 
DEGRADATION OF P(3HB)/P(3HO) SCAFFOLDS 
 
 
5.1  Introduction 
 
To  develop  scaffolds  for  the  engineering  of  cartilage,  it  is  important  that  the 
scaffolds  are  degradable  and  resorbable  by  the  body.  This  avoids  the  storage  of 
unnecessary foreign materials in the body, or a further surgery to remove the implant. 
Ideally, the scaffolds should degrade at a rate that matches the formation of new 
extracellular  matrix.  If  the  degradation  process  is  too  rapid,  the  ingrowing  new 
cartilage may not be able to sustain the loading forces. In contrast, if the scaffold is 
degrading too slowly it may cause the body to recognise the degradable prosthetic 
material as foreign materials, which could cause an inflammatory response. An ideal 
time match between scaffold degradation and tissue formation during the healing 
process is shown in Figure 5.1 (Hutmacher, 2000, Eglin et al., 2009). 
 
 
Figure 5.1: The relationship between the mechanical integrity of scaffolds and neo-
cartilage  in  cartilage  repair.  Stage  I  is  the  in  vitro  culturing  period  before 
implantation. Stage II is the initial period after implantation, often associated with 
inflammation response. At Stage III, mechanical integrity of scaffolds reduces and 
mechanical integrity of neo-cartilage builds up. At Stage IV, the mechanical integrity 
of neo-cartilage becomes dominant [adapted from Eglin et al.  (2009)]. 82 
 
Scaffolds are normally seeded with cells and cultured in the laboratory for 3-4 weeks 
(Stage I). During the culturing period, there is little degradation of scaffolds taking 
place and the growth of cartilage is at an early stage. Therefore, the mechanical 
integrity of constructs is mainly contributed by the scaffolds. With increasing culture 
time, a chondrogenic induction condition promotes the formation of neo-cartilage. 
However,  during  the  time  of  implantation  (Stage  II),  mechanical  integrity  of  the 
newly formed neo-cartilage may be still far below the mechanical integrity of the 
native AC. Therefore, degradation of scaffolds should be minimal at this stage so 
that they can provide sufficient temporary mechanical support to withstand the in 
vivo stresses and loading forces. Some minimal inflammatory response might occur 
at this stage, but it should be low enough to not disrupt the repair process. At Stage 
III, the scaffolds should degrade gradually to allow further ingrowth of neo-cartilage. 
At the point where both curves cross each other, the mechanical integrity of neo-
cartilage  should  outweigh  the  scaffolds  and  the  neo-cartilage  should  become 
predominant  support  at  the  defect  site.  At  Stage  IV,  new  cartilage  should  be 
regenerated and the scaffolds should be completely degraded and resorbed by the 
body.   
 
When  further  discussing  degradability,  the  biological  derived  PHAs  are  clearly 
different compared to petrochemical derived polymers. Two of the most common 
mechanisms involve in the degradation of PHAs are biodegradation and hydrolytic 
degradation. Biodegradation describes a degradation reaction that involves enzymes. 
In the natural environment such as soil, compost, or marine sediment, PHAs are 
biodegraded upon exposure to the bacteria that produce them. Biodegradation starts 
when the bacteria begin growing on the surface of the polymers and secrete enzymes, 
i.e.,  microbial  depolymerase  or  esterase,  which  break  down  the  polymers  into 
hydroxyl acid monomeric units. While the mechanism for degradation of PHAs in 
the  environment  is  widely  considered  to  be  via  enzymatic  attack  and  can  be 
relatively  rapid,  the  mechanism  for  degradation  in  the  body  generally  involves 
simple  hydrolytic  reactions  with  the  water  present  in  tissue  and  organs,  namely, 
hydrolysis or hydrolytic degradation, which may or may not be protein mediated 
(Martin et al., 2004, Vert et al., 2012).    
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Previous in vitro hydrolytic degradation studies have found that the scission rate of 
PHAs chains depends on a number of factors, e.g. chemical structure, surface area 
and morphology (amorphous to crystalline phase ratio). Among them, the chemical 
structure determines the hydrophilicity of a polymer, which is the most important 
parameter that affects degradation. Hydrophilicity is dependent on the ratio between 
the number of ester groups and the number of carbon atoms along the polymer chain, 
and the polymers become more hydrophilic with a higher ratio. In addition to the 
chemical structure, the rate of water uptake also depends on the phase morphology, 
e.g.,  a  densely  packed  crystalline  phase  is  less  permeable  to  water  than  the 
amorphous phase. Therefore, the degradation rate of a blend of different polymers is 
faster than the degradation rates of homopolymers (Kim et al., 1999), because the 
crystallinity of a blend is lower. Taken together, the relative rates of water uptake 
and  bond  cleavage  determines  which  degradation  route  the  polymer  undergoes: 
when water uptake is faster than hydrolysis the process involves the entire sample 
(bulk degradation), on the contrary, when water diffusion into the sample is slower 
than hydrolysis, surface degradation is predominant (Gualandi, 2010). 
 
 
5.2  Materials and methods 
 
5.2.1  In vitro degradation test 
 
The in vitro degradation tests were solely based on hydrolytic reactions without the 
presence of cells. The scaffolds were immersed in MEM α medium and incubated at 
37
oC in 5% CO2 humidified atmosphere. The medium was changed every 2 days. 
After 1 and 4 months, the structures of the degraded scaffolds were examined by 
SEM (Section 3.2.3.1), and the stiffness was measured by IT-AFM (Section 4.4.3). 
 
 
5.2.2  Gel permeation chromatography 
 
The molecular weight of scaffolds was analysed by gel permeation chromatography 
(GPC; 1090 HPLC; Hewlett-Packard, Burlington, MA) equipped with UV-Visible 
and  differential  refractive  index  detectors.  Dried  samples  were  dissolved  in 84 
 
chloroform at a concentration of 0.10 mg/ml and eluted through PLgel 5 µm Mixed 
C column (Polymer Laboratories, Church Stretton, UK) at a flow rate of 1 ml/min. 
Calibration of the instrument was done using a polystyrene standard with toluene as 
a flow marker to ensure the accuracy of the calibration. All analysis was carried out 
at 40°C. Data analysis was done using the Cirrus GPC software. The percentage of 
molecular weight loss was calculated using Equation 5.1. 
 
%               ℎ       = 
                                                     
                           
                        (Equation 5.1) 
 
 
5.3  Results 
 
5.3.1  Structure of degraded P(3HB)/P(3HO) scaffolds 
 
The  column  of  Figure  5.2,  A-D  shows  the  uniform  fibril  morphology  before 
degradation and changes of the morphology after 1 month (Fig. 5.2, E-H) and 4 
months of degradation (Fig. 5.2, I-L). The rows show the electrospun scaffolds with 
increasing composition of P(3HO). As a result of water absorption, fibrils after 1 
month of degradation look swollen with thickened fibrils and formation of nodules. 
With the progression of degradation, some fibrils were dissolved and fused together, 
causing the individual fibril boundaries to become indistinguishable. A reduction in 
mesh size is also visible, which may reduce the overall scaffold volume, especially 
in  the  two  scaffolds  with  P(3HB)/P(3HO)  ratios  of  1:0.67  and  1:1.  Despite  the 
progressive dissolution, overall fibril structure still remained visible at 4 months. 
 
The  diameter  of  degraded  fibrils  was  averaged  from  50  fibrils  and  displayed  in 
Figure 5.3. During initial degradation (t = 1 month), fibrils of all the samples were 
swollen  extensively,  which  resulted  in  increased  fibril  size.  The  average  fibril 
diameter increased by 67% for P(3HB)/P(3HO) ratios of 1:0.25, 40% for 1:0.43, 59% 
for 1:0.67 and 22% for 1:1. After 4 months, the fibrils started to dissolve to smaller 
size or fused together. Most of the fibril size reduced by approximately 13-24% from 
their size at 1 month.  85 
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Figure 5.2: Comparison of SEM micrographs of P(3HB)/P(3HO) scaffolds before 
and after hydrolytic degradation. (A-D) The original fibril structure. (E-H) After 1 
month  of  hydrolytic  degradation  the  fibrils  show  larger  variations  in  thickness 
compared to the original fibrils. The majority of fibrils look thicker, with some of the 
fibrils fused together. Also, a few fibrils became thinner. (I-L) After 4 months of 
degradation some of the fibrils show a reduced thickness (arrow heads). The mesh 
size of the scaffold was reduced because some of the fibrils were dissolved and fused 
together. Scale bars: 2 µm.   
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Figure 5.3: Average diameters of fibrils during the course of degradation. The fibrils 
were swollen into larger sizes after 1 month and have started to dissolve into smaller 
fibril size after 4 months of degradation. 
 
 
5.3.2  Stiffness of degraded P(3HB)/P(3HO) scaffolds 
 
Degradation of the scaffolds decreased the mechanical properties of scaffolds, but 
the  stiffness  should  remain  sufficient  to  withstand  joint  loading  forces  during 
cartilage  repair.  As  shown  in  Figure  5.4,  after  1  month,  the  stiffness  of 
P(3HB)/P(3HO) 1:0.25 scaffold reduced by 34% to 577 ± 475 kPa, which is still 
close to the stiffness of the superficial zone human AC. After 4 months, its stiffness 
further  reduced  to  206 ±  173  kPa,  corresponding  to  a  total  reduction of  76%  in 
stiffness. In comparison, the stiffness of P(3HB)/P(3HO) 1:0.43 scaffold reduced by 
65% to 230 ± 178 kPa after 1 month, and by 82% to 119 ± 53 kPa after 4 months. 
Similarly, the stiffness of scaffolds with P(3HB)/P(3HO) ratios of 1:0.67 and 1:1 
also reduced to 186 ± 120 kPa and 108 ± 44 kPa, respectively, after 4 months of 
degradation. This indicates that by 4 months the mechanical integrity of all but the 
P(3HB)/P(3HO)  1:0.25  scaffolds  was  mostly  impossible  to  support  joint  loading 
forces.  The  high  standard  deviation  associated  with  the  stiffness  of  degraded 
scaffolds also reflects the irregularity of the degraded structures. 87 
 
 
Figure 5.4: Decrease in the stiffness of scaffolds following hydrolytic degradation. 
The  red  curve  shows  the  original  stiffness  of  the  scaffolds  made  from  the  four 
different P(3HB)/P(3HO) ratios. The green curve shows the decrease of stiffness 
after 1 month of degradation, whereas the blue curve shows a further reduction in 
stiffness after 4 months of degradation.  
 
 
5.3.3  Molecular weight of degraded P(3HB)/P(3HO) scaffolds 
 
To get more insight on the degradation process, the reduction of molecular weight in 
two of the scaffolds, P(3HB)/P(3HO) 1:0.25 and 1:0.43, were analysed. Since trace 
amounts  of  protein  were  detected  by  FTIR  spectroscopy  (Section  3.4.3),  the 
molecular weight of the raw P(3HB) and P(3HO) polymers were also analysed. This 
allows to determine the potential effect of electrospinning on the molecular weight 
of polymers, and to detect the presence of impurities. As shown in Figure 5.5, the 
chromatograms  for  both  raw  P(3HB)  and  P(3HO)  polymers  reveal  a  main  peak 
(Peak 1) at the retention time of 13 minutes, corresponding to the molecular weight 
of the P(3HB) or P(3HO) polymer. A small peak (Peak 2) is also visible at the 
retention time of 17.5 minutes, which corresponds to molecular weight of ~640-760 
g/mol,  and  is  attributed  to  the  protein  and  lipid  residues  in  the  polymers.  The 
presence of Peak 2 also further confirms the finding from FTIR analysis. Table 5.1 
tabulates the analysed number-average molecular weight (Mn) and weight-average 88 
 
molecular weight (Mw) of raw P(3HB) and P(3HO) polymers, in comparison to their 
blends at P(3HB)/P(3HO) ratios of 1:0.25 and 1:0.43.  
 
 
Figure 5.5: Chromatograms of the raw P(3HB) polymer and raw P(3HO) polymer 
before electrospinning. The main peak (Peak 1) indicates the molecular weight of the 
polymers while the smaller peak (Peak 2) is due to the presence of trace impurities. 
The molecular weight of polymer is determined from a calibration curve (● symbol 
line)  that  is  obtained  from  the  logarithm  of  the  molecular  weight  of  polystyrene 
standard versus the retention time. Peak “F” is due to toluene, which is the flow 
marker that indicates the end of each run and ensures the performance of instrument.   
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Table 5.1: The initial number-average molecular weight (Mn) and weight-average 
molecular weight (Mw) of raw P(3HB) and P(3HO) and their blends.  
 
Raw P(3HB)  Raw P(3HO) 
P(3HB)/P(3HO) 
1:0.25  1:0.43 
Mn (g/mol)  50859  59537  64099  64610 
Mw (g/mol)  181343  222270  145093  137324 
 
Figure  5.6  demonstrates  the  changes  on  the  chromatograms  of  P(3HB)/P(3HO) 
1:0.25 scaffolds following hydrolytic degradation for 1 and 4 months. A reduction 
on the scaffold molecular weight was indicated by shifting of the peak at 13 minutes 
(Peak  1)  to  a  higher  retention  time.  Similar  observation  was  also  found  on 
P(3HB)/P(3HO) 1:0.43 scaffolds (chromatograms not shown). In addition, a small 
peak (Peak 2) at approximately time 17.5 minutes was also detected, indicating the 
presence of impurities. 
 
Figure 5.7 demonstrates the reduction of molecular weight on the scaffolds with 
P(3HB)/P(3HO)  ratios  of  1:0.25  and  1:0.43.  The  Mn  of  P(3HB)/P(3HO)  1:0.25 
scaffold  was  reduced  by  approximately  16%  and  25%  after  1  and  4  months 
degradation, respectively. Its Mw also displayed the similar declining trend, i.e., a 
reduction  of  approximately  19%  and  27%  after  1  and  4  months,  respectively. 
Conversely, the P(3HB)/P(3HO) 1:0.43 scaffold experienced less molecular weight 
loss, with approximately 5% Mn loss and 9% Mw loss at 1 month, and 15% Mn loss 
and 12% Mw loss at 4 months. Both scaffolds  showed higher rates of  molecular 
weight loss at 1 month compared to at 4 months.  
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Figure 5.6: Chromatograms of P(3HB)/P(3HO) 1:0.25 scaffolds before degradation 
(t = 0), and after undergoing hydrolytic degradation for 1 month (t = 1 month) and 4 
months (t = 4 months). Peak 1 indicates the molecular weight of the polymers. It was 
shifted to a higher retention time after degradation (shown with blue dashed line), 
due to the lower molecular weight of the degraded structure.  
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Figure  5.7:  Comparing  the  reduction  of  Mw  and  Mn  on  scaffolds  with 
P(3HB)/P(3HO) ratios of 1:0.25 and 1:0.43, as a result of hydrolytic degradation.  
 
The polydispersity of polymers indicates the distribution of molecular weight and is 
calculated from the ratio of Mw to Mn. The polydispersity of P(3HB)/P(3HO) 1:0.25 
scaffold  remained  similar  in  the  range  of  2.19-2.26  during  the  course  of  the 
degradation, whereas the polydispersity of P(3HB)/P(3HO) 1:0.43 scaffold was in 
the  range  of  2.03-2.20.  Both  scaffolds  showed  no  statistical  differences  in  their 
polydispersity despite degradation. 
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5.4   Discussion 
 
5.4.1  Structure of degraded P(3HB)/P(3HO) scaffolds 
 
A  suitable  degradation  is  important  for  scaffolds  to  maintain  their  role  and 
functionalities for a limited period of time before they are resorbed by the body. A 
structure  that  is  degraded  with  time  gradually  generates  more  space  within  the 
scaffold to allow cell proliferation and deposition of newly synthesised extracellular 
matrix (Freed et al., 1994, Shoichet et al., 1996). When fibrils are in contact with the 
medium,  they  absorb  water  and  form  a  thick  swollen  layer  on  the  fibril  surface 
(Ueberreiter, 1968), which increases the fibril size, as demonstrated in Figure 5.2 
and  5.3.  This  swollen  layer  allows  the  dissolved  polymers  to  mobilise  into  the 
surrounding  fluid  (Miller-Chou  and  Koenig,  2003).  Subsequently,  the  hydrated 
region of polymers initiates degradation through ester bond hydrolysis, which leads 
to the cleavage of polymer backbone and reduction of molecular weight (Wu and 
Wang, 2001, Doi et al., 1989). 
 
It  has  been  estimated  that  the  process  of  hydrolytic  degradation  of  PHAs  could 
exceed 1 year (Marois et al., 1999), and was also evidenced from the overall fibril 
structure after 4 months of degradation (Fig. 5.2, I-L). At 4 months, some of the 
fibrils  dissolved  into  smaller  sizes  while  fibrils  that  were  adjacent  to  each  other 
became fused together. The fibril structure of P(3HB)/P(3HO) 1:0.25 scaffold was 
better  maintained  than  other  scaffolds.  This  can  be  attributed  to  the  rigidity  of 
P(3HB), which helps to maintain the  fibril structure integrity. Meanwhile, fibrils 
with higher content of P(3HO) were difficult to keep in their original shape due to 
the soft and elastomeric nature of P(3HO) (Kai et al., 2003). The collapsed fibrils 
reduce the mesh size of the scaffolds, which obstructs cell migration. 
 
 
5.4.2  Stiffness of degraded P(3HB)/P(3HO) scaffolds 
 
At the time of implantation, the mechanical properties of scaffolds play an important 
role  because  the  newly  formed  extracellular  matrix  is  still  unable  to  support  the 
defect  site.  As  a  consequence  of  polymer  chain  scissions  and  loss  of  structure 93 
 
integrity, only P(3HB)/P(3HO) 1:0.25 scaffold exhibited sufficient stiffness at the 
point of implantation (Fig. 5.4). The stiffness of this scaffold was 577 ± 475 kPa at 1 
month, which is similar to the stiffness of the superficial zone human AC (600 ± 150 
kPa).  A  sufficient  stiffness  is  essential  to  facilitate  matrix  deposition  by  the 
chondrocytes, as well as sustaining in vivo joint loading forces to allow for early 
mobilization  of  the  treated  site.  At  1  month,  the  stiffness  of  scaffolds  with 
P(3HB)/P(3HO) ratios of 1:0.43, 1:0.67 and 1:1 reduced to a level that was lower 
than the stiffness of cartilage, making them unable to support the entire joint loading 
forces. Large standard deviations were obtained for stiffness measurements on all the 
degraded  scaffolds,  which  reflect  great  variations  on  the  structural  properties  of 
fibrils. This is in good agreement with the varying fibril thickness and rough surface 
morphology of the fibrils due to the effect of degradation, as shown in Figure 5.2.  
 
Generally,  the  stiffness  of  scaffolds  reduced  at  a  great  extent  due  to  hydrolytic 
degradation. For example, P(3HB)/P(3HO) 1:0.25 scaffold experienced 34% and 76% 
reduction in stiffness at 1 month and 4 months, respectively, which is attributed to 
water absorption by the polymers. Due to plasticisation of the polymer by water, a 
gel-like swollen layer is formed along with two separate interfaces, one between the 
polymer and the gel layer, and the other between the gel layer and the water (Miller-
Chou and Koenig, 2003). These gel-like layers contain some dissolved polymers and 
have  a  lower  polymer  concentration  compared  to  the  bulk  structure.  Therefore, 
measurements on these structures resulted in a lower stiffness.   
 
 
5.4.3  Molecular weight of degraded P(3HB)/P(3HO) scaffolds 
 
The present work utilised the two most common molecular weights, Mn and Mw, to 
describe the extent of polymer chain scissions. Number-average molecular weight is 
obtained  by  counting  the  number  of  molecules  per  unit  weight  of  sample,  and 
analysing them regardless of weight or size. Therefore, any small changes in the 
weight fractions of the low molecular weight molecules can result in a big difference 
in the Mn. The Mn can be related to the colligative properties of a polymer, such as 
vapour pressure, freezing point, boiling point and osmotic pressure. In comparison, 
weight-average molecular weight is obtained by the weighted method, where large 94 
 
molecules are weighted more to the final molecular weight than small molecules. It 
fairly accounts for the contributions of different sized chains to the overall behaviour 
of  the  polymer.  The  Mw  reflects  the  various  bulk  properties  of  polymers,  e.g., 
rheological, resistance and mechanical properties.  
 
A  progressive  reduction  of  molecular  weight  was  detected  in  all  scaffolds.  The 
degradation rate is slower with the increasing amount of P(3HO). This is due to the 
presence  of  long  alkyl  pendant  group  that  sterically  hinders  the  attack  of  water 
molecules,  making  the  P(3HO)  more  hydrophobic  (Sudesh  et  al.,  2000,  Wu  and 
Wang,  2001).  Hence,  the  cleavage  of  P(3HO)  polymer  chains  is  slower.  Similar 
result have also been reported on the degradation of P(3HB-co-3HV) copolyester, 
where  the  hydrolysis  rate  for  ester  bonds  decreased  with  increasing  amount  of 
P(3HV), which has a longer alkyl pendant group than P(3HB) (Choi et al., 2004). In 
addition, the surface to volume ratio also affects the scaffold degradation rate. The 
degradation rate was highest on P(3HB)/P(3HO) 1:0.25 scaffold, which exhibited the 
smallest fibril size and highest surface to volume ratio. The small fibril size provides 
more surface area for hydrolytic reaction, although P(3HB)/P(3HO) 1:0.25 scaffold 
exhibited a higher water contact angle, as shown in Figure 3.9 (Ying et al., 2008). 
This also indicates that water contact angle analysis, which was measured within the 
initial few seconds of contact between water droplet and scaffolds, did not represent 
the actual water absorption rate of scaffolds in the long term.  
 
The reduction of molecular weight was faster during the first month and then slowed 
down from 1 month to 4 months. According to Wu and Wang (2001), there are 3 
phases occur during hydrolytic degradation. The first phase involves the hydration of 
polymers, which lasts approximately for 1 week. The aqueous medium penetrates 
into the polymer matrix to allow initial degradation starts in the hydrated region 
through ester bond hydrolysis, accompanied by a slow degradation rate. The second 
phase progresses from the second week into the fifth week. Polymer chain scission 
continues  and  is  evidenced  by  molecular  weight  loss.  The  second  phase  has  the 
fastest degradation rate, as experienced in this study, with high Mw loss at 1 month. 
In the third phase, the degradation rate slows down due to the low molecular weight 
of the remaining polymers, and also the reduction of surface area for hydrolysis.  
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The extent of degradation can be revealed from the changes on the molecular weight 
distribution,  which  is  determined  by  the  polydispersity.  The  polydispersity  of 
P(3HB)/P(3HO) 1:0.25 scaffolds measured before and after degradation were in the 
range of 2.19-2.26, which shows a difference of less than 10%. This suggests that the 
scaffolds  were  not  degraded  considerably  and  changed  the  molecular  weight 
distribution.  This  is  attributed  to  the  degradation  mechanism  of  PHAs  through 
surface  degradation,  which  is  different  from  the  mechanism  through  bulk 
degradation. When polymers are degraded through bulk degradation, for example on 
PGA, PLA, or PLGA, the molecular weight distribution can rapidly become bimodal. 
Due to the autocatalysis reaction by the entrapped degradation by-products or the 
entrapped chain-cleaving reagent within the matrix, bulk degradation is faster at the 
inner region of scaffolds (Vert et al., 2012). In comparison, the surface degradation 
progresses from the surface to the interior, and is slower.  
 
The degradation rate of P(3HB)/P(3HO) blends are generally higher compared to the 
homopoplymer of P(3HB) or P(3HO). Even after being degraded for 12 months,  no 
reduction of molecular weight was detected in P(3HO), and there was merely a 30% 
molecular weight loss after 24 months (Marois et al., 2000). A blend polymer system 
exhibits a lower crystallinity compared to homopolymer. When P(3HO) is blended 
with P(3HB), there are two opposite effects brought by the P(3HO) (Chen et al., 
2013): (1) the addition of the long alkyl pendant group of P(3HO) into the blend 
increases the hydrophobicity, which hinders the penetration of water and slows down 
the hydrolysis rate; (2) the long alkyl pendant group reduces the overall crystallinity 
of the polymer blend, which then leads to an increase in the hydrolysis rate that is 
compensating the hydrophobicity otherwise caused by the long alkyl pendant group. 
Therefore,  the  degradation  rate  of  the  blends  is  slightly  faster  than  that  of  neat 
P(3HB) or neat P(3HO). In vivo, the degradation rate of these scaffolds would be 
even faster due to the additional enzymatic reactions from cells and tissues (Marois 
et al., 1999). 
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5.5  Summary 
 
The  degradation  of  P(3HB)/P(3HO)  scaffolds  was  characterised  by  structural 
changes,  associated  with  the  reduction  of  stiffness  and  molecular  weight.  The 
P(3HB)/P(3HO) scaffolds undergo hydrolytic degradations between one to a few 
years until the polymer scaffolds are completely  resorbed by the body. With the 
increasing amount of P(3HO), the degradation rate of scaffolds can be slowed down. 
In comparison to the reduction of molecular weight, the stiffness of scaffolds was 
degraded  to  an  even  greater  extent.  Among  the  four  blend  compositions, 
P(3HB)/P(3HO) 1:025 scaffold was the only one that had a stiffness similar to that 
exhibited by the native cartilage after 1 month. The stiffness of other scaffolds after 
degradation reduced to a level that would not provide sufficient support for cartilage 
repair. 
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CHAPTER 6 
 
BIOCOMPATIBILITY OF P(3HB)/P(3HO) SCAFFOLDS 
 
 
6.1  Introduction 
 
Biocompatibility is one of the most important requirements for an implant material. 
During the years between 1940 and 1980 when the first generation of implantable 
devices were developed, the requirement for a biocompatible material is minimum 
chemical reactivity: it had to be non-mutagenic, non-antigenic, non-carcinogenic and 
non-toxic. It later became obvious that the response to specific individual materials 
differs between applications. In 1987, biocompatibility was re-defined as the ability 
of a material to perform with an appropriate host response in a specific situation 
(Williams, 1987). This definition emphasises that: (1) a material has to perform and 
not just simply exist in a tissue, (2) the response which the material evokes has to be 
appropriate  for  the  application,  and  (3)  the  nature  of  the  response  to  a  specific 
material and its appropriateness may vary from one situation to another (Williams, 
1999).  When  a  biomaterial  is  brought  into  contact  with  tissues,  response  is  first 
coming  from  the  cells,  due  to  stimuli  to  the  cell  surface  receptors.  Material 
characteristics  such  as  structure  and  morphology,  mechanical  properties, 
hydrophobic-hydrophilic balance, scaffold porosity, surface chemical composition, 
degradation  profile  and  toxicity  of  the  degradation  products  provide  different 
microenvironments  that  modulate  the  cell  fate.  The  cell  fate  is  reflected  on  cell 
phenotype, cell proliferation rate and tissue regeneration.  
 
A standard measure to determine the biocompatibility of a scaffold is the viability of 
cells, which is defined as the ratio between the number of cells that are alive and 
those that are dead in a sample. When cells are seeded onto a biocompatible scaffold, 
some of them may survive and undergo cell adhesion, in which they spread and 
organise the cell’s actin cytoskeleton to form focal adhesion points. In contrast, a 
toxic environment induces cell necrosis. The presence of live and dead cells in a 
sample can be shown by fluorescent dyes. Live cells are stained with membrane-98 
 
permeable dye, which is cleaved by esterase in the live cells to yield cytoplasmic 
green  fluorescence.  Dead  cells  are  stained  with  membrane-impermeable  DNA 
binding molecule, which labels the nucleic acids of membrane-compromised cells to 
yield red fluorescence. The amounts of live and dead cells can then be easily counted 
under a fluorescence microscope.    
  
The biocompatibility of scaffolds is also determined by their ability to support the 
cells to function normally. This includes supporting the chondrocytes to maintain 
their phenotype and proliferation rate, and to secrete specific signals to guide them to 
produce  cartilage.  Neo-cartilage  can  be  grown  in  the  laboratory  with  controlled 
nutrient supply, biological stimuli and mechanical loading. An engineered cartilage 
with  biochemical  composition,  architecture,  and  biomechanical  properties 
indistinguishable  from  the  host  cartilage  will  have  a  higher  success  rate  for  the 
regeneration  of  joint  function  (LeBaron  and  Athanasiou,  2000).  Therefore,  many 
researchers  have  emphasised  on  in  vitro  development  of  construct  for  the 
engineering of AC (Athanasiou et al., 2009).  
 
To evaluate the expression levels of proteins within an engineered cartilage, dyes 
such  as  Alcian  blue,  Safranin-O  and  Sirius  red  are  regularly  employed  to 
histologically demonstrate the location of GAGs, collagen, and other extracellular 
matrix,  along  with  dyes  such  as  haematoxylin  to  histologically  demonstrate  the 
location of cells. The distribution of specific types of collagen and proteoglycan can 
be discerned using immunohistochemistry, to determine whether the newly formed 
tissue is hyaline-like or fibrous-like. 
 
 
6.2  Materials and methods 
 
6.2.1  Isolation of human articular chondrocytes 
 
Human articular chondrocytes (HACs) were kindly supplied by the Bone and Joint 
Group, University of Southampton. In brief, pieces of deep zone AC were minced in 
PBS and treated with 500 µg/ml trypsin-EDTA for 30 minutes, followed by 1 mg/ml 
hyaluronidase for 30 minutes to extract the hyaluronan in cartilage. The cartilage 99 
 
pieces  were  then  treated  with  10  mg/ml  collagenase  B  (11088831001;  Roche 
Diagnostics,  West  Sussex,  UK)  for  15  hours  to  digest  the  collagen  fibrils.  The 
resulting suspension was filtered through a 70 µm cell strainer to separate any traces 
of undigested cartilage chondrocytes. The filtered solution was centrifuged at 1500 
rpm for 5 minutes at room temperature and washed with PBS and MEM α medium. 
The isolated chondrocytes were then frozen in 90% (v/v) fetal bovine serum (FBS; 
10270-106; Life Technologies) and 10% (v/v) dimethyl sulfoxide (DMSO; D4540; 
Sigma-Aldrich) until used. 
 
 
6.2.2  Expansion of human articular chondrocytes 
 
The  isolated  HACs  were  cultured  as  monolayer  cultures  in  MEM  α  medium 
supplemented  with  10%  FBS,  100  unit/ml  penicillin,  100  µg/ml  streptomycin 
(Penicillin-Streptomycin;  P4333;  Sigma-Aldrich)  and  100  µM  L-ascorbic  acid  2-
phosphate  sequimagnesium  salt  hydrate  (A8960;  Sigma-Aldrich).  Cultures  were 
maintained in a humidified atmosphere at 37
oC and 5% CO2. The culture medium 
was changed every 2 days. 
 
 
6.2.3  Seeding human articular chondrocytes on scaffolds 
 
The HACs were harvested at confluence by trypsinization (500 µg/ml trypsin-EDTA) 
and neutralised with 10% FBS. Prior to cell seeding, scaffolds were sterilized with 
absolute ethanol and rinsed with PBS. HACs were then seeded onto the scaffolds at a 
density of ~7 × 10
5 cells/cm
2 and incubated for 3 days to allow penetration of cells 
into  the  inner  layer  of  scaffolds.  Culturing  was  carried  out  under  chondrogenic 
induction  medium  made  up  of  MEM  α  medium  supplemented  with  10  ng/ml 
recombinant human transforming growth factor-β3 (TGF-β3; 100-36E; Peprotech, 
London, UK), 100 µM L-ascorbic acid 2-phosphate sequimagnesium salt hydrate, 10 
nM dexamethasone (D4902; Sigma-Aldrich), and 1x Insulin-Transferrin-Selenium-G 
(ITS-G; 41400; Life Technologies) (Tare et al., 2005, Malpeli et al., 2004). These 
specific growth factors have previously been shown to enhance HAC proliferation 
and  post-expansion  re-differentiation  capacity  (Barbero  et  al.,  2004).  All  tissue 100 
 
cultures were incubated in humidified atmosphere with 5% CO2 at 37
oC. Media were 
changed every 2 days. After 3 weeks, the constructs were harvested for live/dead cell 
staining, histological and immunohistochemical analysis, and stiffness measurement. 
 
 
6.2.4  Tissue repair in partial thickness defect model 
 
A partial thickness cartilage defect with diameter of ~2 mm and depth of ~1 mm was 
created with a biopsy punch. The 3-week-old construct prepared in Section 6.2.3 was 
implanted  to  fill  the  defect  site.  Serum-free  MEM  α  medium  was  used  as  the 
culturing medium to represent the physiological fluid. Integration of the repair tissue 
and  the  host  cartilage  was  inspected  after  10  weeks,  by  histology  and 
immunohistochemistry.  
 
 
6.2.5  Live/dead cell staining 
 
To examine the presence of live and dead cells on the P(3HB)/P(3HO) scaffolds, a 
fluorescent  double  staining  protocol  was  used.  Metabolically  active  cells  were 
labelled  with  10  µg/ml  Cell  Tracker  Green  CMFDA  (5-chloromethylfluorescein 
diacetate; C7025; Invitrogen, Eugene, Oregon). Cell Tracker Green exhibits bright 
green fluorescence  when esterase cleavage occurs in the cytoplasm of cells. The 
nucleic acids of necrotic cells were labelled with 5 µg/ml Ethidium Homodimer-1 
(E1169;  Invitrogen),  which  emits  red  fluorescence.  The  labelling  reactions  were 
performed at 37ºC in dark for 60 minutes. After recovered in tissue culture medium 
for 45 minutes, the constructs were fixed with 4% paraformaldehyde in PBS. The 
specimens were processed through graded ethanol (50-100%) and Histoclear (HS200; 
National Diagnostics, Leicestershire, UK) prior to embedding in paraffin wax and 
sectioning at 7 µm. After de-wax with Histoclear and re-hydrated through graded 
ethanol,  the  cell  nuclei  were  stained  with  DAPI  (4’,6-diamidino-2-phenylindole, 
dilactate; D3571; Life Technologies).  
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6.2.6  Histological staining 
 
Sections containing the specimens were de-waxed with Histoclear and re-hydrated 
through graded ethanol. The cell nucleus was counter-stained with Weigert’s iron 
haematoxylin, which was prepared by mixing equal parts of 10 g/l haematoxylin 
(H/0010/46;  Fisher  Scientific)  in  methanol  and  12  g/l  ferric  chloride  in  1% 
hydrochloric acid. The proteoglycan content was stained with 5 mg/ml Alcian blue 
8GX (40046-0100; Acros Organics, Geel, Belgium) in 1% (v/v) glacial acetic acid, 
while the total collagen content was stained with 10 mg/ml Direct Red 80 (365548; 
Sigma-Aldrich) in saturated picric acid.  
 
 
6.2.7  Immunohistochemical staining 
 
The expression of SOX-9, aggrecan, collagen types I, II and X in the neo-cartilage 
was  detected  by  immunohistochemical  staining.  Prior  to  immunohistochemical 
staining  procedure,  sections  were  put  through  Histoclear  to  remove  wax  and 
hydrated  through  graded  ethanol.  For  antibodies  against  SOX-9  and  aggrecan, 
sections were treated with heat-induced antigen retrieval in 0.01 M citrate buffer at 
60°C  for  25  minutes,  followed  by  quenching  endogenous  with  3%  hydrogen 
peroxide  (H1009;  Sigma-Aldrich)  and  blocking  with  1%  bovine  serum  albumin 
(A3294; Sigma-Aldrich) in PBS. For antibodies against collagen types I, II and X, 
sections  were  quenched  with  3%  hydrogen  peroxide,  incubated  with  520  µg/ml 
bovine  hyaluronidase  at  37°C  for  20  minutes  and  then  blocked  with  1%  bovine 
serum  albumin.  Then,  the  sections  were  incubated  with  the  relevant  primary 
antibody  at  4
oC  for  18  hours.  The  anti-SOX-9  antibody  (AB5535;  Millipore, 
Billerica, MA) and anti-aggrecan antibody (ab36861; Abcam, Cambridge, UK) were 
used at  a dilution of 1:150, anti-collagen  I  antibody  (gift from  Larry  W. Fisher, 
National  Institutes  of  Health,  Maryland)  at  1:1000,  anti-collagen  II  antibody 
(ab34712; Abcam) and collagen X antibody (234196; Millipore) at 1:100. This was 
followed  by  incubation  with  biotinylated  secondary  antibody  (B7389;  Sigma-
Aldrich) at a dilution of 1:100 for 60 minutes.  
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Visualization of the immune complex involved the avidin-biotin method linked to 
peroxidase (ExtrAvidin Peroxidase, E2886; Sigma-Aldrich) at a dilution of 1:50 and 
3-amino-9-ethylcarbazole  (AEC;  132-32-1;  Acros  Organics,  New  Jersey).  The 
reaction products were reddish brown in colour. Negative controls (omission of the 
primary antibody) were included in the control sections.  
 
 
6.2.8  Image acquisition 
 
Fluorescence images were acquired using an Axiovert 200 microscope (Carl Zeiss 
Microscopy,  Jena,  Germany)  equipped  with  Zeiss  AxioCam  HR  colour  camera, 
AxioCam MR3 monochrome camera and Zeiss AxioVision 4.6 software. By using a 
fluorescein isothiocyanate (FITC) long-pass filter, which has a blue-light excitation 
(wavelength 488 nm) and a long-pass secondary filter with cut-off at about 515 nm, 
both the red and  green  fluorochromes  can be  made visualised (Rost, 1995, Key, 
2009). A DAPI filter was used for detecting the fluorescence emission from the cell 
nuclei. Optical images  were acquired using an inverted light microscope (BX51; 
Olympus Corporation, Tokyo, Japan) equipped with a dotSlide virtual slide system. 
 
 
6.3  Results 
 
6.3.1  Cell viability on P(3HB)/P(3HO) scaffolds 
 
The viability of HACs on P(3HB)/P(3HO) scaffolds was determined by calculating 
the ratio between live and dead cells on the scaffold after culturing for 3 weeks. 
Figure 6.1 shows that only scarce amounts of necrotic cells (red fluorochrome) were 
detected  in  all  P(3HB)/P(3HO)  scaffolds.  Since  both  of  the  fluorochromes  are 
excited  at  a  different  efficiency,  the  resulting  fluorescence  signals  had  different 
intensities. The cell viability was over 98% on all scaffolds.  103 
 
  
     
Figure 6.1: Viability test of HACs seeded on the P(3HB)/P(3HO) scaffolds. The 
detected  metabolically  active  cells  (green  fluorescence)  and  necrotic  cells  (red 
fluorescence, arrow heads) on scaffolds with P(3HB)/P(3HO) ratio of (A) 1:0.25, (B) 
1:0.43, (C) 1:0.67 and (D) 1:1. The images were taken in a single exposure through 
FITC long-pass filter appropriate for fluorescein. Scale bars: 50 µm.   
 
Auto fluorescence caused by the polymer scaffolds can produce false signals that 
cause difficulties in detecting fluorescence signals from the cells. Therefore, DAPI 
was added to stain the cell nuclei so that the presence of cells can be detected when 
there were simultaneous fluorescence of both DAPI and Cell Tracker Green. Figures 
6.2 to 6.5 show the light phase contrast images and the detected fluorescence signals 
of DAPI and Cell Tracker Green on 3-week-old constructs with P(3HB)/P(3HO) 
ratios of 1:0.25, 1:0.43, 1:0.67 and 1:1, respectively. Figure 6.2-6.5, A and C show 
the cells have migrated into the voids between fibrils in all scaffolds. In the higher 
magnification of the images as shown in Figure 6.2-6.5, B and D, the location of 
cells is distinguishable from the auto-fluorescent scaffolds when blue fluorescent cell 
nuclei and green fluorescent cells are revealed simultaneously.  
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Figure 6.2: Images of HACs seeded on the P(3HB)/P(3HO) 1:0.25 scaffold. (A, C) 
Phase contrast images showing the cells located in between the electrospun fibrils. 
(B, D) Cell nuclei are shown in blue (DAPI staining), whereas the cell cytoplasm is 
shown in green (Cell Tracker Green staining). Scale bars: 100 µm (A, B) and 50 µm 
(C, D). 
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Figure 6.3: Images of HACs seeded on the P(3HB)/P(3HO) 1:0.43 scaffold. (A, C) 
Phase contrast images showing the cells located in between the electrospun fibrils. 
(B, D) Cell nuclei are shown in blue (DAPI staining), whereas the cell cytoplasm is 
shown in green (Cell Tracker Green staining). Scale bars: 100 µm (A, B) and 50 µm 
(C, D). 
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Figure 6.4: Images of HACs seeded on the P(3HB)/P(3HO) 1:0.67 scaffold. (A, C) 
Phase contrast images showing the cells located in between the electrospun fibrils. 
(B, D) Cell nuclei are shown in blue (DAPI staining), whereas the cell cytoplasm is 
shown in green (Cell Tracker Green staining). Scale bars: 100 µm (A, B) and 50 µm 
(C, D). 
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Figure 6.5: Images of HACs seeded on the P(3HB)/P(3HO) 1:1 scaffold. (A, C) 
Phase contrast images showing the cells located in between the electrospun fibrils. 
(B, D) Cell nuclei are shown in blue (DAPI staining), whereas the cell cytoplasm is 
shown in green (Cell Tracker Green staining). Scale bars: 100 µm (A, B) and 50 µm 
(C, D). 
 
 
6.3.2  In vitro chondrogenesis on P(3HB)/P(3HO) scaffolds 
 
After 3 weeks of cell culturing, the constructs appeared cartilage-like with a smooth 
and shiny appearance, as well as sufficient mechanical properties to withstand the 
handling by forceps. Mechanically, the constructs transitioned from loose fibrous 
materials  to  an  elastic-like,  discrete  mass  of  tissue.  The  biosynthesis  and 
accumulation  of  extracellular  matrix  on  the  constructs  based  on  P(3HB)/P(3HO) 
ratios  of  1:0.25,  1:0.43,  1:0.67  and  1:1  was  revealed  by  histological  staining,  as 
shown in Figure 6.6A, 6.7A, 6.8A and 6.9A, respectively. There was intense Sirius 
red  staining  for  total  collagen  matrix  at  the  outer  rim  of  the  constructs,  which 
surrounding Alcian blue staining for proteoglycan matrix at the central core. Also 
noteworthy is the proteoglycan content formed on the P(3HB)/P(3HO) 1:1 scaffold 
(Fig. 6.9A) was significantly higher compared to that on other scaffolds. The HACs 108 
 
in  constructs  were  stained  with  haematoxylin  in  black  and  were  located  within 
lacunae, as typically seen in the native AC.  
 
Immunohistochemistry further investigated the composition of extracellular matrix 
in  each  construct.  Immunohistochemical  staining  for  the  master  regulator  of 
chondrocyte differentiation, SOX-9, was detected in large amount of cells (Fig. 6.6B, 
6.7B, 6.8B and 6.9B). The SOX-9 expressed cells were observed in between the 
fibrils on most of the scaffolds, with exception on parts of the P(3HB)/P(3HO) 1:1 
scaffold  that  exhibit  bead-like  fibrils  (Fig.  6.9B).  HACs  along  the  periphery 
exhibited fibroblast-like cell morphology while those penetrated into the inner part 
of  scaffolds  showed  typical  chondrocytes’  rounded  morphology.  A  significant 
amount of the cartilage-specific aggrecan was only detected on the P(3HB)/P(3HO) 
1:0.25 scaffold (Fig. 6.6C) but not on other scaffolds (Fig. 6.7C, 6.8C and 6.9C). 
Positive staining of aggrecan was mainly detected alongside the SOX-9 expressed 
HACs.  
 
Native AC comprises type II collagen but a common issues with tissue engineering 
of  cartilage  is  the  formation  of  type  I  and  type  X  collagen.  Therefore, 
immunohistochemistry of three types of collagen: type I, type II and type X, was 
studied. Type II collagen was detected extensively throughout the constructs based 
on P(3HB)/P(3HO) 1:0.25 (Fig. 6.6D) and P(3HB)/P(3HO) 1:0.43 scaffolds (Fig. 
6.7D). However, the  formation of type  II collagen decreased with the increasing 
composition  of  P(3HO),  as  evidenced  by  the  weaker  immunostaining  on  the 
P(3HB)/P(3HO)  1:0.67  and  1:1  scaffolds  (Fig.  6.8D  and  6.9D).  The  expression 
levels of the fibrous type I collagen on P(3HB)/P(3HO) 1:0.25 scaffold (Fig. 6.6E) 
was  weaker  compared  to  the  expression  levels  of  type  II  collagen  (Fig.  6.6D), 
whereas on the P(3HB)/P(3HO) 1:1 scaffold, the expression levels of type I collagen 
(Fig. 6.9E) was stronger compared to the expression levels of type II collagen (Fig. 
6.9D). As shown in Figure 6.6F, 6.7F, 6.8F and 6.9F, considerable amount of type X 
collagen  were  present  in  all  constructs.  Expression  of  type  X  collagen  is  an 
indication of hypertrophic chondrocytes and it  was particularly intense along the 
periphery of the constructs. 
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Figure 6.6: Extracellular matrix formation on HACs-seeded P(3HB)/P(3HO) 1:0.25 scaffold: (A) Histology of proteoglycan matrix is 
shown in blue and the total collagen matrix in red. Cell nuclei are shown in black. Immunohistochemistry of (B) SOX-9, (C) aggrecan, 
(D) type II collagen, (E) type I collagen, (F) type X collagen. Positive reaction was detected with the chromogenic AEC substrate and 
shown in reddish brown colour. Scale bars: 50 µm. 
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Figure 6.7: Extracellular matrix formation on HACs-seeded P(3HB)/P(3HO) 1:0.43 scaffold: (A) Histology of proteoglycan matrix is 
shown in blue and the total collagen matrix in red. Cell nuclei are shown in black. Immunohistochemistry of (B) SOX-9, (C) aggrecan, 
(D) type II collagen, (E) type I collagen, (F) type X collagen. Positive reaction was detected with the chromogenic AEC substrate and 
shown in reddish brown colour. Scale bars: 50 µm. 
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Figure 6.8: Extracellular matrix formation on HACs-seeded P(3HB)/P(3HO) 1:0.67 scaffold: (A) Histology of proteoglycan matrix is 
shown in blue and the total collagen matrix in red. Cell nuclei are shown in black. Immunohistochemistry of (B) SOX-9, (C) aggrecan, 
(D) type II collagen, (E) type I collagen, (F) type X collagen. Positive reaction was detected with the chromogenic AEC substrate and 
shown in reddish brown colour. Scale bars: 50 µm. 
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Figure 6.9: Extracellular matrix formation on HACs-seeded P(3HB)/P(3HO) 1:1 scaffold: (A) Histology of proteoglycan matrix is 
shown in blue and the total collagen matrix in red. Cell nuclei are shown in black. Immunohistochemistry of (B) SOX-9, (C) aggrecan, 
(D) type II collagen, (E) type I collagen, (F) type X collagen. Positive reaction was detected with the chromogenic AEC substrate and 
shown in reddish brown colour. Scale bars: 50 µm. 
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6.3.3  Stiffness of construct cultured for three weeks  
 
The  distribution  of  proteoglycan  and  collagen  content  in  the  repair  tissue  was 
significantly different to that in the native AC. This is also reflected on their stiffness 
measurements, as displayed in Figure 6.10.  
 
 
Figure 6.10: Images and measurements of stiffness of human AC and HACs-seeded 
P(3HB)/P(3HO) 1:0.25 scaffold cultured for 3 weeks. (A) Histology of human AC 
showing  the  proteoglycan  matrix  in  blue  and  total  collagen  matrix  in  red  (black 
arrow heads indicate the surface side for stiffness measurement). (B) Stiffness of the 
superficial zone of human AC shows a unimodal distribution. (C) Histology shows 
the localized distributions of proteoglycan (blue) and collagen (red) matrix of the 
construct.  (D)  The  stiffness  of  3-week-cultured  construct  revealed  soft  and  stiff 
regions. Scale bars: 200 µm. 
 
As shown in Figure 6.10A, the histological section of human AC shows a uniform 
distribution of collagen content (red) at the surface region and proteoglycan content 
(blue) at the inner region. Correspondingly, Figure 6.10B documents the uniformity 
of the content as a unimodal stiffness distribution. In contrast, the construct cultured 
for 3 weeks revealed discrete regions of proteoglycan and total collagen content (Fig. 
6.10C). It exhibited stiffness that varied with the locations being measured, with an 114 
 
average stiffness of 9 ± 3 kPa at the soft region versus 1061 ± 600 kPa at the stiff 
region (Fig. 6.10D). The variations in the stiffness distribution are in agreement with 
the histological analysis.  
 
 
6.3.4  Tissue repair in partial thickness defect model 
 
To  determine  the  integration  of  the  repair  tissue  with  the  native  cartilage,  the 
P(3HB)/P(3HO) 1:0.25 construct cultured for 3 weeks was implanted into a partial 
thickness cartilage defect model. As shown in Figure 6.11, the construct was loosely 
located  within  the  defect  after  being  cultured  in  MEM  α  medium  for  10  weeks. 
Histology of the construct shows predominant proteoglycan content in the deeper 
zone  and  total  collagen  content  in  the  superficial  zone  of  the  construct.  The 
proteoglycan content in the repair tissue was significantly lower compared to that in 
the host cartilage. All defects had clearly discernible boundaries between the new 
repair tissue and the surrounding cartilage. Layers of the fibrous scaffold are also 
noticeable.  Cartilage  specific  markers  such  as  SOX-9  and  aggrecan  were  also 
detected in the newly formed extracellular matrix, as shown in Figure 6.11, B and C, 
respectively. The SOX-9-expressed cells located at the corner and floor of the defect.  
A large amount of type II collagen was also present (Fig. 6.11D), with negligible 
amounts of type X collagen (Fig. 6.11F). As shown in Figure 6.11E, type I collagen 
present mainly at the superficial zone of the implanted construct.  115 
 
 
Figure 6.11: The repair of a partial thickness cartilage defect by an engineered cartilage based on P(3HB)/P(3HO) 1:0.25 scaffold after 
10 weeks. (A) Histology of proteoglycan matrix is shown in blue and the total collagen matrix in red. Immunohistochemistry of (B) 
SOX-9,  (C)  aggrecan,  (D)  type  II  collagen,  (E)  type  I  collagen,  (F)  type  X  collagen.  Positive  reaction  was  detected  with  the 
chromogenic AEC substrate and shown in reddish brown colour. The interfaces between the implanted construct (denoted as “C”) and 
the native AC (denoted as “AC”) are shown with black arrow heads. There is lack of integration between the newly formed extracellular 
matrix and the native AC. Scale bars: 200 µm.  
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6.4  Discussion 
 
For  a  successful  AC  repair  or  regeneration,  the  engineering  of  cartilage  requires 
effective in vitro synthesis of cartilaginous tissue. Autologous chondrocytes are most 
commonly  used  in  cartilage  engineering  because  of  their  ability  to  readily 
differentiate  into  the  target  phenotype  and  their  capacity  to  secrete  cartilage-
appropriate matrix molecules (Athanasiou et al., 2009). A cell density of 7 × 10
5 
cells/cm
2 was used, as the preliminary assessment at 1 week found that a cell density 
in between 5 × 10
5 cells/cm
2 and 10 × 10
5 cells/cm
2 is sufficient for seeding the 
scaffolds (Appendix C). The response of chondrocytes to the scaffolds is reflected in 
the cell viability and functionality.  
 
 
6.4.1  Cell viability on P(3HB)/P(3HO) scaffolds 
 
The in vitro cell viability tests demonstrated that the P(3HB)/P(3HO) scaffolds are 
non-toxic and able maintain high cell viability (Fig. 6.1). Previous research reported 
that cell viability on PHAs scaffolds during early culturing could be low due to the 
low  hydrophilicity  of  the  polymers.  However,  it  was  improved  later  during  the 
culturing period when there were higher cell attachment and proliferation, and even 
better than that on the polystyrene culture flask (Sombatmankhong et al., 2007). The 
high  cell  viability  also  proves  that  the  degradation  products  released  during  the 
course of degradation were non-cytotoxic. The degradation products of PHAs are 
mainly  monomers  of  PHAs,  3-hydroxybutyric  acids,  which  occur  naturally  in 
various human tissues (Chen and Wu, 2005). Such monomers are synthesized in the 
liver  from  where  they  are  released  into  blood  circulation  and  absorbed  by 
extrahepatic tissues, such as heart and skeletal muscles. Therefore, the degradation 
products of PHAs are well known to be unharmful to the host body, a feature that is 
significantly different with many currently used synthetic absorbable polymers, such 
as PGA and PLA, which release acidic and inflammatory degradation by-products 
(Weng et al., 2011, Chen et al., 2013).  
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6.4.2  In vitro chondrogenesis on P(3HB)/P(3HO) scaffolds 
 
The electrospun fibrous meshworks possess unique physical characteristics, such as 
high  surface  area-volume  ratio,  interconnectivity  and  pore  void  volume.  These 
unique characteristics facilitate cell attachment and penetration, which were proven 
by the high cellularity displayed throughout the constructs (Fig. 6.6-6.9). In addition 
to a physical structure environment, growth factors such as TGF-β3 and ITS-G are 
also needed to enhance the proliferation and turnover rate of chondrocytes, as well as 
to  increase  hyaline-like  cartilage  production  on  scaffolds  (Zimber  et  al.,  1995, 
Toolan et al., 1996). It has been demonstrated that chondrocytes respond to growth 
factors  that  are  naturally  present  in  their  joint  environment,  e.g.,  the  TGF-β 
superfamily that naturally present in the developing bone and cartilage. In vitro, the 
chondro-inductive  cues  provided  by  TGF-β3  were  shown  to  maintain  the 
chondrogenic or pre-hypertrophic phenotype of differentiated mature chondrocytes 
(Athanasiou et al., 2009, Saha et al., 2010, Saha et al., 2013). Therefore, in addition 
to promote cell penetration and retention by using a scaffold with fibrous structure, 
TGF-β3  and  ITS-G  were  added  into  the  chondrogenic  medium  to  facilitate  the 
release of trophic factors by the chondrocytes for tissue production (Coburn et al., 
2012). 
 
The potential maintenance of chondrogenesis was evidenced by histological staining 
of  constructs  with  Alcian  blue  and  Sirius  red.  For  constructs  based  on 
P(3HB)/P(3HO)  ratios  of  1:0.25,  1:0.43  and  1:0.67,  similar  formation  of 
proteoglycan and total collagen contents were observed (Fig. 6.6A, 6.7A and 6.8A). 
Conversely, the construct based on P(3HB)/P(3HO) 1:1 scaffold displayed a slightly 
different matrix content, with relatively higher proteoglycan content in comparison 
to the total collagen content, as shown in Figure 6.9A. This suggests that the HACs 
secrete  more  proteoglycan  in  a  softer  and  more  elastomeric  scaffold.  Both  the 
proteoglycan and total collagen contents were formed at the extracellular regions of 
the  scaffolds.  This  shows  that,  by  3  weeks,  the  scaffolds  had  degraded  to  allow 
diffusion of the large proteoglycan and collagen molecules. It was understood that in 
scaffolds that are non-degradable, the large proteoglycan molecules would remain 
within the lacunae, as they are unable to diffuse into the scaffold structure. Similarly 
for the collagen molecules, which were restricted to the pericellular regions (Bryant 118 
 
et al., 2004). Since histology of the constructs showed a potential chondrogenesis, 
immunohistochemistry was carried out to visualize the presence of specific antigens 
or proteins in the newly synthesized extracellular matrix. 
 
The key factor in AC formation is SOX-9, which is expressed in the differentiated 
chondrocytes, and is needed to support the chondrocytes to function properly and 
produce a structurally well-organised, interactive set of cartilage matrix (Hiramatsu 
et al., 2011). Indeed, the importance of this gene in chondrogenesis had been shown 
by transfecting cells with a vector containing SOX-9, which resulted in chondrocytic 
cells, whereas knocking out the gene prevented the formation of cartilage (Bi et al., 
2001).  Positive  staining  of  SOX-9  was  immunolocalised  to  large  amounts  of 
chondrocytes in all constructs (Fig. 6.6B, 6.7B, 6.8B and 6.9B). The HACs were 
observed to respond directly to the morphological features of their environment, by 
mainly  located  among  the  straight  and  fine  fibrils  and  absent  around  the  bead-
forming fibrils (Fig. 6.9B). In addition, cell morphology of HACs located on the 
surface of fibrous scaffolds were spread and fibroblast-like, whereas HACs located 
inside  the  scaffolds  showed  typical  chondrocyte’s  rounded  morphology.  This 
observation accords well with the physiological situation (Hunziker, 2001), and is 
similar  to  the  previous  observation  on  the  behaviour  of  chondrocytes  on 
P(3HB)/P(3HHx)  scaffolds  (Rai  et  al.,  2011).  However,  the  scaffolds  did  not 
promote the organisation of chondrocytes into columnar arrangement. 
 
The presence of SOX-9 determines the production of chondroid matrix, such as the 
aggrecan  and  the  type  II  collagen.  Aggrecan  is  the  most  abundant  type  of 
proteoglycan while type II collagen is the principal collagen component in the AC. 
Aggrecan was immunolocalised abundantly on the P(3HB)/P(3HO) 1:0.25 construct 
(Fig.  6.6C),  alongside  the  SOX-9  expressed  cells  as  SOX-9  promotes  the  gene 
expression  of  aggrecan  (Tare  et  al.,  2005,  Saha  et  al.,  2010).  However,  the 
immunostaining  of  aggrecan  was  weak  and  almost  absent  on  the  rest  of  the 
constructs, as shown in Figure 6.7C, 6.8C and 6.9C. It is unclear at this stage why 
the formation of aggrecan was not detected on these constructs. The chondrocytes 
might  have  de-differentiated  and  causing  the  loss  of  large  molecule  type  of 
proteoglycan,  the  aggrecan,  and  the  switch  to  the  synthesis  of  small  non-
cartilaginous  proteoglycan  (Vonwil,  2010),  because  the  structure  and  stiffness 119 
 
microenvironment of these scaffolds were different compared to the P(3HB)/P(3HO) 
1:0.25 scaffold. The P(3HB)/P(3HO) 1:0.25 scaffold exhibited the smallest fibril size 
and the highest stiffness property than the other scaffolds, and is more mimicking to 
the  native  AC.  Therefore,  the  proteoglycan  content  shown  by  the  Alcian  blue 
staining in histology could be attributed to the small non-cartilaginous type but not 
the aggrecan type proteoglycans.  
 
Type II collagen was detected extensively in the P(3HB)/P(3HO) 1:0.25 construct, 
not only in most chondrocytes, but also in the extracellular matrix (Fig. 6.6D). In 
comparison, the amount of type I collagen in this construct was quantitatively minor 
(Fig. 6.6E), presumably the vast amount of SOX-9 expressed chondrocytes have 
suppressed its production (Hiramatsu et al., 2011). With the increasing composition 
of P(3HO) and hence, decreasing scaffold stiffness, there was a decrease in the type 
II collagen content and an increase in the type I collagen content. In particular, the 
expression of type I collagen was significantly higher than type II collagen on the 
P(3HB)/P(3HO) 1:1 construct (Fig. 6.9, D and E). It is suggested that chondrocytes 
are susceptible to de-differentiation on the softer scaffolds. This again shows the 
differences  in  microenvironment  influence  the  fate  of  chondrocytes,  their  protein 
expression and tissue formation.   
 
Type X collagen, which is a marker for the transition of chondrocytic phenotype to 
the terminal phase of hypertrophic differentiation, was present considerably in all the 
constructs (Fig. 6.6F, 6.7F, 6.8F and 6.9F). This is presumably due to the expression 
of SOX-9 in the chondrocytes not continuing throughout the culture period to delay 
the onset of hypertrophic chondrocytes. In addition, while the typical chondrogenic 
stimuli  (TGF-β  and  ITS-G)  can  induce  chondrogenic  differentiation,  they  also 
promote the up-regulation of type X collagen (Johnstone et al., 2013). The potential 
of matrix calcification brought by type X collagen might assist in the integration of 
the newly formed repair tissue with the subchondral bone, or it may be indicative of 
cartilage remodeling and provide an interim collagen scaffold, as demonstrated in 
the  growth  plate  (Richardson  et  al.,  1999).  However,  it  may  also  exert  other 
influences on the neo-cartilage, such as altering the accumulation of proteoglycans, 
thereby modifying the diffusion properties of the matrix (Richardson et al., 1999). In 120 
 
the  application  of  tissue  engineering  technology  for  AC  repair,  sustaining  the 
expression of SOX-9 during culturing period to prevent the onset of hypertrophy still 
remains as a challenge (Hiramatsu et al., 2011). Therefore, further optimization on 
the chondrogenic induction medium is needed. 
 
 
6.4.3  Stiffness of construct cultured for three weeks 
 
A  common  phenomenon  for  engineered  cartilage  is  the  uneven  local  stiffness 
properties of the constructs, which reflects the variation in the composition of neo-
cartilage compared to the native cartilage (Klein et al., 2007). A spherical indenter 
with  a  radius  of  5  µm  was  unable  to  detect  the  variations  in  the  structural 
components on the surface of native AC, hence, demonstrated a unimodal stiffness 
distribution (Fig. 6.10B). In comparison, the variations in the structural components 
of neo-cartilage were large enough to be detected by the indenter, revealing discrete 
soft and stiff regions on the surface (Fig. 6.10D). This is due to the local organisation 
of proteoglycan  and  collagen contents during the in  vitro  culturing process (Fig. 
6.10C).  The  incorporation  of  cells  into  the  network  also  adds  complexity  in 
determining the stiffness properties, as the cells may absorb some of the load applied 
to  the  construct  and  subsequently  deform,  and  hence,  influence  the  stiffness 
measurements (Bryant and Anseth, 2002). Considering that cells have a stiffness of 3 
orders  of  magnitude  smaller  than  the  extracellular  matrix  (~3  kPa),  and 
proteoglycans  exhibit  soft  gel-like  properties,  the  low  stiffness  region  of  the 
construct  is  attributed  to  the  cell-  and  proteoglycan-rich  content.  Meanwhile,  the 
high  stiffness  region  is  attributed  to  the  collagen-rich  content  or  the  scaffold 
structure  (Fig.  6.10C)  (Loparic  et  al.,  2010).  Nevertheless,  the  amount  of  neo-
cartilage formed is considered as encouraging for a 3-week-old construct.  
 
 
6.4.4  Tissue repair in partial thickness defect model 
 
The partial thickness defect model created in this study is defined as a structural 
defect from which tissue was missing or had been removed, and was treated with the 
3-week-old construct based on P(3HB)/P(3HO) 1:0.25 scaffold. A construct that had 121 
 
been  pre-cultured  under  chondrogenic  condition  was  employed  because  it  can 
maintain a long-term chondrogenic phenotype, and hence, improve the quality of 
cartilage  genesis  in  vivo  (Liu  et  al.,  2007).  Tissue  repair  in  the  partial  thickness 
defect model after 10 weeks in vitro culturing is shown in Figure 6.11. Due to the 
intrinsic anti-adhesive property of AC, there was clear discernible boundary between 
the  implanted  constructs  and  the  host  cartilage  (Fig.  6.11A).  The  newly  formed 
repair tissue also contained lower proteoglycan and total collagen contents compared 
to  the  adjacent  host  cartilage.  It  is  however  worth  noting  that  the  repair  tissue 
demonstrated a zonal differentiation gradient, with higher collagen content in the 
superficial  region  and  higher  proteoglycan  content  in  the  deeper  region.  This  is 
similar to the native AC, which has a higher composition of water and collagen in 
the  superficial  zone,  and  higher  proteoglycan  content  in  the  deep  zone.  A  clear 
difference between the 10-week-old defect model and the 3-week-old construct is the 
lower expression of fibrillar type I collagen and calcified type X collagen in the 10-
week-old  defect  model.  This  suggests  that  the  chondrocytes  with  a  reduced 
proliferation rate do not further maturate into the hypertrophic state.  
 
 
6.5  Summary 
 
The  P(3HB)/P(3HO)  scaffolds  are  capable  of  supporting  high  cell  viability, 
evidenced by the HACs displaying a phenotype similar to those in the native AC. 
The  different  stiffness  properties  of  P(3HB)/P(3HO)  scaffolds  regulate  the  gene 
expression  and  secretion  of  extracellular  matrix  by  the  chondrocytes.  The 
extracellular matrix formed on the stiffer P(3HB)/P(3HO) 1:0.25 scaffold was more 
hyaline-like compared to that on the softer P(3HB)/P(3HO) 1:1 scaffold. Since type 
X collagen was considerably present in all constructs, optimisation of the culture 
medium is needed to sustain the differentiation of chondrocytes and suppress the 
formation of collagen type X. To immobilise the construct within the defect site, and 
promote the integration between the repair tissue and the surrounding host cartilage, 
the application of an adhesive such as chondroitin sulphate (Coburn et al., 2012) or 
fibrin glue (Schlag and Redl, 1988) is needed. 123 
 
CHAPTER 7 
 
CHITOSAN/POLY(ETHYLENE OXIDE) SCAFFOLDS 
 
 
7.1  Introduction 
 
7.1.1  Chitosan/PEO 
 
Chitosan  is  the  primary  structural  polymer  in  arthropod  exoskeletons,  shells  of 
crustaceans, or the cuticles of insects (Freier et al., 2005). It is a polysaccharide 
made of amino sugars obtained by deacetylating chitin and is technically  widely 
used because of its biocompatibility (Chandy and Sharma, 1990, Lee et al., 1995b). 
As shown in Figure 7.1, chitosan is composed of randomly distributed β-(1,4) linked 
D-glucosamine  (deacetylated  unit)  and  N-acetyl-glucosamine  (acetylated  unit).  It 
shares some characteristics with GAGs, which are important structural components 
of  the  cartilage  extracellular  matrix  that  modulate  the  chondrocytes  morphology, 
differentiation and function (Suh and Matthew, 2000, Drury and Mooney, 2003). 
The  cationic  characteristic  of  chitosan  also  allows  for  its  ionic  interactions  with 
anionic GAGs (Madihally and Matthew, 1999), chondrocytes (Lahiji et al., 2000, 
Kuo and Hsu, 2009), growth factors and cytokines (Suh and Matthew, 2000, Iwasaki 
et al., 2010).  
 
 
Figure 7.1: Structure of chitosan. 
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Although  chitosan  demonstrates  biocompatibility  with  chondrocytes  and  in  vivo 
biodegradability, it is rigid and brittle in nature. In its solid state, chitosan molecules 
organise themselves into ordered crystalline regions that co-exist with an amorphous 
phase, forming what is considered as a semi-crystalline polymer (Nicu et al., 2011). 
These characteristics limit the use of chitosan as scaffold materials for engineering 
of cartilage, as they are prone to rupture when loaded. Therefore, the mechanical 
integrity of chitosan needs to be improved for application as pre-engineered cartilage 
constructs  (Cheng  et  al.,  2003,  Neto  et  al.,  2005,  Sarasam  and  Madihally,  2005, 
Subramanian and  Lin, 2005).  In addition, the conventional methods of preparing 
chitosan solution produce deep atomization and a very high charge density that is not 
suitable for the electrospinning process (Subramanian et al., 2005). This is due to the 
polyelectrolyte  nature  of  chitosan,  which  when  dissolved  in  dilute  acetic  acid 
solution, becomes cationic and carries positive charges. Repulsive forces are formed 
between the positive charges in chitosan chains or molecules. These forces prevent 
the chitosan molecule forming a random coil configuration as in the case with an 
uncharged polymer chain. There are also limited chain entanglements because the 
chitosan  chains  repel  each  other,  making  them  break  up  into  polydisperse 
electrosprays (Zhang et al., 2008).  
 
The  morphology  and  ductility  of  chitosan  can  be  improved  by  blending  or 
copolymerizing with other polymers. Blending polymers of the same charged groups 
results in segregation, while blending with those of the oppositely charged groups 
causes inclusion into the intermolecular complexes. As a consequence, properties of 
the polymer blends are affected due to microphase separation of the constituents 
(Alexeev et al., 2000). Poly(ethylene oxide) (PEO) is a biocompatible polymer and 
one of the few synthetic polymers with FDA approval. The structure of PEO, as 
illustrated  in  Figure  7.2,  reveals  it  to  be  uncharged  thereby  preventing  strong 
interaction between components. 
 
 
Figure 7.2: Structure of PEO. 
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Poly(ethylene  oxide)  exhibits  a  structure  of  which  each  ethylene  oxide  unit  is 
capable of binding with two to three water molecules (Aray et al., 2004). This gives 
PEO  a  highly  hydrated  nature  that  is  similar  to  the  native  AC  (Lowman  and 
Mathiowitz, 1999). In addition, the rapidly moving hydrated PEO chains associated 
with  a  large  excluded  volume  tend  to  repel  protein  molecules  and  most 
macromolecules from attaching to its surface (Lee et al., 1995a). This is important to 
reduce the clinical problems of infection, because the presence of adsorbed proteins 
can modulate host inflammatory cell interactions and adhesions (Anderson et al., 
2008). PEO is biocompatible with chondrocytes, as evident both in vitro and in vivo, 
by evoking cell proliferation and the extracellular matrix generation (Sims et al., 
1996, Elisseeff et al., 1999, Bryant and Anseth, 2001). PEO at low molecular weight 
(<400 Da) degrades in vivo by alcohol dehydrogenase to toxic metabolites, but the 
degradation products from PEO with molecular weight above 1000 Da are non-toxic 
(Clark et al., 1996, Roberts et al., 2002). Below a molecular weight of 20 kDa, PEO 
can  be  cleared  in  the  urine  without  structural  change,  and  the  clearance  speed 
decreases  with  increasing  molecular  weight.  At  high  molecular  weight,  PEO  is 
weakly immunogenic (Roberts et al., 2002).   
 
Blending  PEO  with  chitosan  will  inevitably  reduce  the  brittle  nature  of  chitosan 
(Alexeev et al., 2000, Kolhe and Kannan, 2003). This is because PEO with ultra-
high molecular weight (>1 million Da) exists in flexible long chains that can serve to 
transfer load more effectively to the polymer backbone, thus, allow its application as 
a cartilage repair material. The addition of PEO to chitosan also allows concentrated 
chitosan  solution  to  become  electrospinnable  due  to  the  formation  of  hydrogen 
bonding  between  amino  hydrogen  from  chitosan  and  oxygen  from  PEO,  which 
enhances chain entanglement (Sun et al., 2000, Bhattarai et al., 2005, Subramanian 
et  al.,  2005,  Zhang  et  al.,  2008).  Electrospun  chitosan/PEO  nanofibrils  serve  as 
temporary  cell  matrices  to  transmit  the  tensile  loads,  whereas  the  glucosamine 
chemistry of chitosan could support the compressive stresses, mimicking the roles of 
fibrous collagens and GAGs in the natural extracellular matrix (Vondran et al., 2008). 
In  addition,  the  large  surface  area  of  the  electrospun  chitosan/PEO  fibrils  also 
encourages the attachment of chondrocytes.  
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7.1.2  Crosslinking of chitosan/PEO  
 
Chitosan and PEO are both soluble in water and, therefore, need to be crosslinked to 
reduce  their  solubility  before  they  serve  as  scaffold  materials.  The  crosslinking 
agents bind the polymer network together and prevent the individual kinetic chains 
from dissolving into the surrounding solution (Metters et al., 2000). There are two 
ways of crosslinking  chitosan, namely, ionically or  covalently.  Ionic  crosslinkers 
involve polyanions such as triphosphate or citrate, which interact with chitosan via 
electrostatic forces to form an ionic crosslinked network. Covalent crosslinkers for 
chitosan  include  di-  or  polyaldehydes,  e.g.,  glutaraldehyde,  oxidised  starch  and 
oxidised cyclodextrin, and carboxylic acids, azides, epoxides, diisocyanates, silane 
and  genipin.  During  covalent  crosslinking,  the  amino  (NH2)  and  hydroxyl  (OH) 
groups  of  chitosan  (Fig.  7.1)  react  with  the  functional  groups  of  crosslinker 
molecules. 
 
Pure  chitosan  and  its  blends  are  often  crosslinked  with  glutaraldehyde  for  tissue 
engineering  applications  (Schiffman  and  Schauer,  2007,  Vondran  et  al.,  2008, 
Hoffmann  et  al.,  2009),  but  the  release  of  glutaraldehyde  over  time  results  in 
cytotoxicity. Even prolonged washing of 60 minutes is insufficient to remove the 
cytotoxic effects of glutaraldehyde due to its slow leaching behaviour (Gendler et al., 
1984). For example, Speer et al. (1980) found cytotoxic effects on fibroblasts in 
tissue culture and foreign body reaction to their glutaraldehyde crosslinked collagen 
bio-implants.  Human  osteoblasts  were  also  observed  to  undergo  apoptosis  on 
exposure to glutaraldehyde crosslinked collagen/PVA composite films (Gough et al., 
2002). This excludes the use of  glutaraldehyde crosslinker for tissue engineering 
applications.  
 
Genipin is a crosslinker isolated from Gardenia jasminoides Ellis fruit, and has been 
used in traditional Chinese medicine. The structure of genipin is illustrated in Figure 
7.3.  
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Figure 7.3: Structure of genipin. 
 
Genipin was originally identified as a protein crosslink agent, which reacts with free 
amino groups through oxygen radical-induced polymerisation and dehydrogenation 
of several intermediate pigments (Touyama et al., 1994, Park et al., 2002). Since 
genipin is a naturally occurring, biodegradable molecule with low cytotoxicity, it has 
recently been investigated as a crosslinking material in many biological applications. 
As an example, its use has been reported for crosslinking collagen (Sundararaghavan 
et al., 2008, Bi et al., 2011, Mekhail et al., 2011), gelatin (Chiono et al., 2008),  
chitosan (Chiono et al., 2008, Silva et al., 2008b, Bi et al., 2011) and silk fibroin 
(Silva et al., 2008a, Zhang et al., 2010).  
 
The biocompatibility of genipin has been reported as better than synthetic crosslink 
agents such as glutaraldehyde, formaldehyde, and epoxy compounds (Zhang et al., 
2010, Mekhail et al., 2011). Indeed, genipin was about 10,000 times less cytotoxic 
and  evoked  5000  times  more  cell  proliferation  than  glutaraldehyde  (Sung  et  al., 
1999a, Tsai et al., 2000). It has also been shown that tissue and scaffolds crosslinked 
by  genipin  exhibit  improved  tensile  strength  and  toughness,  compared  to 
glutaraldehyde and epoxy crosslinkers (Sung et al., 1999b, Sell et al., 2008). Hence, 
genipin was used as the crosslinking agent in this study. 
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7.2  Materials and methods 
 
7.2.1  Preparation of chitosan/PEO scaffolds 
 
7.2.1.1 Electrospinning  
 
Chitosan from crab shells with degree of deacetylation >85% (28191; Sigma-Aldrich) 
and PEO with molecular weight >5 MDa (A15536; Alfa Aesar, Lancaster, UK) were 
blended at a weight ratio of 1:0.33. Due to the formation of unwanted defects as a 
result of insufficient amount of PEO (Appendix D), an optimum chitosan/PEO ratio 
of 1:0.33 was employed for the electrospinning of defect-free fibrils. The mixture 
was then dissolved in aqueous solvent of 3.0% (w/w) acetic acid (33209; Sigma-
Aldrich) to prepare a polymer solution at a concentration of 3.2% (w/w). To improve 
electrospinning conditions, 10% (w/w) of DMSO and 0.3% (w/w) of Triton X-100 
(437002A; VWR International, Poole, UK) were added as co-solvents. The blend 
solutions were stirred at room temperature for 24 hours until viscous transparent 
solutions were obtained. The electrospinning of chitosan/PEO was carried out as 
described in Section 3.2.1, with a flow rate of 2 µl/min. Voltage supply and distance 
between the spinneret and collector were adjusted until a stable jet was obtained. 
 
 
7.2.1.2 Crosslinking with genipin 
 
Genipin  powder  (98%;  Challenge  Bioproducts,  Yun-Lin  Hsien,  Taiwan)  was 
dissolved in aqueous solution of 90% ethanol to obtain concentrations of 0.5%, 0.8%, 
1.0% and 1.5% (w/w). A minimum concentration of 0.5% was used as a requirement 
to ensure the complete crosslinking (Yao et al., 2004). The electrospun chitosan/PEO 
scaffolds  were  immersed  into  the  genipin  solution  in  a  vial.  The  completion  of 
crosslinking reaction was indicated by a colour change of the scaffolds from white to 
greenish blue (Touyama et al., 1994), which occurred after a period of approximately 
14 days. Next, the crosslinked scaffolds were rinsed with excess of deionised water 
and immersed in water overnight to eradicate excess or unreacted genipin. 
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7.2.2  Characterisation of chitosan/PEO scaffolds  
 
The structure of scaffolds was examined by SEM as described in Section 3.2.3.1 and 
the stiffness was measured by IT-AFM and calculated as described in Section 4.4.3 
and Section 4.4.4.  
 
 
7.2.3  In vitro degradation of chitosan/PEO scaffolds 
 
An In vitro degradation test of the scaffolds was performed as described in Section 
5.2.1. The structure and stiffness of the scaffolds was examined after 1 and 4 months 
of degradation.  
 
 
7.2.4  Biocompatibility of chitosan/PEO scaffolds 
 
The  chitosan/PEO  scaffolds  were  seeded  with  HACs  and  cultured  for  3  weeks. 
Live/dead cell, histological and immunohistochemical analysis were carried out as 
described  in  Section  6.2.5,  Section  6.2.6  and  Section  6.2.7,  respectively. 
Fluorescence and optical images were acquired as described in Section 6.2.8. 
 
 
7.3  Results 
 
7.3.1  Structure of electrospun chitosan/PEO scaffolds 
 
Chitosan/PEO blended at a ratio of 1:0.33 was electrospun into randomly oriented 
fibrils that are similar to the collagen fibril meshwork in native AC. Figure 7.4A 
shows the collagen fibril meshwork in human AC after enzymatic extraction of the 
proteoglycan  and  cellular  contents.  Figure  7.4B  shows  that  the  electrospun 
chitosan/PEO fibrils were defect-free with smooth surface morphologies. The fibrils 
exhibited fairly uniform geometry and clear boundaries between the fibrils can be 
seen. The average fibril diameter estimated from approximately 50 fibrils was 99 ± 
23 nm, twofold larger than the collagen fibrils.  130 
 
      
Figure  7.4:  SEM  micrographs  comparing  the  collagen  meshwork  of  AC  with 
scaffolds  made  of  electrospun  chitosan/PEO  fibrils.  (A)  The  collagen  fibril 
meshwork of human AC after proteoglycan extraction consists of a pseudo-random 
meshwork  of  smooth  collagen  fibrils.  (B)  The  fine  and  straight  electrospun 
chitosan/PEO 1:0.33 fibrils with smooth surfaces. Scale bars: 500 nm. 
 
 
7.3.2  Structure of crosslinked chitosan/PEO scaffolds  
 
The as-spun chitosan-PEO fibrils were stable in dry state, but they rapidly dissolved 
after exposure to an aqueous environment. Therefore, crosslinking was required to 
improve the water resistance of chitosan/PEO scaffolds. After electrospinning, the 
chitosan/PEO scaffold was immersed in genipin solution with concentrations ranging 
from 0.5%, 0.8%, 1.0% to 1.5%. This yielded scaffolds which remained undissolved 
upon  contact  with  aqueous  solution,  indicating  that  crosslinking  conferred  water 
resistance  to  the  chitosan/PEO  fibrils.  Figure  7.5  shows  the  structure  of  the 
crosslinked fibrils, which some of the adjacent fibrils were fused together.  
 
Figure 7.6 compares the average diameter of collagen fibrils to the average diameters 
of  chitosan/PEO  fibrils  before  and  after  crosslinked  with  four  different  genipin 
concentrations. All the crosslinked fibrils displayed an increased fibril size due to 
swelling after crosslinking, and the increment on fibril size was higher when lower 
concentration of genipin was used. Before crosslinking, the average diameter of the 
as-spun chitosan/PEO fibrils was 99 ± 23 nm. The average fibril diameter increased 
43% after crosslinking with 0.5% genipin, 21% with 0.8% genipin, 4% with 1.0% 
genipin and 8% with 1.5% genipin. 
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Figure  7.5:  SEM  micrographs  comparing  electrospun  chitosan/PEO  fibrils 
crosslinked with different concentrations of genipin: (A) 0.5%, (B) 0.8%, (C) 1.0%, 
and (D) 1.5% genipin. Adjacent fibrils were fused together, forming bundle of fibrils. 
Crosslinkages between some fibrils can be observed as indicated by the white arrow 
heads. Scale bars: 500 nm. 
 
 
Figure  7.6:  Average  diameters  of  electrospun  chitosan/PEO  fibrils  without 
crosslinking,  and  after  crosslinking  with  various  concentrations  of  genipin,  in 
comparison to the diameter of collagen fibrils in human AC. 132 
 
7.3.3  Stiffness of crosslinked chitosan/PEO scaffolds  
 
Figure 7.7 shows the typical load-displacement curves of electrospun chitosan/PEO 
scaffolds crosslinked with different concentrations of genipin crosslinker.  
 
 
Figure  7.7:  The  unloading  part  of  the  load-displacement  curves  measured  on 
chitosan/PEO  scaffolds  crosslinked  with  different  concentrations  of  genipin 
crosslinker, in comparison to that of human AC. 
 
Stiffness was calculated using data from the upper 25% of the unloading curves. As 
shown  in  Figure  7.8,  the  stiffness  of  chitosan/PEO  scaffolds  increased  with  the 
increasing concentration of the genipin crosslinker. Scaffold crosslinked with 1.5% 
genipin  exhibited  the  highest  stiffness,  1875  ±  532  kPa,  which  is  similar  to  the 
stiffness of deep zone human AC (1854 ± 483 kPa). The stiffness of 1.0% genipin 
crosslinked scaffold was 890 ± 311 kPa, in between the stiffness of the deep zone 
and superficial zone human AC (600 ± 150 kPa). The 0.8% crosslinked scaffold 
exhibited a stiffness of 719 ± 240 kPa, which is similar to the superficial human AC, 
while the stiffness of 0.5% crosslinked scaffold was the lowest, measured at 137 ± 
47 kPa. 
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Figure 7.8: Stiffness of the chitosan/PEO scaffolds in comparison to the superficial 
zone  and  deep  zone  of  human  AC.  The  stiffness  of  scaffolds  increases  with  the 
increasing concentration of genipin crosslinker. The area in light grey shows the 
range of stiffness measured on the superficial zone human AC, whereas the area in 
dark grey shows the range of stiffness measured on the deep zone human AC.  
 
 
7.3.4  In vitro degradation of crosslinked chitosan/PEO scaffolds 
 
The  column  of  Figure  7.9  (Fig.  7.9,  A-D)  shows  the  uniform  fibril  morphology 
before degradation and changes of the morphology after 1 month (Fig. 7.9, E-H) and 
7 months of degradation (Fig. 7.9, I-L). The rows show the electrospun scaffolds 
crosslinked  with  increasing  concentration  of  genipin.  Signs  of  degradation  were 
observed  on  the  scaffolds  crosslinked  with  0.5%,  0.8%  and  1.0%  genipin.  At  1 
month, some adjacent fibrils were fused together. At 7 months, some of the fused 
fibrils had started to dissolve and lost their fibrillar structure. A reduction in mesh 
size is also visible, which may reduce the overall scaffold volume. As shown in 
Figure 7.9, H and L, the structure of the 1.5% genipin-crosslinked scaffold remained 
stable with no signs of degradation. 
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Figure 7.9: Comparison of SEM micrographs of chitosan/PEO scaffolds before and 
after hydrolytic degradation. (A-D) The original fibril structure. (E-G) After 1 month 
of  hydrolytic  degradation,  some  adjacent  fibrils  were  fused  together.  (H)  The 
structure of scaffold crosslinked with 1.5% genipin remained unchanged. (I-K) After 
7 months, the fibrils further dissolved with a loss of fibril structure. (L) The structure 
of scaffold crosslinked with 1.5% genipin still remained unchanged. Scale bars: 500 
nm.   
 
As shown in Figure 7.10, the stiffness of chitosan/PEO scaffolds crosslinked with 
0.5%, 0.8% and 1.0% genipin reduced as a result of scaffold degradation. A great 
reduction of stiffness was observed as early as 1 month, with 15% reduction on 
scaffold crosslinked with 0.5% genipin, 57% reduction on that with 0.8% genipin 
and 64% reduction on that with 1.0% genipin. At 7 months, the stiffness of scaffolds 
crosslinked with 0.5%, 0.8% and 1.0% reduced to a similar level, approximately 100 135 
 
kPa, although they exhibited varied initial stiffnessed. In comparison, the scaffold 
crosslinked with 1.5% genipin maintained its stiffness throughout the course of the 
degradation period, with a remaining stiffness of 1865 ± 708 kPa after 7 months. 
This agrees well with the scaffold structure shown in Figure 7.9, H and L.  
 
 
Figure  7.10: Decrease in the stiffness of chitosan/PEO scaffolds after hydrolytic 
degradation. The original stiffness of the scaffolds crosslinked with four different 
genipin concentrations is indicated by “■”. The stiffness of scaffolds after 1 month 
of  degradation  is  indicated  by  “●”,  whereas  the  stiffness  after  7  months  of 
degradation is indicated by “▲”.  
 
 
7.3.5  Biocompatibility of crosslinked chitosan/PEO scaffolds 
 
Figure 7.11 shows the fluorescence images of live and dead HACs on chitosan/PEO 
scaffolds crosslinked with 4 different genipin concentrations. To further distinguish 
the  cells  from  the  auto  fluorescent  scaffolds,  the  simultaneous  events  of  DAPI 
stained cell nuclei and Cell Tracker Green stained cell cytoplasm are demonstrated 
in Figure 7.12. The comparison between Figures 7.11 and 7.12 deduces that the large 
area of red fluorochromes detected in Figure 7.11 was due to the auto fluorescent 
nature of the scaffolds, as the red fluorochromes do not exhibit the typical shape of 
HACs.  In  addition,  Figure  7.12  shows  that  the  cells  (where  the  blue  and  green 
fluorescence  were  detected  simultaneously)  mainly  agglomerated  outside  the 136 
 
scaffold structure but not penetrated in between the fibrils of the scaffolds (where the 
green auto fluorescence occurred). Due to the indistinguishable fluorescence events 
between the dead cells and the scaffold structure, and the lack of cells present in the 
scaffolds, the determination of actual cell viability on the scaffolds was difficult.  
 
  
    
Figure  7.11:  Viability  test  of  HACs  seeded  on  the  chitosan/PEO  scaffolds.  The 
detected  metabolically  active  cells  (green  fluorescence)  and  necrotic  cells  (red 
fluorescence, arrow heads) on chitosan/PEO scaffolds crosslinked with (A) 0.5%, (B) 
0.8%, (C) 1.0% and (D) 1.5% genipin. The auto fluorescent scaffold structure is 
denoted with “S”. The images were taken in a single exposure through FITC long-
pass filter appropriate for fluorescein. Scale bars: 50 µm.  
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Figure  7.12:  Images of HACs seeded on the  chitosan/PEO scaffolds crosslinked 
with  (A,  B)  0.5%,  (C,  D)  0.8%,  (E,  F)  1.0%  and  (G,  H)  1.5%  genipin.    Phase 
contrast  images  (A,  C,  E,  G)  show  most  of  the  cells  were  located  outside  the 
scaffolds. Fluorescence images (B, D, F, H) show cell nuclei in blue (DAPI staining), 
and  cell  cytoplasm  in  green  (Cell  Tracker  Green  staining).  The  auto  fluorescent 
scaffold structure is denoted with “S”. Scale bars: 50 µm.   138 
 
The biosynthesis and accumulation of extracellular matrix on chitosan/PEO scaffolds 
crosslinked  with  1.0%  and  1.5%  genipin  is  displayed  in  Figure  7.13  and  7.14, 
respectively.  The  genipin  crosslinked  chitosan/PEO  scaffolds  are  dark  green  in 
colour.  Both  figures  show  that  the  scaffolds,  which  consisted  of  fibrils  of  small 
dameters,  were  not  filled  with  cells  (haematoxylin  stained)  or  newly  formed 
extracellular matrix after 3 weeks. The cells were agglomerated on the surface of the 
scaffolds and unable to penetrate into the voids between fibrils. This is presumably 
due to the small mesh size of the scaffolds compared to the size of the cells. Hence, 
histological staining of proteoglycan (Alcian blue stained) and total collagen (Sirius 
red stained) contents were mainly observed among the cell agglomerates outside the 
scaffold structure (Fig. 7.13A and 7.14A). The amount of extracellular matrix on the 
1.0% genipin crosslinked scaffold (Fig. 7.13A) was higher than the 1.5% genipin 
crosslinked scaffold (Fig. 7.14A).  
 
A considerable amount of the chondrogenic differentiation marker, SOX-9, was also 
detected in the cell agglomerates on both constructs (Fig. 7.13B and 7.14B). The 
expression level of the cartilage specific proteoglycan, the aggrecan, was higher on 
the 1.0% genipin crosslinked scaffold (Fig. 7.13C) compared to on the 1.5% genipin 
crosslinked scaffold (Fig. 7.14C). This complies well with the histological analysis, 
which showed a more intense proteoglycan content on the 1.0% genipin crosslinked 
scaffold.  As  shown  in  Figure  7.13D  and  7.14D,  the  expression  levels  of  type  II 
collagen on both constructs was lower compared to the expression levels of type I 
collagen shown in Figure 7.13E and 7.14E. This indicates a fibrous characteristic of 
the repair tissue. Figure 7.13F and 7.14F show that the presence of type X collagen 
is negligible on both constructs. 139 
 
 
Figure 7.13: Extracellular matrix formation on HACs-seeded chitosan/PEO scaffold crosslinked with 1.0% genipin. (A) Histology of 
proteoglycan matrix is shown in blue and the total collagen matrix in red. Cell nuclei are shown in black. Immunohistochemistry of (B) 
SOX-9,  (C)  aggrecan,  (D)  type  II  collagen,  (E)  type  I  collagen,  (F)  type  X  collagen.  Positive  reaction  was  detected  with  the 
chromogenic AEC substrate and shown in reddish brown colour. Extracellular matrix is absent within the scaffold structure (dark 
green). Scale bars: 50 µm. 
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Figure 7.14: Extracellular matrix formation on HACs-seeded chitosan/PEO scaffold crosslinked with 1.5% genipin. (A) Histology of 
proteoglycan matrix is shown in blue and the total collagen matrix in red. Cell nuclei are shown in black. Immunohistochemistry of (B) 
SOX-9,  (C)  aggrecan,  (D)  type  II  collagen,  (E)  type  I  collagen,  (F)  type  X  collagen.  Positive  reaction  was  detected  with  the 
chromogenic AEC substrate and shown in reddish brown colour. Extracellular matrix is absent within the scaffold structure (dark 
green). Scale bars: 50 µm. 141 
 
7.4  Discussion 
 
7.4.1  Structure of electrospun chitosan/PEO scaffolds 
 
The addition of non-ionogenic and flexible super-long-chain PEO macromolecules 
plays a crucial part in enhancing the chain entanglements to form stable solid fibrils. 
With the increasing amount of PEO, the overall viscosity of the polymer solution 
could be decreased monotonically, leading to a reduction in bead formation on the 
fibrils (Bhattarai et al., 2005). The decrease in the viscosity of chitosan solution due 
to the addition of PEO can be attributed to the changes in intra- and inter-molecular 
interactions  of  chitosan.  Molecular  interactions  between  chitosan  and  PEO  are 
established  by  the  formation  of  hydrogen  bonding  between  the  amino  groups  in 
chitosan  and  the  ether  groups  in  PEO.  This  disrupts  the  self-association  among 
chitosan chains, i.e., strong hydrogen bonding between NH2 and OH groups, which 
always  results  in  a  highly  viscous  chitosan  solution.  The  interaction  between 
chitosan and PEO at the molecular level would favour the formation of a miscible 
polymer  blend  system  and  interchain  entanglement  (Zhang  et  al.,  2008),  thus, 
stretching the polymer fibrils efficiently during electrospinning process to produce 
continuous fibrils. A similar scaffold structure with porosity up to 85% has been 
reported when electrospinning chitosan/PEO blend solution with at least 25 wt% of 
PEO (equivalent to chitosan: PEO = 1:0.33) (Kuo and Hsu, 2009). 
   
Co-solvents, such as DMSO and Trito X-100, were also introduced into the solution 
to improve electrospinning conditions and to increase fibril yield. DMSO relaxes 
chain entanglement of chitosan to enhance structural uniformity in fibrils (Bhattarai 
et al., 2005). Trace amounts of Triton X-100 (0.3%) act as a non-ionic surfactant, so 
that an improved fibrous structure could be obtained at high chitosan-to-PEO ratio, 
which is desirable for tissue engineering applications (Bhattarai et al., 2005). With 
an optimum polymer concentration forming the appropriate viscosity, the solvent 
completely evaporated as the jet travels to the collector, producing continuous and 
almost defect-free fibrils (as shown in Fig. 7.4). In addition, some ultrafine-threaded 
fibrils were formed within the chitosan/PEO fibrils. This is attributed to the high 
charge  density  of  chitosan  solution,  which  causes  the  polymer  jet  to  split  into 142 
 
multiple smaller jets when they travel from the spinneret to the collector, resulting in 
fibrils with different diameters (Deitzel et al., 2001, Subbiah et al., 2005).  
 
 
7.4.2  Structure of crosslinked chitosan/PEO scaffolds  
 
The as-spun chitosan/PEO scaffolds are soluble in aqueous media and this severely 
limits  their  applications  in  tissue  engineering.  To  increase  the  stability  of  the 
scaffolds, genipin was used as the crosslinking agent because it not only exhibits a 
lower  cytotoxicity  compared  to  other  synthetic  crosslinking  agents,  but  can  also 
result in high crosslinking efficiency. During crosslinking reaction, covalent bonding 
is formed between the nitrogen from amino group of chitosan with carbonyl carbon 
of genipin. This prevents dissolution of the materials in physiological conditions. 
 
After crosslinking, some of the fibrils were fused together and form bundles of fibres, 
as  shown  in  Figure  7.5.  As  the  polymer  chains  are  entangled  by  intermolecular 
forces, crosslinkages were observed at the junctions where two or more fibrils met. 
As a result, there is an interconnected network that can restrain chain slippage and 
increase the stiffness and stability of the scaffolds (Franke et al., 2007). A higher 
concentration of genipin solution can usually improve the crosslinking efficiency. 
However, the images from SEM do not provide a quantitatively estimates of the 
degree of crosslinking and the associated changes in mechanical properties.   
 
All  scaffolds  showed  increased  fibril  diameter  after  crosslinking.  When  a  lower 
genipin concentration was used, a higher degree of swelling was observed (Fig. 7.6). 
A similar observation was also reported on genipin-crosslinked PEG (Moffat and 
Marra, 2004). This is  attributed to the higher proportion of water in the  genipin 
solution of lower concentration (Mekhail et al., 2011). As a result of swelling, pore 
size of the scaffolds is reduced. Nevertheless, an increase reaction time does not 
significantly influence the structure of the end product (Bi et al., 2011). 
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7.4.3  Stiffness of crosslinked chitosan/PEO scaffolds 
 
Genipin crosslinker is effective in regulating the mechanical properties of scaffolds 
(Sell  et  al.,  2008).  By  using  a  range  of  genipin  concentrations  to  crosslink 
chitosan/PEO,  scaffolds  of  the  same  chemistry  but  with  a  range  of  crosslinking 
degrees were produced. Due to the formation of more crosslinking sites between the 
fibrils (Hoffmann et al., 2009) and a decrease in water content (Bryant et al., 2004a), 
the stiffness of crosslinked scaffolds increased with the increasing concentration of 
genipin (Fig. 7.8). However, this effect of stiffness enhancement is applicable only 
up to a threshold concentration, beyond which there will be an increase in pore size 
and crosslinking reaction that is limited at the scaffolds surface, associated with a 
reduction  of  stiffness  (Bi  et  al.,  2011).  Furthermore,  it  is  important  to  obtain  a 
balance between maintaining a high water content for cell viability and exhibiting 
adequate  mechanical  integrity  to  restore  function.  Therefore,  the  highest  genipin 
concentration used for crosslinking the chitosan/PEO in this study was 1.5%. 
 
In general, the stiffness of crosslinked chitosan/PEO scaffolds in this study is lower 
compared to the chitosan/PEO scaffolds reported in the literature. In previous studies, 
3D chitosan/PEO (ratio of 1:0.33) porous scaffold crosslinked with 1.0% genipin 
exhibited  a  stiffness  of  ~2000  kPa  (Kuo  and  Ku,  2008,  Kuo  and  Hsu,  2009), 
compared to ~890 kPa in this study. Such variation is not unexpected, since there are 
distinct difference in the structure of both cases, the scaffolds of Kuo and co-workers 
were solution cast films while scaffolds in this study were formed of electrospun 
fibrils.  Nonetheless,  both  scaffolds  crosslinked  with  1.0%  and  1.5%  genipin 
exhibited stiffness that is comparable to the native AC (Fig. 7.8).  
 
 
7.4.4  In vitro degradation of crosslinked chitosan/PEO scaffolds 
 
Although crosslinking with genipin yields interatomic and intermolecular bonding, 
the physical and chemical structure of the crosslinked scaffolds is still susceptible to 
hydrolytic degradation (Hutmacher, 2000). In vivo, chitosan is degradable by the 
protein lysozyme, which is also present in the synovial fluid of cartilage (Greenwald 
et al., 1972, Josephson and Greenwald, 1974, Bennett and Skosey, 1977, Okamoto et 144 
 
al., 1987). Due to the strong intra and intermolecular hydrogen bonds that restrain 
the infiltration and diffusion of lysozymes to the binding site, the degradation rate of 
chitosan  is  slow  compared  to  other  natural  hydrogels.  Indeed  chitosan  with 
deacetylation >85% exhibits a degradation rate of several months in vivo, which is 
considered as suitable for cartilage repair purposes (Tomihata and Ikada, 1997, Suh 
and Matthew, 2000).  
 
Due to the intrinsic resistance of genipin towards enzymatic degradation (Sung et al., 
1998), the degradation rate of genipin crosslinked scaffolds was inversely related to 
the genipin concentration being used (Ferretti et al., 2006, Sell et al., 2008). Under 
the effect of MEM α medium at 37°C, chitosan/PEO crosslinked with 0.5%, 0.8% 
and  1.0%  genipin  demonstrated  a  loss  in  structure  integrity,  e.g.,  swollen  and 
dissolved  fibrils  with  reduced  mesh  size  (Fig.  7.9).  In  comparison,  scaffold 
crosslinked with 1.5% genipin retained its structure integrity. This complies well 
with  the  stiffness  measurements  of  the  scaffolds,  in  which  the  stiffnesses  of  the 
scaffolds with degraded structures were reduced, while the scaffold with unchanged 
structure was measured with negligible stiffness loss. Scaffolds with higher degree 
of crosslink are apparently more stable. The crosslinking of chitosan/PEO might be 
incomplete when a lower genipin concentration was used, which causing the non-
crosslinked  chains  dissolved  rapidly  into  the  aqueous  environment  (Moffat  and 
Marra, 2004). In addition, crosslinking reaction is in effect similar to the side chain 
substitution  with  a  crosslinking  molecule.  The  introduction  of  more  crosslinker 
molecules into the polymer backbone will hinder the attack of water molecules, and 
hence, slows down the degradation rate. 
 
 
7.4.5  Biocompatibility of crosslinked chitosan/PEO scaffolds 
 
A  porous  structure  with  interconnecting  pores  is  essential  in  designing  tissue 
engineering scaffolds to provide necessary space for cell adhesion and matrix growth. 
Although  the  electrospinning  of  chitosan/PEO  produced  scaffolds  that  exhibit  a 
porous network, the high density of the nanometre-sized electrospun fibrils resulted 
in  a  small  mesh  size.  The  relatively  smaller  mesh  size  compared  to  the  HACs 
inhibits the cells from penetrating into the voids between the fibrils, and deposition 145 
 
of new extracellular matrix within the scaffolds. Subsurface migration of cells is also 
limited  by  the  overly  crosslinked  fibrils  that  had  become  brittle,  which  greatly 
reduces bioactivity on the scaffolds (Sell et al., 2008). This can be seen from the 
fluorescence images of the HACs-seeded chitosan/PEO scaffolds, where the DAPI 
fluorescent cell nuclei were absent in the green fluorescent scaffold structure (Fig. 
7.12). Furthermore, the ultrahigh molecular weight PEO is generally regarded as a 
hydrophilic  polymer  with  minimum  interfacial  free  energy  with  water.  As  the 
interfacial  free  energy  decreases,  the  driving  force  for  protein  adsorption  also 
decreases, which delays cell attachment and proliferation (Subramanian et al., 2005). 
Therefore, extracellular matrix formation is only observed among HACs that were 
located on the scaffold surface.  
 
An increase crosslinking density also decreases cell proliferation and proteoglycan 
synthesis (Ferretti et al., 2006, Bryant et al., 2004b). As shown in Figure 7.13A and 
7.14A, extracellular matrix formation on the 1.0% genipin crosslinked scaffold was 
higher  than  the  1.5%  genipin  crosslinked  scaffold.  This  phenomenon  may  be 
attributed to the differences in the scaffolds’ mesh size. A smaller mesh size of the 
higher crosslinked scaffold results in a slower diffusion of physiological nutrients 
that can promote cell proliferation (Mikos et al., 1993). It can also physically hinder 
cell expansion, which prevents the cells from entering into their proliferating phase. 
Previous research also reported that chondrocytes within PEG hydrogels of higher 
crosslinking density exhibit decreased cell proliferation, which was associated with a 
lower total DNA content (Bryant et al., 2004b). In the higher crosslinked and stiffer 
gels, the chondrocytes were less metabolically active and sterically impeded from 
increasing in cell diameter (Bryant et al., 2004a). In addition, the non-degradable 
behaviour of the 1.5% genipin crosslinked scaffold also obstructs the ingrowth of 
extracellular matrix.  
 
Although histologic assessment of the constructs shows a formation of extracellular 
matrix,  the  newly  formed  tissue  was  fibrous-like  with  higher  content  of  type  I 
collagen  than  type  II  collagen,  which  indicates  an  inadequate  support  of  these 
scaffolds on chondrogenesis. In particular, with an increase of genipin concentration, 
i.e., 1.5% vs. 1.0%, the tissue formation is more fibrous-like, suggesting that a higher 
crosslinking density exert an effect on the de-differentiation of chondrocytes.   146 
 
7.5  Summary 
 
Electrospinning  of  chitosan/PEO  produced  nanometre-sized  fibrils  that  were 
randomly oriented and allow to closely mimicking the collagen fibril meshwork in 
native  AC.  As  both  chitosan  and  PEO  are  soluble  in  water,  genepin  with 
concentrations range from 0.5% to 1.5% was used to crosslink the scaffolds, which 
resulted in a slight increase in the fibril sizes. With an increasing concentration of 
genepin, there was less swelling effect on the fibril size, and the stiffness of scaffolds 
increased.  Degradation  of  structure  and  stiffness  was  observed  when  the 
concentration of genipin crosslinker was lower than 1.0%, whereas scaffold that was 
crosslinked  with  1.5%  genipin  was  non-degradable,  even  after  7  months  of 
degradation.  Due  to  the  high  fibril  density  of  the  nanometre-sized  fibrils,  the 
scaffolds exhibited mesh sizes that are relatively smaller than the HACs and hinder 
cell migration into the scaffolds. In addition, although the 1.5% genipin crosslinked 
scaffold exhibited the highest stiffness that was similar to the stiffness of deep zone 
human AC, the non-degradable nature of the scaffolds and the overly crosslinked 
fibrils did not promote chondrogenesis within the scaffold structure.  
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CHAPTER 8 
 
FABRICATION OF THREE-DIMENSIONAL NANOFIBROUS 
SCAFFOLDS 
 
 
8.1  Introduction 
 
Both the P(3HB)/P(3HO) and chitosan/PEO scaffolds produced in the present study 
exhibited a maximum thickness of  around 0.3  mm. To obtain scaffolds with the 
desired  thickness  of  human  AC,  which  is  approximately  1.5-3.5  mm,  the 
electrospinning  process  needs  to  be  refined.  This  cannot  be  achieved  by  simply 
increasing the electrospinning time to accumulate the fibrils layer by layer, as simply 
extending the electrospinning process will build up meshes with high fibril density, 
and  greater  number  of  fibril-to-fibril  contacts  per  unit  length,  which  reduces  the 
mean pore size of the mesh (Eichhorn and Sampson, 2005). The pore size of fibril 
meshes generated from electrospinning is usually less than 10 µm whereas human 
cells are typically greater than 10 µm in size (Stevens and George, 2005, Lee et al., 
2008). Scaffolds fabricated with too small pore sizes obstruct cell penetration and 
hence tissue formation. Therefore, electrospinning needs to be optimised to produce 
a  low  density  of  nanometre-sized  fibrils  in  a  3D  structure,  which  allows  cell 
population for the engineering of cartilage.  
 
A recent research published by Coburn et al. (2012) presented the construction of 3D 
fibrous scaffolds with fibril dimensions at the nanometre scale, while maintaining 
low  density  of  fibrils  with  sufficient  large  pores  that  facilitated  cell  infiltration. 
According  to  their  method,  electrospinning  into  an  aqueous  solution  (wet 
electrospinning), eliminates fibril compaction and fusion that occur in the standard 
electrospinning when fibrils are collected on a solid substrate (dry electrospinning). 
Following  their  approach,  P(3HB)/P(3HO)  and  chitosan/PEO  fibrils  were 
electrospun into an ethanol bath, as illustrated in Figure 8.1. 
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8.2  Materials and methods 
 
Figure 8.1 illustrates the set-up for wet electrospinning. The flow rate of polymer 
solution was controlled by a syringe pump and the solution was passed through a 
PTFE tube and ejected through a spinneret placed vertically to the collector. The 
aluminium  plate  collector  employed  in  the  dry  electrospinning  (Figure  2.1)  was 
replaced  with  an  ethanol  bath  for  wet  electrospinning.  The  ethanol  bath  was 
grounded using a piece of aluminium foil that was immersed in the ethanol bath. 
Electrospinning  of  P(3HB)/P(3HO)  scaffolds  was  done  using  the  procedures  as 
outlined in Section 3.2.1, whereas the electrospinning of chitosan/PEO was done 
using the procedures as outlined in Section 7.2.1.1.  
 
 
Figure 8.1: Schematic of wet electrospinning. The polymer solution is placed in a 
syringe and ejected through a spinneret. A high voltage power is connected between 
the spinneret and a piece of aluminium foil immersed in a vessel containing ethanol. 
Fibrils are electrospun from the spinneret and deposited in the ethanol bath [adapted 
from Bhardwaj and Kundu (2010)]. 
 
 
8.3  Results 
 
When an ethanol bath was placed between the spinneret and the grounded electrode 
(piece of aluminium foil), the polymer jet solidified rapidly in the ethanol before 
reaching the grounded electrode. As shown in Figure 8.2A, wet electrospinning of 
P(3HB)/P(3HO) 1:0.25 formed an entangled fibrous meshwork with 3D structure. 149 
 
Figure 8.2B shows that the randomly oriented fibrils exhibited a very rough surface 
morphology, which were associated with pores and protrusions. The average fibril 
diameter was 1556 ± 439 nm, about 463% larger than the dry electrospun fibrils 
shown in Figure 3.6B, which had an average diameter of 336 ± 98 nm.  
 
    
Figure 8.2: P(3HB)/P(3HO) 1:0.25 scaffold obtained by wet electrospinning method. 
(A) The scaffold was collected in ethanol solution and exhibited a 3D structure. (B) 
SEM micrograph of the fibrils showing rough surface morphologies and large fibril 
diameters. Scale bar: 4 µm. 
 
Figure  8.3A  shows  the  chitosan/PEO  scaffold  obtained  with  wet  electrospinning 
method. The continuous and randomly oriented fibrils formed a 3D structure with a 
shiny gel-like appearance. As shown in Figure 8.3B, the fibrils exhibited uniform 
geometry  and  smooth  surface  morphology,  similar  to  the  dry-electrospun  fibrils 
shown in Figure 7.4B. The average fibril diameter was 171 ± 23 nm, about 173% 
larger than the dry electrospun fibrils that had an average diameter of 99 ± 23 nm.  
 
    
Figure 8.3: Chitosan/PEO scaffolds obtained by wet electrospinning method. (A) 
The scaffold was collected in ethanol solution and exhibited a 3D structure. (B) SEM 
micrograph of the fibrils showing smooth surface morphology with uniform fibril 
sizes. Scale bar: 500 nm. 150 
 
8.4  Discussion 
 
Wet  electrospinning  was  employed  to  fabricate  3D  nanofibrous  scaffolds  with 
sufficient scaffold thickness, and a sufficient low density fibril meshwork. For wet 
electrospinning, a collection bath made of non-solvent for the polymers is required, 
e.g., ethanol was used as the collection bath because it is a poor solvent for both the 
P(3HB)/P(3HO) and chitosan/PEO polymer blends. Furthermore, the collection bath 
should be able to dissolve the solvent used for producing the polymer solution. For 
example, ethanol is able to dissolve the solvent used for P(3HB)/P(3HO), which is 
the chloroform, and the solvent used for chitosan/PEO, which is the acetic acid. 
Thereby, both the chloroform and acetic acid solvents can be removed in the ethanol 
bath to allow solidification of the fibrils (Zhu et al., 2012).  
 
There are some differences between dry electrospinning and wet electrospinning. 
During  dry  electrospinning,  the  distance  between  the  spinneret  and  the  metal 
collector provides sufficient time for the solvents to evaporate. Therefore, both the 
dry  electrospun  P(3HB)/P(3HO)  and  chitosan/PEO  fibrils  were  able  to  solidify 
before  reaching  the  collector,  thus  forming  a  smooth  and  continuous  fibril 
morphology. In wet electrospinning, the structure of fibrils are largely dependent on 
the solubility of polymer solvent in the ethanol bath, as double diffusion of solvent 
and non-solvent occurs  simultaneously with solidification at the periphery of the 
polymer jet. The solvent diffuses from the polymer jet into the ethanol bath and 
meanwhile non-solvent diffuses from the ethanol bath to the polymer jet (Liu et al., 
2014).  Acetic  acid  (the  solvent  for  chitosan/PEO)  exhibits  a  polarity  similar  to 
ethanol, and hence, acetic acid can dissolve almost immediately into the ethanol bath 
during the wet electrospinning process. While ethanol is a polar solvent, chloroform 
(the solvent for P(3HB)/P(3HO)) is non-polar. The lower solubility of chloroform in 
ethanol causes the fibrils to solidify incompletely when the polymer jet entering the 
ethanol  bath.  As  a  result,  the  P(3HB)/P(3HO)  fibrils  produced  with  wet 
electrospinning method exhibited higher irregularity and surface roughness.  
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8.5  Summary 
 
Wet electrospinning allows to fabricate scaffolds with thickness that are sufficient to 
fill the cartilage defects. However, the resultant fibril structure is highly dependent 
on the types of solvent used for dissolving the polymers and the types of non-solvent 
used  for  collecting  the  fibrils.  By  using  ethanol  as  the  collection  bath,  wet 
electrospinning  of  P(3HB)/P(3HO)  resulted  into  large  fibrils  with  rough  surface 
morphology, whereas the wet electrospinning of chitosan/PEO resulted into fibrils 
with structure similar to the dry electrospun fibrils. Therefore, a right combination of 
polymer  solvent  and  non-solvent  collection  bath  is  the  key  determinant  of  fibril 
structure. To obtain a defined overall shape the scaffolds could be electrospun into a 
mould. 
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CHAPTER 9 
 
CONCLUSIONS AND OUTLOOK 
 
 
9.1  Conclusions 
 
Some  species  develop  elaborate  mechanisms  to  repair  damaged  body  parts.  The 
salamander  is  the  classical  example  that  can  even  regrow  an  entire  limb. 
Unfortunately,  the  human  body  lacks  such  ability  and  to  heal  an  even  relatively 
small cartilage defects, human body needs structural support to facilitate the body’s 
natural healing capacity. Numerous biomaterials have been developed to fulfil this 
requirement but they resulted in unsatisfactory long-term outcomes. This may be due 
to  a  lack  of  understanding  on  the  influence  of  structure  and  mechanical 
microenvironment in directing the development of cartilage. Therefore, this research 
was based on the hypothesis that any successful strategy to support the regeneration 
of  cartilage  in  the  body  requires  scaffolds  that  closely  match  the  collagen  fibril 
meshwork in native AC, structurally and mechanically, to provide an appropriate 
microenvironment for chondrogenesis. The scaffolds should also be degradable to 
allow ingrowth of new cartilage and can be resorbed by the body.  
 
To  address  the  first  objective,  that  is  to  produce  an  ultrastructure  similar  to  the 
collagen  fibril  meshwork,  electrospinning  was  employed.  In  comparison  to  the 
collagen  fibrils  with  diameters  between  10-300  nm,  P(3HB)/P(3HO)  was 
successfully electrospun into fibrils with diameter as small as 336 ± 98 nm, whereas 
chitosan/PEO was electrospun into fibrils with diameter as small as 99 ± 23 nm. 
Porous  scaffolds  with  interconnecting  pores  have  been  produced.  Among  the  4 
different  blend  compositions  of  P(3HB)/P(3HO)  scaffolds,  the  ratio  of  1:0.25 
produced fibrils with the smallest diameter of 336 ± 98 nm, which were shown to 
allow cell attachment and cell penetration in between the fibrils, as well as support 
chondrogenesis.  The  structure  of  scaffolds  determines  the  microenvironment  and 
directs the formation of cartilage. This has been shown by the response of HACs 
towards the fibril morphology, with the SOX-9 expressed cells mostly found around 154 
 
the  fine  and  straight  fibrils,  but  absent  around  the  fibrils  with  bead  formation. 
However, one of the main drawbacks of electrospinning is that with a smaller fibril 
size, fibril density increases and a greater number of fibril-to-fibril contacts per unit 
length are generated. This reduces the mean pore size of the mesh and obstructs the 
subsurface cell migration, as in the case of chitosan/PEO scaffolds. Due to overly 
crosslinking  effect  by  the  1.0%  and  1.5%  genipin,  the  chitosan/PEO  fibrils  had 
become brittle and, thus, did not allow the cells to contract the fibrils and migrate 
into  the  scaffolds.  In  view  of  the  reduced  flexibility  of  fibrils  due  to  chemical 
crosslinking  effect,  P(3HB)/P(3HO)  scaffolds  that  do  not  require  chemical 
crosslinking  and  still  exhibit  stable  conformation  are  more  favourable  for  tissue 
engineering applications.  
 
To  address  the  second  objective,  that  is  to  produce  scaffolds  with  mechanical 
properties  similar  to  the  native  AC,  the  stiffness  of  each  produced  scaffold  was 
measured  with  IT-AFM  and  compared  with  the  native  AC.  The  mechanical 
microenvironment triggers the mechano-receptors of cells, which ultimately alters 
protein  expressions.  The  P(3HB)/P(3HO)  1:0.25  scaffold  exhibited  the  highest 
stiffness properties, 868 ± 540 kPa, which is similar to the stiffness of human AC 
(600 ± 150 kPa at superficial zone and 1854 ± 483 at deep zone). The HACs seeded 
on this scaffold better maintained their chondrogenic phenotype, in comparison to 
other scaffolds that exhibited larger fibril size and lower stiffness properties. Large 
amounts of cells were immunolocalised with SOX-9, the cell differentiation marker 
that  promotes  the  formation  of  hyaline-like  cartilage,  as  evidenced  by  the  high 
expression level of type II collagen and negligible expression level of type I collagen. 
Furthermore,  this  scaffold  was  the  only  one  that  was  immunolocalised  with 
significant amount of aggrecan. In comparison, HACs that were seeded on scaffolds 
with higher P(3HO) composition and lower stiffness properties displayed a different 
behaviour.  They  secreted  more  type  I  collagen  than  type  II,  and  without  the 
production of aggrecan. This shows that a mechanical microenvironment that closely 
matches  the  native  cartilage  promotes  gene  expression  of  the  chondrocytes  to 
produce hyaline-like cartilage.   
 
Finally, the third objective was addressed, that is to produce degradable scaffolds, 
and  examine  the  effects  of  hydrolytic  degradation  on  the  scaffolds’  structure, 155 
 
stiffness and molecular weight. The high molecular weight polymeric scaffolds serve 
their  purpose  to  support  the  structure  and  mechanical  integrity  during  the  initial 
period, and then they degraded into lower molecular weight polymers. After three 
weeks, the degradation of P(3HB)/P(3HO) scaffolds was sufficient to generate space 
for  the  diffusion  of  the  large  proteoglycan  and  collagen  molecules  to  the 
extracellular regions. Although the water contact angle of P(3HB)/P(3HO) 1:0.25 
scaffold was higher than the other three scaffolds, this scaffold exhibited the highest 
degradation  rate,  as  indicated  by  its  highest  molecular  weight  loss.  The  residual 
stiffness of this scaffold at the time of implantation still matched the stiffness of 
native AC, which is important for supporting the defect site. In view of the extent of 
degradation during a 4 months’ period, the degradation of P(3HB)/P(3HO) may last 
between one to several years until the polymer scaffolds are completely resorbed by 
the body. The gradual degradation of P(3HB)/P(3HO) through surface degradation 
mechanism is beneficial for the ingrowth and development of new cartilage. 
 
The electrospun P(3HB)/P(3HO) blends demonstrated some first promising results 
towards the production of functional cartilage: they exhibit structure and mechanical 
microenvironment to direct chondrogenesis, and they can be degraded gradually in 
the body. By manipulating the compositions of the blends, these polymers exhibit a 
wide range of mechanical and degradation properties, which can be tailored into 
various tissue specific fine structures to suit various biomedical applications. For 
instance, higher P(3HB) composition can be used for application on stiffer tissues, 
such as the bone, whereas higher composition of P(3HO) can be applied if a more 
flexible property is required, such as for the cardiovascular stents and heart valves. 
The ease of processing and a wide range of available mechanical properties allow 
these polymer blends to provide a microenvironment that is similar to the native 
extracellular matrix of a tissue to be repaired. 
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9.2  Outlook 
 
1.   Wet electrospinning 
There is a need to produce fibrils with smaller sizes to better mimic the collagen 
fibrils  in  native  AC.  This  requires  further  improvement  and  fine-tuning  on  the 
current  electrospinning  set-up.  Wet  electrospinning  could  produce  fibrils  with 
nanometre size and meanwhile provide sufficient pore volume for cell migration. 
The wet electrospinning of P(3HB)/P(3HO) as described in Chapter 8 resulted in 
fibrils with large diameters and rough morphologies. To improve the fibril structure, 
a  collection  bath  (non-solvent)  that  exhibits  a  polarity  similar  to  the  solvent  of 
P(3HB)/P(3HO), i.e., chloroform, is needed. Since solvents with similar polarity are 
more readily miscible, this can allow chloroform to dissolve into the collection bath 
efficiently, leaving the fibrils to solidify more completely. Furthermore, to mimic the 
structure and stiffness gradient of native AC, a more sophisticated electrospinning 
set-up is required, e.g., continuous electrospinning of polymer solutions of different 
concentrations using spinnerets of different sizes. 
 
2.   Biodegradation of scaffolds in the presence of cells 
The  current  study  investigated  the  hydrolytic  degradation  behaviour  of 
P(3HB)/P(3HO) scaffolds without taking into account the effect from the bioactivity 
of cells and tissues. This was done to clarify the extent of molecular weight loss on 
P(3HB)/P(3HO)  scaffolds  using  gel  permeation  chromatography.  To  further 
investigate  the  degradation  rate  of  P(3HB)/P(3HO)  scaffolds  in  the  body,  future 
work  should  study  the  degradation  tests  in  the  presence  of  cells  and  tissues.  To 
investigate  the  in  vivo  bioresorption  pathways,  radioactivity  labelling  can  be 
employed  to  follow  the  elimination  of  a  substance  by  metabolism,  secretion  or 
excretion.    
 
3.   Surface functionalisation 
P(3HB)/P(3HO) scaffolds are hydrophobic. To render the fibrils with hydrophilic 
surfaces  that  are  favoured  in  biology,  the  surfaces  could  be  functionalised  to 
transform the fibrils into biomimetic or even bioactive scaffolds. To improve cell 
attachment  and  bioactivity,  fibrils  can  be  coated  by  layers  of  proteins  or  self-
assembling  peptides.  There  are  different  approaches  for  the  functionalization  of 157 
 
scaffolds,  e.g.,  plasma  processing  to  conjugate  various  functional  groups  to  the 
surface of inert materials like polymers. Surface functionalization can also fine-tune 
the degradation rate of scaffolds. In addition, by incorporating different functional 
groups onto the fibril surface, the degradation of scaffolds can be accelerated or 
delayed to suit the special requirements.   
 
4.   Optimisation of chondrogenic induction medium 
High amounts of type X collagen were detected in the newly formed extracellular 
matrix.  In  addition  to  the  effects  of  microenvironment  from  the  scaffolds,  the 
chondrogenic induction medium used in the present study might have accelerated the 
transition of chondrocytes into the terminal phase of hypertrophic differentiation. 
This is an undesired condition for the engineering of cartilage. Further studies should 
optimise  the  concentration  of  growth  factors  and  nutrients  in  the  chondrogenic 
medium to delay the onset of hypertrophy, while sustaining the expression levels of 
SOX-9 to promote the formation of functional cartilage. 
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Appendix A  
 
 
 
Figure A: Correlation table for the infrared absorption bands of polymers (Sandler et 
al., 1998).  
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Appendix B 
 
 
Comparison of Indentation Test at Different Scales 
 
B.1  Introduction 
 
The stiffness of AC measured with IT-AFM in this study was twofold lower than the 
stiffness reported in a previous study by Stolz et al. (2009). According to the study, 
the stiffness of bovine and human cartilage was 1.3 MPa, when measured with IT-
AFM at the micrometre scale. Although traditionally the stiffness measurements on 
cartilage span in a wide range from 0.5 to 1.3 MPa, further validation on the results 
of IT-AFM measurement was performed by instrumented indentation testing (IIT). 
The scale of measurement was defined by the size of indenter. Measurement at the 
millimetre scale was performed with IIT, by employing a spherical indenter with 
diameter of millimetre size. This measurement was used to validate the micrometre 
and  nanometre  scale  measurements  obtained  from  IT-AFM,  which  employed  a 
micrometre  sized  spherical  indenter  and  a  nanometre  sized  pyramidal  indenter, 
respectively.  
 
 
B.2  Materials and methods 
 
Agarose gels with various concentrations were prepared by dissolving 0.75%, 1.0%, 
2.0% and 3.0% (w/w) agarose (AGAR Noble; DIFCO Laboratories, Detroit, MI) in 
deionised water. To prepare the agarose gel sample for IIT, the melted agarose was 
poured into cylindrical wells (25 mm diameter × 20 mm height). For the IT-AFM 
sample preparation, plastic rings for reinforce paper-punch holes (inner ring diameter 
~5 mm; outer ring diameter ~12 mm; thickness ~0.08 mm), were adhered onto a 
glass slide. An aliquot of melted agarose was then pipetted at the centre of the plastic 
ring  and  allowed  to  spread  and  solidify.  To  prevent  dehydration,  the  solidified 
agarose gels were covered with deionised water throughout the indentation tests.   
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Indentation tests at the millimetre scale were performed using an ElectroForce 3200 
test instrument equipped with WinTest software (Bose Corporation, Hopkins, MN). 
A stainless steel spherical indenter (radius = 2.5 mm) was used because it minimises 
plastic  deformation  and  stress  concentrations  while  avoid  damaging  the  sample 
(Ebenstein and Pruitt, 2006). To ensure sample contact, the indenter was lowered 
manually  to  a  preload  of  2  mN.  By  employing  a  displacement-controlled  ramp 
function, each sample was indented to a total displacement of 0.5 mm at a loading 
rate of 2 × 10
-6 mm/s, to match the tip velocity of IT-AFM indentation testing. At 
least three locations were indented on each sample.   
 
For indentation tests at the micrometre scale, the indenter probe was made of a hard 
borosilicate  glass  sphere  (radius  =  5  µm)  that  was  glued  at  the  end  of  a  tipless 
rectangular cantilever (kc ~0.15 N/m, type All In One-TL). For indentation tests at 
the nanometre scale, the indenter probe was a pyramidal tip (radius ≤ 20 nm) on V-
shaped cantilever with kc ~0.06 N/m (type NPS; Veeco Metrology, Santa Barbara, 
CA).  Indentation  testing  was  performed  as  described  in  Section  4.4.3,  using  a 
maximum deflection of 100 nm, which corresponds to a maximum applied load of 
~15 nN at the micrometre scale and ~6 nN at the nanometre scale. Each individual 
data set consisted of 256 load displacement curves in a 16 × 16 curve grid, covering 
a sample area of 20 × 20 µm, at a minimum of 3 different locations.  
 
The stiffness values were calculated as described in Section 4.4.4. For indentation 
testing  at  the  millimetre  and  micrometre  scales  using  spherical  indenters,  the 
stiffness was calculated by Equation 4.4. For indentation testing at the nanometre 
scale using a pyramidal indenter, the stiffness, E, was calculated by Equation B.1.  
 
    = 
        
  ·                               (Equation B.1) 
where S is the contact stiffness, ν is the Poisson’s ratio of sample, h is the contact 
depth and θ is the half-opening angle of the tip. The contact stiffness was obtained 
by fitting the upper 75% of the unloading curve (Stolz et al., 2004). 
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B.3  Results  
 
B.3.1  Stiffness of agarose gels measured with instrumented indentation testing 
 
Figure  B.1  shows  the  representative  load-displacement  curves  obtained  from  the 
indentation testing by IIT on agarose gels with different concentrations. The applied 
load on the sample and the displacement of indenter is displayed as the y- and x-axis, 
respectively. By fitting linear regression on the upper 25% of the unloading part of 
the curves, the stiffness of each gel was calculated and displayed in Figure B.2. The 
spherical indenter with radius of 2.5 mm was capable of detecting even the small 
stiffness differences between 0.75% and 1.0% agarose gels. The stiffness of agarose 
gels increased non-linearly with increasing gel concentrations. 
 
 
Figure B.1: Load-displacement curves obtained from IIT measurements on agarose 
gels with concentrations of 0.75%, 1.0%, 2.0% and 3.0%. Measurements were done 
by ElectroForce 3200 employing spherical indenter with radius of 2.5 mm.  
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Figure B.2: Stiffness values of agarose gels with concentrations of 0.75%, 1.0%, 2.0% 
and 3.0% obtained with IIT measurements. 
 
 
B.3.2  Stiffness  of  agarose  gels  measured  with  indentation-type  atomic  force 
microscopy 
 
Figure B.3 shows the representative unloading part of the load-displacement curves 
obtained by IT-AFM at the micrometre scale. Stiffness values were calculated from 
the  upper  25%  of  the  unloading  part  of  the  load-displacement  curves  and  the 
stiffness  distributions  are  displayed  in  Figure  B.4.  The  overall  micrometre  scale 
measurements  show  a  non-linear  increase  in  stiffness  with  the  increasing  gel 
concentrations. When compared to the stiffness at millimetre scale, the stiffness of 
0.75% and 1.0% gels at micrometre scale were 23% and 22% lower, respectively. 
Meanwhile, stiffness of the 2.0% gel at micrometre scale was in good agreement 
with  its  stiffness  at  millimetre  scale,  only  9.0%  higher.  However,  there  was  a 
substantial difference between the stiffness of 3.0% gel at both scales; the stiffness at 
micrometre scale was 37.8% higher than that at the millimetre scale.  
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Figure B.3: The unloading part of the load-displacement curves measured on 0.75%, 
1.0%, 2.0% and 3.0% agarose gels, tested with IT-AFM by employing cantilever 
with kc ~0.15 N/m and a spherical indenter with radius of 5 μm. A reference slope 
obtaining on a hard surface is also depicted. 
 
 165 
 
 
Figure B.4: Distribution of stiffness data at the micrometre scale for agarose gels of 
different concentrations, measured with IT-AFM using spherical indenter (radius = 5 
µm).  Normal distribution of the data is indicated with blue curve. Bin size: 2 kPa. 
 
Figure B.5 shows the representative unloading part of the load-displacement curves 
obtained by IT-AFM at the nanometre scale. Stiffness values were calculated from 
the upper 75% of the unloading part of the curves and the stiffness distributions are 
displayed in Figure B.6. The nanometre scale stiffness of 0.75% gel was 19% higher, 
while  the  1.0%  gel  was  18%  higher,  compared  to  the  millimetre  scale  stiffness. 
However, there were substantial differences on the stiffness of 2.0% and 3.0% gels. 
The stiffness of 2.0% and 3.0% gels at the nanometre scale was 35% and 45% lower, 
respectively, compared to measurements at the millimetre scale.  166 
 
 
Figure B.5: The unloading part of the load-displacement curves measured on 0.75%, 
1.0%, 2.0% and 3.0% agarose gels, tested with IT-AFM by employing cantilever 
with  kc  ~0.06  N/m  and  a  sharp  pyramidal  tip as  the  indenter.  A  reference  slope 
obtaining on a hard surface is also depicted. 167 
 
 
Figure B.6: Distribution of stiffness data at the nanometre scale for agarose gels of 
different  concentrations,  measured  with  IT-AFM  using  sharp  pyramidal  indenter 
(radius ≤ 20 nm). Normal distribution of the data is indicated with blue curve.  Bin 
size: 2 kPa. 
 
Table B.7 tabulates the stiffness values obtained at the three different length scales. 
For the 0.75% and 1.0% gels, stiffness values obtained from the micrometre scale 
measurement  were  lower,  whereas  the  values  obtained  from  the  nanometre  scale 
measurement were higher, in comparison to the millimetre scale values. In addition, 
the  stiffness  values  measured  at  the  nanometre  scale  were  closer  to  the  values 
measured at the millimetre scale. For the 2.0% agarose gel, both the micrometre and 
nanometre scale measurements were higher than the millimetre scale measurement, 
with stiffness at the micrometre scale only 9% higher than the millimetre scale. For 168 
 
the  3.0%  agarose  gel,  both  the  micrometre  and  nanometre  scale  measurements 
showed very low stiffness values compared to the millimetre scale.   
 
Table  B.7:  Stiffness  of  agarose  gels  with  different  concentrations  as  a  result  of 
indentation tests at different length scales. 
Agarose 
concentration (%) 
Stiffness (kPa) 
Millimetre scale  Micrometre scale  Nanometre scale 
0.75  21.8 ± 1.6  16.8 ± 0.7  25.9 ± 4.6 
1.0  22.4 ± 3.0  17.5 ± 1.2  26.5 ± 5.3 
2.0  90.8 ± 5.9  99.0 ± 5.1  122.6 ± 22.1 
3.0  328.1 ± 12.8  204.1 ± 14.7  182.0 ± 43.3 
 
 
B.4  Discussion 
 
The accuracy of the stiffness measurements obtained from IT-AFM at smaller length 
scales  was  compared  with  those  from  the  macroscale.  Agarose  gels  exhibit  an 
amorphous and mechanically isotropic structure not only at the micrometre scale but 
also at the nanometre scale (Stolz et al., 2004). Thereby, the stiffness of agarose gel 
should be similar when measured at different length scales. However, the stiffness 
results demonstrated variations at different measurement scales. These variations can 
be explained by the suitability of the cantilever spring constant with respect to the 
sample stiffness, and errors in measuring the cantilever spring constant and sphere 
radius.  
 
The flexibility of a cantilever is dependent on its spring constant. The cantilever used 
for nanometre scale testing had a kc of approximately 0.06 N/m.  It deflects to a 
greater extent compared to the cantilever that was used for micrometre scale testing 
and had a kc of 0.15 N/m. For the soft 0.75% and 1.0% gels, it resulted in stiffness 
values that were 18-19% higher than the value measured by IIT. Meanwhile, the kc 
of 0.15 N/m was relatively stiff for the gels and deflected less with response to the 
sample  stiffness,  hence,  resulted  in  values  that  were  22-23%  lower  than  that 
measured by IIT. For the 2.0% gel, a kc of 0.15 N/m was more appropriate, as it 
resulted in stiffness value that was only 9% different from the value measured by IIT, 169 
 
whereas the kc of 0.06 N/m resulted in a value that was 35% higher than the value 
measured  by  IIT.  Taken  together,  stiffness  measurement  by  IT-AFM  is  most 
sensitive  when  the  kc,  and  the  contact  stiffness,  S,  of  sample,  are  of  a  similar 
magnitude (Loparic et al., 2010). When the kc is too soft compared to the sample 
stiffness, the cantilever deflects at a great extent and results in a stiffness value that 
does not reflect the real properties of the sample, e.g., the stiffness of a 3.0% gel is 
beyond the measurement range of both cantilevers with kc of 0.06 N/m and 0.15 N/m, 
hence,  resulted  in  stiffness  values  that  were  completely  different  with  the  IIT 
measurement.  
 
The stiffness differences are also explained by the errors in measuring the kc and 
radius for stiffness calculations, when the kc and S are considered as of a similar 
magnitude, as in the case of nanometre scale measurements on 0.75% and 1.0% gels, 
and  micrometre  scale  measurement  on  2.0%  gel,  which  had  less  than  20% 
differences  compared  to  the  IIT  measurement.  According  to  the  supplier,  the  kc 
might have up to 10-15% of uncertainty, even for cantilevers from the same wafer, 
and the sphere size measurements might have variations of up to 14%. Therefore, 
variations in the stiffness values of 0.75% and 1.0% gels at the nanometre scale, as 
well as 2.0% gels at the micrometre scale, in comparison to the IIT measurements, 
were indistinguishable within the range of errors. 
 
The  stiffness  of  agarose  gels  is  different  with  those  previously  reported  in  the 
literature  and  even  a  review  on  the  literature  reports  also  results  in  substantial 
discrepancies (de Freitas et al., 2006). A wide range of stiffness has been reported 
for  agarose  gels  of  a  given  composition.  For  example,  reported  values  for  2.0% 
agarose  gels  range  from  1.5,  14,  34,  50  to  240  kPa,  in  comparison  to  ~91  kPa 
measured  in  this  study.  Analogous  to  the  variations  in  the  stiffness  of  cartilage 
discussed in Section 4.6.1, these stiffness variations may be explained by systematic 
errors, which were difficult to distinguish and the data is consistently off in the same 
direction.  
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B.5  Summary 
 
The stiffness of agarose gels at the nanometre, micrometre and macro scales was 
measured and verified using conventional IIT. The stiffness values obtained from IT-
AFM  are  most  accurate  when  cantilevers  with  a  spring  constant  at  the  similar 
magnitude with the sample stiffness are employed.  
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Appendix C 
 
 
Three different cell densities: 3 × 10
5 cells/ml, 5 × 10
5 cells/ml and 1 × 10
6 cells/ml, 
were  used  to  determine  the  most  suitable  cell  density  for  seeding  the  scaffolds. 
P(3HB)/P(3HO)  scaffolds  at  two  different  compositions  were  used:  1:0.25  and 
1:0.67.  Preliminary  assessment  was  carried  out  after  one  week  culturing. 
Histological  staining  for  proteoglycan  and  total  collagen  contents  synthesis  from 
different cell densities are shown in Figure C. HACs were observed to penetrate into 
the voids between fibrils. The proteoglycan and total collagen contents produced by 
cell density of 3 × 10
5 cells/ml were the lowest compared to two other higher cell 
densities.  The  proteoglycan  and  total  collagen  contents  produced  by  HACs  at 
densities of 5 × 10
5 cells/ml and 1 × 10
6 cells/ml were similar. This indicates that 
low HACs density is insufficient to secrete enough matrixes throughout the scaffolds. 
The preliminary results showed that cell density of at least 5 × 10
5 cells/ml should be 
used for seeding the nanofibrous scaffolds. 
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Cell density (cells/ml)  P(3HB)/P(3HO) = 1:0.25  P(3HB)/P(3HO) = 1:0.67 
3 × 10
5 
   
5 × 10
5 
   
1 × 10
6 
   
Figure C: Histology of P(3HB)/P(3HO) scaffolds after being seeded with three different densities of HACs for one week. Histology of 
proteoglycan matrix is shown in blue and the total collagen matrix in red. Cell nuclei are shown in black. Scale bars: 40 μm.  173 
 
Appendix D 
 
 
Variation  in  the  process  parameters  during  electrospinning  strongly  affects  the 
uniformity and structure of nanofibrils. Two major structures usually found in the 
electrospun fibrils are a uniform, continuous fibrous structure or a bead-containing 
fibrous  structure.  When  insufficient  amount  of  PEO  was  blended  with  chitosan 
(chitosan/PEO = 1:0.25), unwanted defects such as large splash of solutions and 
beads on string morphology were obtained. 
 
    
Figure  D:  SEM  micrographs  of  electrospun  chitosan/PEO  1:0.25  scaffolds  that 
contain insufficient amount of PEO. Bead defects are seen on the fibrils. Scale bars: 
(A) 2 µm, (B) 500 nm. 
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